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 i 
Abstract 
The phosphoinositide 3-kinase (PI3K) signalling pathway is activated in macrophages in 
response to many bacterial pathogens, triggering phagocytic uptake mechanisms and 
phosphorylation-associated activation of the serine/threonine kinase AKT. Enteropathogenic 
E. coli (EPEC) inhibits both PI3K mediated phagocytosis and AKT phosphorylation; dependent 
on a type 3-secretion system (T3SS) critical for delivering up to 24 known effector proteins 
into target cells. The efficient translocation of most EPEC effectors is dependent on the T3SS 
effector chaperone CesT. Although the effectors and mechanisms for inhibiting phagocytosis 
are well described, little is known how EPEC inhibits AKT phosphorylation. AKT activation is a 
multi-step process involving its recruitment to the cell membrane and phosphorylation of 
Thr308 by PDK1 and Ser473 by mTORC2. This activation process is supressed by inositol 
(such as PTEN) and protein (such as PP1 & PP2A) phosphatases. Altered AKT signalling is 
associated with many cancers, diabetes, cardiovascular and infectious disease, thus 
identifying how EPEC inhibits AKT activity could provide insight into its complex regulatory 
process and/or new therapeutic strategies. 
Screening of bacterial strains, lacking or expressing subsets of EPEC effectors, by western 
blot analysis suggests that the inhibitory mechanism depends on the CesT chaperone but not 
the function of the 21 most studied effectors. The EPEC inhibitory mechanism was 
investigated through the development of a two-wave infection model, examining for T3SS 
dependent changes in AKT phosphorylation (Thr308 & Ser473), membrane localisation and 
activity of AKT associated signalling proteins (PDK1 & PTEN). This strategy revealed inhibition 
of AKT phosphorylation to be stable (up to 3 h) and linked to increased activity of 
serine/threonine protein phosphatase(s). This finding was supported by phosphatase 
inhibitor studies, suggesting the involvement of a host activated or bacterial delivered 
protein phosphatase. Thus, this study provides new insights into the requirement of the 
EPEC effector repertoire and suggests a novel mechanism by which EPEC inhibits AKT 
signalling. 
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1.1 General introduction 
Pathogenic bacteria manipulate many key host cellular processes to promote bacterial 
colonisation and the establishment of a replicative niche (Grishin et al., 2015). The virulence 
of invading bacteria is often dependent on the secretion of bacterial proteins known as 
effectors. These effector proteins are typically delivered into host cells via a specialised 
secretion system. Once in the host cell, these effectors function to modify the cellular 
environment through a variety of mechanisms, including the modification of eukaryotic 
signal transduction pathways (Cui and Shao, 2011). Indeed, one of the most significant 
mechanisms is the manipulation of cell signalling through modifications of the host 
phosphoproteome (Rogers et al., 2011; Grishin et al., 2015; Scholz et al., 2015). How 
bacterial effectors function to subvert eukaryotic signalling cascades is the subject of 
continuing investigation. This study will focus its discussion towards the role of the 
enteropathogenic Escherichia coli (EPEC) bacteria and its capacity to subvert host cellular 
processes, including the activity of the eukaryotic protein kinase B, also known as AKT. 
 
1.2 Protein kinases and cellular function 
Protein kinases are important regulators of cellular function, forming one of the largest and 
most important of gene families in eukaryotes (Manning et al., 2002). These kinase proteins 
play a crucial role in regulating signal transduction pathways through the modification of 
proteins by the addition of phosphate groups to Serine (Ser), Threonine (Thr) or Tyrosine 
(Tyr) residues. The phosphorylation of proteins typically serves to induce a functional change 
in the target protein, including a change in activity (activation/inhibition), the location and 
overall function (Bononi et al., 2011). As such, protein kinases act to coordinate the activity 
of almost all cellular processes including metabolism, transcription, cell cycle progression, 
cytoskeletal rearrangement and apoptosis (Manning et al., 2002); including those of the 
phosphoinositide-3-kinase (PI3K)/AKT signalling pathway (Fayard et al., 2005). The activity of 
protein kinases are themselves controlled through a highly regulated process, including: 
gene transcription, inhibitory/activating proteins, protein degradation, protein 
phosphorylation and cellular localisation (Endicott et al., 2012). It is therefore unsurprising 
that the dysregulation of protein kinases are implicated in many human diseases.  
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The human genome encodes approximately 518 putative protein kinases, encompassing 
approximately 1.7% of all human genes (Manning et al., 2002). Although relatively few in 
number, the activity of kinases is vast with approximately 30% of all cellular proteins 
estimated to be modified by protein kinase activity (Manning et al., 2002). Crosstalk 
between signalling pathways adds an extra level of complexity in cell regulation, playing an 
important role in fine-tuning the cell response, which is often dependent on the context of 
cell activation (Bononi et al., 2011). This is particularly apparent for mitogen activated 
protein kinase (MAPK) and PI3K signalling pathways, noted for their numerous 
interconnections (Bononi et al., 2011). 
Despite significant progress in characterising kinase regulatory cascades, understanding the 
discrete nature of the many signalling pathways communicating together cannot always be 
predicted by studying individual pathways alone (Krachler et al., 2011). To further 
understand these complex kinase signalling networks it is becoming increasingly popular to 
examine the mechanisms by which pathogens have evolved to subvert them, such as the 
Salmonella enterica, Shigella flexneri and EPEC (Krachler et al., 2011). 
 
1.3 The PI3K/AKT signalling pathway 
1.3.1 PI3K and phosphoinositides 
Phosphatidylinositol and its phosphorylated form (phosphoinositide; PI) play a critical role in 
many cell signalling pathways. Often referred to as second messengers, phosphoinositides 
function as membrane scaffolds, recruiting specific proteins of a signalling cascade via their 
phosphoinositide binding domains (Pendaries et al., 2006). Among the best characterised 
binding domains identified so far include the pleckstrin homology (PH) domain, phox 
homology (PX) domain and Fab1p/YOTB/Vac1p/EEA1 (FYVE) domain (Pendaries et al., 2003). 
The importance of phosphoinositides is highlighted through their organisation and 
spatiotemporal control of key signalling cascades, including the PI3K/AKT signalling pathway 
(Vanhaesebroeck and Alessi, 2000). The structure of phosphatidylinositol consists of a 
diacylglycerol backbone linked to an inositol ring via a phosphate group (Figure 1). This 
inositol ring can be phosphorylated at free –OH groups located at positions 3, 4 and 5 in 
different combinations (Vanhaesebroeck and Alessi, 2000).  
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PI3K is a conserved family of intracellular lipid kinases that phosphorylate the 3’ hydroxyl 
group on the inositol ring of phosphoinositides. This family of kinase are classified into three 
groups based on their structure and substrate specificity, known as class I, class II or class III 
PI3K (Liao and Hung, 2010). However, only class I PI3Ks are reported to stimulate AKT 
activity (Vanhaesebroeck and Alessi, 2000). The structure of class I PI3Ks is of a heterodimer 
composed of a catalytic subunit (p110) and an adaptor/regulatory subunit (Shepherd et al., 
1998). Class I PI3Ks may be further divided into a subgroup known as class IA (p110, p110 
or p110) and class IB (p110). Although the catalytic subunits of PI3K subgroups shows 
significant sequence homology, class IA and class IB kinases each associate with a distinct 
family of adaptor proteins (p85/ & p101 respectively), which enables their association 
and activation downstream of receptor tyrosine kinase (RTKs) and G-protein coupled 
receptors (GPCRs) respectively (Shepherd et al., 1998; Vanhaesebroeck and Alessi, 2000; 
Yuan and Cantley, 2008). In addition, class IA PI3K are also activated downstream of cytokine 
receptors and integrin dependent signalling (Wymann et al., 2003; Fayard et al., 2005). A 
more detailed review of PI3K structure and function is available elsewhere (Vanhaesebroeck 
and Waterfield, 1999; Papakonstanti et al., 2008). 
In resting cells, class I PI3K are predominantly located in the cell cytosol in an inactive state. 
Following receptor activation, class IA PI3K are recruited to the RTKs via interaction of 
sequence specific phospho-tyrosine residues with the Src homology 2 (SH2) domains on p85 
adaptor proteins (Figure 2A) (Foster et al., 2003). This recruitment relieves p85 mediated 
inhibition of p110 catalytic subunit resulting in the activation of PI3K (Berenjeno and 
Vanhaesebroeck, 2009). In contrast, Class IB PI3K are recruited to GPCRs through p101 
adaptor protein mediated interaction with G subunits of GPCRs (Figure 2B) (Foster et al., 
2003). However, it is becoming increasingly suggested that most class I PI3K subunits may in 
fact be activated by GPCRs, either directly or indirectly through Ras family proteins that can 
be activated by both RTK and GPCR (Vanhaesebroeck et al., 2010). It is therefore likely that 
class IA PI3K may be more responsive to GPCR signalling than initially predicted. Once at the 
membrane, class I PI3K preferentially target PtdIns-[4,5]-bisphosphate (PI[4,5]P2), 
generating the lipid product PtdIns-[3,4,5]-trisphosphate (PI[3,4,5]P3) (Figure 2) (Yuan and 
Cantley, 2008). An increase of PtdIns-[3,4]-bisphosphate (PI[3,4]P2) is also observed at the 
membrane, though this is thought to occur through dephosphorylation of PI[3,4,5]P3 by 5’-
inositol phosphatases (Vanhaesebroeck and Alessi, 2000). This localised increase of 3-
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phosphoinositides (PI[3,4,5]P3 and PI[3,4]P2) now functions as a second messenger, 
activating downstream pathways that regulate cell growth, cell survival and other metabolic 
processes (Bononi et al., 2011). This includes the extensively studied downstream PI3K 
effector kinase AKT; often used as a marker of PI3K activity (Vasudevan and Garraway, 2010; 
Bononi et al., 2011). 
 
 
 
Figure 1 Simplified illustration of phosphatidylinositol.  
Phosphatidylinositol is composed of two fatty acid chains embedded in the membrane lipid 
bilayer, attached at carbon positions 1 and 2 of a glycerol backbone. The inositol ring is 
attached to the glycerol backbone at carbon position 3 via a phosphate group. The free OH 
groups on the inositol ring may be phosphorylated, except for positions 2’ and 6’. PI3K 
phosphorylate the inositol group at position 3’ on the carbon ring as indicated. Adapted 
from Vanhaesebroeck and Alessi (Vanhaesebroeck and Alessi, 2000). 
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Figure 2 Receptor mediated activation of class I PI3K.  
Recruitment and activation of class I PI3K is predominantly mediated through receptor 
tyrosine kinase (RTK) and G-protein coupled receptor (GPCR) signalling. (A) Class IA PI3K 
catalytic subunit p110 (,,) is recruited to the membrane by its adaptor protein p85. p85 
contains two Src-homology 2 (SH2) domains that bind phosphorylated tyrosine residues of 
RTK, induced by auto-phosphorylation following receptor ligand binding. (B) The catalytic 
subunit p110 of class IB PI3K is recruited to membrane via the adaptor protein p101, which 
interacts with the G subunits of GPCRs post ligand binding. At the membrane, class I PI3K 
generate lipid products PI[3]P, PI[3,4]P2 and PI[3,4,5]P3 by phosphorylating the inositol ring 
of phosphoinositides at the 3’ carbon position. Phosphorylation of PI[4,5]P2 to PI[3,4,5]P3 is 
the preferred target of class I PI3K activity. Adapted from Vanhaesebroeck and Alessi 
(Vanhaesebroeck and Alessi, 2000). 
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1.3.2 AKT structure and function 
The serine/threonine protein kinase AKT belongs to the AGC subgroup of protein kinases; 
named after its homology with the kinase catalytic domains of protein kinase A, G and C 
(Fayard et al., 2010). AKT is reported to phosphorylate up to 130 known substrates, 
regulating a number of host cell processes including cell proliferation, transcription, 
translation, apoptosis and metabolism (lipid and glucose) (Pearce et al., 2010; Bononi et al., 
2011). AKT is regarded as one of the most important and best understood downstream 
effectors of PI3K activity (Shepherd et al., 1998; Bononi et al., 2011). Originally identified in 
1995 to be activated by insulin signalling, AKT has undergone a surge in interest for its role in 
cell signalling pathways and its mechanisms of regulation (Kohn et al., 1995; Hers et al., 
2011).  
AKT exists as three isoforms (known as AKT1, AKT2 & AKT3) that share approximately 80% 
amino acid sequence identity and are widely expressed throughout human tissues (Liao and 
Hung, 2010); except for AKT3 which is expressed mainly in neuronal tissues (Vanhaesebroeck 
and Alessi, 2000). Although AKT isoforms show overlapping functions, mouse knockout 
studies have suggested specific/dominant roles for each isoform: AKT1, cell survival and 
proliferation; AKT2, glucose homeostasis; and AKT3, brain development (Cho et al., 2001; 
Tschopp et al., 2005). Each AKT isoform possesses a highly conserved domain structure 
made up of an N-terminal pleckstrin homology (PH) domain, a central kinase catalytic 
domain and a C-terminal regulatory tail, containing the hydrophobic motif (Vanhaesebroeck 
and Alessi, 2000). This architecture is highly conserved amongst AGC kinase members, such 
as protein kinase C (PKC) and S6 kinase (S6K).  
In un-stimulated cells, AKT is predominantly localised to the cell cytosol in an inactive state 
through an intramolecular interaction between its PH domain and its central catalytic kinase 
domain (Figure 3) (Calleja et al., 2007). Following the stimulation of PI3K activity, AKT is 
recruited to the plasma membrane in a PH dependent manner, binding with similar high 
affinity for 3-phosphoinositides PI[3,4,5]P3 and PI[3,4]P2 (Frech et al., 1997). This 
recruitment of AKT to the membrane induces a conformational change, leading to the 
disruption of the PH-kinase domain interaction resulting in the exposure of its ‘activation 
loop’ (Milburn et al., 2003; Calleja et al., 2007). This step is critical to expose the residue 
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Thr308 within the catalytic kinase domain for phosphorylation by the key activating kinase, 
phosphoinositide-dependent kinase 1(PDK1) (Calleja et al., 2007). 
 
 
Figure 3 A model of PI3K dependent activation of AKT.  
Upstream receptor agonist interaction stimulates the recruitment and activation of class I 
PI3K to the membrane. Once recruited, class I PI3K phosphorylates PI[4,5]P2 to PI[3,4,5]P3. 
The increase of PI[3,4,5]P3 stimulates the recruitment and co-localisation of AKT and PDK1 
to the membrane. AKT and PDK1 interact with PI[3,4,5]P3 through binding via their 
respective pleckstrin homology (PH) domains. Binding of AKT to PI[3,4,5]P3 alters the 
conformation of AKT, exposing the catalytic kinase domain. PDK1, which is now in close 
proximity, can now phosphorylate and activate AKT within the activation loop at Thr308. 
AKT is then phosphorylated within its hydrophobic motif at Ser473, leading to its full 
activation, by the mammalian target of rapamycin complex 2 (mTORC2). AKT is also 
constitutively phosphorylated at Thr450 to stabilise newly synthesised AKT, which is 
dependent on mTORC2. Adapted from Hers et al., (Hers et al., 2011). 
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1.3.3 AKT activating kinase - PDK1 
PDK1 is a serine/threonine kinase, consisting of a C-terminal kinase domain and an N-
terminal PH domain (Vanhaesebroeck and Alessi, 2000). PDK1 is constitutively active in cells 
through the autophosphorylation of residue Ser241 within the kinase domain (Alessi et al., 
1997a; Casamayor et al., 1999). Autophosphorylation of PDK1 occurs independently of PI3K 
activation. Localised to the plasma membrane in a PH domain dependent manner, PDK1 is 
named after its requirement for 3-phosphoinositides (PI[3,4,5]P3 & PI[3,4]P2) for AKT 
activation (Figure 3) (Alessi et al., 1997b; Currie et al., 1999). Binding with high affinity for 
PI[3,4,5]P3 and PI[3,4]P2, the PH domain of PDK1 can also bind with low affinity to PtdIns-
[4,5]-bisphosphate (PI[4,5]P2) (Currie et al., 1999; Komander et al., 2004). Since PI[4,5]P2 is 
consistently present in the membrane under basal conditions, this may account for the pool 
of PDK1 associated with the plasma membrane in un-stimulated cells (Currie et al., 1999). 
Indeed, whether PDK1 is further recruited to the plasma membrane in response to PI3K 
activation remains controversial, with conflicting studies reporting growth factor stimulated 
translocation or no effect at all (Currie et al., 1999; Filippa et al., 2000). 
 
1.3.4 AKT phosphorylation and activation 
AKT phosphorylation is critical for its activation. Co-localisation of AKT and PDK1 at the 
plasma membrane brings the exposed kinase domain of AKT in close proximity to PDK1, 
leading to the phosphorylation of residue Thr308 (Figure 3) (Alessi et al., 1997b). This 
phosphorylation of Thr308 stabilises the activation loop of AKT into an active conformation, 
increasing its activity by approximately 100 fold (Alessi et al., 1996; Alessi et al., 1997b). To 
achieve maximum activity, AKT undergoes a second phosphorylation step within its 
hydrophobic motif at residue Ser473 (Figure 3) (Alessi et al., 1996; Hers et al., 2011). This 
second phosphorylation event is attributed to the activity of the mammalian target of 
rapamycin complex 2 (mTORC2), though the mechanism by which this is regulated remains 
to be fully defined (Sarbassov et al., 2005; Pearce et al., 2010; Yang et al., 2015). 
Interestingly, studies by Yang et al., have proposed a mechanism by which mTORC2 activity 
is increased through the phosphorylation of its subunit SIN1 by AKT (phosphorylated at 
Thr308), thus stimulating the phosphorylation of AKT at Ser473 in a positive feedback loop 
(Yang et al., 2015). This phosphorylation of AKT at Ser473 is reported to increase AKT activity 
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by approximately 10 fold (Alessi et al., 1996), promote phosphorylation of Thr308 (Sarbassov 
et al., 2005) and contribute to the substrate specificity of AKT (Jacinto et al., 2006). In 
addition, AKT is also constitutively phosphorylated at Thr450 in an mTORC2 dependent, but 
PI3K independent manner (Facchinetti et al., 2008; Liao and Hung, 2010; Pearce et al., 2010). 
This phosphorylation of residue Thr450 is thought to both stabilise and protect AKT from 
dephosphorylation at its hydrophobic motif (Hauge et al., 2007). This phosphorylated and 
active form of AKT can then dissociate from the plasma membrane and translocate to the 
cytosol and nucleus. Once here, AKT can regulate a number of host cellular functions, 
mediated through the phosphorylation of several downstream substrates such as glycogen 
synthase kinase 3 (GSK3), tuberous sclerosis complex 2 (TSC2) and c-rapidly activated 
fibrosarcoma (c-Raf). Phosphorylation by AKT can have various effects on these proteins 
including inhibiting or stimulating their activity, altering subcellular localisation and/or 
protecting proteins from degradation (Manning and Cantley, 2007; Hers et al., 2011). These 
substrates are implicated in many diverse functions, including glycogen metabolism, cell 
cycle progression/survival and ribosome biogenesis.  
AKT signalling is typically short lived, terminated by the rapid dephosphorylation of AKT at 
Thr308 and Ser473 through the action of protein phosphatases 2A (PP2A) and PH domain 
leucine rich repeat phosphatase (PHLPP) respectively (Bayascas and Alessi, 2005; Brognard 
et al., 2007; Liao and Hung, 2010). In addition, the membrane localised phosphatase and 
tensin homolog deleted on chromosome 10 (PTEN) can also negatively regulate the 
PI3K/AKT pathway by dephosphorylation of PI[3,4,5]P3 to PI[4,5]P2, thereby preventing 
further recruitment and activation of AKT (Hers et al., 2011). A similar role has been 
proposed for the SH2 domain containing inositol 5-phosphatase (SHIP), inducing the 
dephosphorylation of PI[3,4,5]P3 to PI[3,4]P2 (Liu et al., 1999b; Carver et al., 2000).  
 
1.3.5 Dysregulation of the PI3K/AKT signalling pathway 
As discussed earlier, the PI3K/AKT signalling pathway plays a critical role in number of 
cellular processes, including cell survival, cell proliferation and metabolism. Due to its 
complex regulation of key cellular events it is unsurprising that altered AKT activity is linked 
with various human diseases including cancer, diabetes and cardiovascular disease (Hers et 
al., 2011). The PI3K/AKT signalling pathway is one of the most frequently mutated pathways 
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in human cancer, with AKT2 found to be the most common isoform overexpressed in 10% of 
pancreatic cancers and 57% of colorectal cancers (Hers et al., 2011). Despite being one of 
the most hyperactive pathways in cancer, mutations of AKT itself are in fact extremely rare. 
Dysregulation of the PI3K/AKT signalling pathway therefore typically occurs through 
mutation or altered expression of the many components regulating AKT activity (Hers et al., 
2011). These include the overexpression or activating mutations of upstream receptor 
signalling (RTKs or GPCRs) (Rusch et al., 1997; Bache et al., 2004), activating mutations of 
PI3K (mutations of the regulatory subunit) (Lin et al., 2001), and inactivating mutations of 
the phosphoinositide 3’-phosphatase PTEN (negatively regulated AKT activity) (Dillon and 
Miller, 2014). Given the central role of AKT in human cancers and other life threatening 
diseases, targeting of AKT is becoming an increasingly explored strategy for therapeutic 
treatment. However, with AKT implicated in numerous biological processes, the risk of 
causing off target effects using inhibitors can be a significant limitation to any potential long-
term therapy (Hers et al., 2011). Better dissection of the PI3K/AKT signalling cascade and its 
interactions with other pathways is therefore required to improve outcomes of future 
treatment strategies. 
 
1.4 Pathogenic Bacteria 
Pathogenic bacteria are often considered the masters of survival, evolving strategies to 
establish colonisation and avoid detection by the host immune system. This is achieved by 
targeting of host cells, either through cell attachment or invasion, before subverting cellular 
functions. An emerging area of study has been the ability of bacteria to subvert host cell 
signalling pathways that control a number of critical cellular functions, including cytoskeletal 
dynamics, cell death and the immune response. Much of this work has focused on defining 
the mechanisms employed by bacteria to disrupt signalling cascades, including MAPK and 
nuclear factor kappa B (NFB) (Vallance and Finlay, 2000; Reddick and Alto, 2014). 
Examining the mechanisms employed by pathogenic bacteria to subvert eukaryotic cell 
signalling has provided critical insight into these signalling cascades and the host proteins 
affected (Cui and Shao, 2011). Thus, studying pathogenic bacteria has proved a unique tool 
to understand the complexities of eukaryotic cell signalling, which may prove useful for the 
identification of potential therapeutic targets for the treatment of disease (Krachler et al., 
2011). 
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1.4.1 Pathogenic bacteria can disrupt MAPK and NFB signalling cascades 
The innate immune response acts as the first line of defence against invading pathogens; 
triggered through recognition of pathogen associated molecular patterns (PAMPs), such as 
the bacterial cell surface protein lipopolysaccharide (LPS). PAMPs are detected by a 
collection of evolutionary conserved receptors known as pattern recognition receptors 
(PRR), which include toll-like receptors (TLR) and NOD-like receptors (NLR). Upon recognition 
of PAMPs, PRRs trigger the rapid initiation of intracellular signalling cascades including the 
MAPK and NFB (Figure 4) (Takeuchi and Akira, 2010). Activation of MAPK and NFB 
signalling induces the transcription of a number of pro-inflammatory genes, including 
cytokines and anti-microbial proteins. Furthermore, both MAPK and NFB signalling also 
regulate other cellular functions including cell proliferation, cell migration and apoptosis. 
The NFB transcription factor exists as a homo or heterodimer of proteins that include RelA 
(p65), RelB, c-Rel, p50, p52 and RPS3 subunit, of which the p65/p50 hetrodimer is the most 
abundant. Under normal conditions, the NFB complex is maintained in an inactive state in 
the cytosol through binding with the inhibitory subunit IB (Figure 4). Activation of the NFB 
signalling pathway induces the phosphorylation of IB, resulting in its dissociation and 
degradation via the ubiquitin-proteasome system. Phosphorylation of IB is mediated by the 
IB kinase kinase (IKK) complex, which is activated downstream of PRR signalling (Figure 4). 
This dissociation of IB enables the NFB complex to translocate to the nucleus, binding 
promoters and enhancers that regulate gene transcription. Alternatively, activation of MAPK 
signalling pathway triggers a series of phosphorylation steps culminating in the activation of 
MAPK family proteins, including p38, JNK and ERK (Figure 4). This kinase cascade is mediated 
by the sequential phosphorylation of MAP kinase kinase kinase (MKKK), then MAP kinase 
kinase (MKK), and finally MAP kinase. Once active, MAPK proteins can then translocate to 
the nucleus, binding and activating transcription factors, including those of the AP-1 family 
(Jun & Fos). Together, induction of NFB and MAPK signalling regulates the transcription of 
many pro-inflammatory genes. Bacteria that interfere with these signalling cascades typically 
target one or more stages in the pathway for inhibition, highlighting their importance to the 
bacteria for establishing an infection (Krachler et al., 2011).  
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The capacity of bacteria to subvert host cellular processes is often dependent on its ability to 
translocate virulence proteins (effectors) into host cells via a delivery system. These effector 
proteins may target and manipulate several critical steps in cell signalling cascades, acting as 
inhibitors or activators of target substrates (Krachler et al., 2011). One of the earliest 
examples of bacteria subverting host signalling was by the effector protein YopJ, delivered 
into host cells by the pathogenic Yersinia species (Palmer et al., 1998; Orth et al., 1999). YopJ 
inhibits MAPK and NFB signalling pathways by preventing activation of regulatory kinases, 
MKKKs and IKK ( subunit only) respectively. The inhibitory capacity of YopJ is dependent on 
its acetyl transferase activity, preventing the phosphorylation of both MKK and IKK through 
acetylation of serine and/or threonine residues within their activation loop (Mukherjee et 
al., 2006). By preventing their phosphorylation, YopJ acts to inhibit MKK and IKK activation, 
thus terminating both MAPK and NFB signalling cascades. The advantage this confers to 
Yersinia include the initiation of host cell death by preventing cell survival and apoptosis 
signals that are critical to the immune response (Alto and Orth, 2012). Other notable 
examples of bacteria subverting MAPK and NFB signaling include Shigella flexneri (IpaH9.8), 
enterohemorrhagic E. coli (EHEC; NleH1/NleH2) and EPEC (NleE) (Alto and Orth, 2012). 
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Figure 4 Simplified representation of the MAPK and NFκB inflammatory signalling cascade.  
PRR ligand binding stimulates the recruitment of adaptor proteins such as MyD88. Binding of 
MyD88 enables the recruitment of IRAK to the receptor complex, which in turn recruits the 
ubiquitin ligase, TRAF6. TRAF6 then recruits TAK1 and TAB2/3, inducing their activation 
through close proximity, before dissociating from the receptor complex. Once active, TAK1 
stimulates pro-inflammatory signalling by two distinct pathways: MAPK and NFB. 1) TAK1 
initiates MAPK signalling through a series of sequential phosphorylation steps (MAPKKK > 
MAPKK > MAPK), resulting in the phosphorylation and activation of activating protein 1 
(AP1) transcription factors (p38, JNK & ERK). This ultimately leads to the activation and 
translocation to the nucleus regulating gene expression. 2) TAK1 activates NFB signalling 
through its activation of the IKK complex, composed of subunits NEMO, IKK and IKK. TAK1 
phosphorylates IKK, which in turn phosphorylates the NFB inhibitory subunit IB, inducing 
its dissociation and degradation by ubiqutination. NFB can now translocate to the nucleus 
and regulate expression of pro-inflammatory genes. Adapted from Krachler et al., (Krachler 
et al., 2011). 
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1.4.2 Pathogenic bacteria can subvert the PI3K-AKT signalling pathway 
The PI3K/AKT signalling pathway is an increasingly recognised target for pathogenic bacteria, 
used to promote their entry into host cells and modulate host survival signals (Pizarro-Cerda 
and Cossart, 2004). Among these bacteria include Shigella flexneri, Salmonella enterica and 
uropathogenic E. coli (UPEC) (Wiles et al., 2008). Shigella flexneri and Salmonella enterica 
are facultative intracellular pathogens, responsible for a number of human diseases 
including gastroenteritis and bacillary dysentery. Like many gram-negative bacteria, 
pathogenicity of Shigella flexneri and Salmonella enterica is dependent on the delivery of a 
plethora of effector proteins into host cells through a type 3 secretion system (T3SS); 
hijacking cellular systems to promote their colonisation. IpgD and SopB are two effector 
proteins synthesised and delivered by Shigella flexneri and Salmonella enterica respectively, 
reported to promote their uptake by host cells through manipulation of phosphoinositide 
metabolism (Pizarro-Cerda and Cossart, 2004). In addition to promoting uptake, IpgD and 
SopB are known to activate the pro-survival kinase AKT; however, the mechanism by which 
this activation occurs remains to be fully defined (Steele-Mortimer et al., 2000; Pendaries et 
al., 2006).  
IpgD and SopB possess phosphoinositide phosphatase activity, which is critical for AKT 
activation; demonstrating preference for phosphoinositides PI[4,5]P2 and 
PI[3,4,5]P3/PI[3,4]P2 respectively (Steele-Mortimer et al., 2000; Pendaries et al., 2006). 
Delivery of IpgD and SopB is associated with the localised accumulation of PtdIns-[5]-
monophosphate (PI[5]P) at the site of infection; though its function is not fully understood 
(Pendaries et al., 2006). Studies by Pendaries et al., have suggested the increase of PI[5]P, 
induced by IpgD, is critical to phosphorylate AKT at Thr308 and Ser473 (Pendaries et al., 
2006). This phosphorylation of AKT was found to be dependent on the activation of class IA 
PI3K via tyrosine phosphorylation, though how PI[5]P might activate PI3K is not known 
(Pendaries et al., 2006). Furthermore, PI[5]P may also indirectly increase AKT activity 
through inhibition of PP2A induced dephosphorylation of AKT at Thr308 (Ramel et al., 2009). 
Although speculative, increased PI[5]P accumulation at the membrane may play a similar 
role in AKT activation, stimulated by Salmonella effector protein SopB (Cooper et al., 2011).  
In addition to the increase of the phosphoinositide PI[5]P, Salmonella enterica infection is 
associated with increased PI[3,4,5]P3 and PI[3,4]P2 at the site of invasion, coupled with the 
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recruitment and co-localisation of AKT and PDK1 (Cooper et al., 2011). In contrast to Shigella 
effector protein IpgD, the requirement of class IA PI3K activity in SopB induced AKT 
phosphorylation has proved controversial. Studies by Cooper et al., have suggested that AKT 
activation stimulated by SopB is both sensitive and insensitive to PI3K inhibitors LY294002 
and Wortmannin respectively (Cooper et al., 2011). However, reports by Roppenser et al., 
have shown the formation 3-phosphoinositides (PI[3,4,5]P3 & PI[3,4]P2) and AKT 
phosphorylation is inhibited by both PI3K inhibitors (LY294002 & wortmannin) at high 
concentrations (Roppenser et al., 2013). Discrepancies between the two studies may 
represent differences in cell model used; suggesting that AKT phosphorylation induced by 
Salmonella enterica may employ PI3K dependent and/or independent mechanisms 
depending on cell type (Cooper et al., 2011; Roppenser et al., 2013). This finding is 
supported by Roppenser et al., who revealed that up to 90 kinases linked to AKT activation 
are influenced by Salmonella enterica infection (Roppenser et al., 2013).  
In contrast to Shigella flexneri and Salmonella enterica, active AKT is rapidly decreased 
following infection with the uropathogenic bacteria, UPEC. The leading cause of urinary tract 
infections, UPEC triggers the rapid dephosphorylation of AKT at Thr308 and Ser473 (Foxman 
and Brown, 2003; Wiles et al., 2008). Dephosphorylation of AKT and the resulting loss of 
activity are dependent on UPEC secretion of the potent pore-forming toxin HlyA; used to 
enhance pathogenesis and promote bacterial crossing of mucosal barriers, thereby 
promoting colonisation (Wiles et al., 2008). Although the precise mechanism through which 
HlyA induces the loss of AKT activity is unknown, Wiles et al., have shown this rapid 
dephosphorylation of AKT (Thr308/Ser473) to be dependent on the activity of protein 
phosphatases, protein phosphatase 1 (PP1) and PP2A (Wiles et al., 2008). This seemingly 
aberrant activation of protein phosphatases is dependent on the pore forming activity of 
HlyA, which is linked to the stimulation of osmotic stress (Meier et al., 1998; Wiles et al., 
2008). Similar observations have been identified using other pore forming toxins including 
aerolysin and -toxin, indicating HlyA targeting of AKT for inactivation is not unique (Wiles et 
al., 2008). This suggests the activity of pore forming toxins may have additional major 
pathogenic roles other than cell lysis through modulation of host cell signalling pathways. 
The enteric pathogen EPEC is also recognised to target and inhibit the PI3K/AKT signalling 
pathway, though how this occurs is not understood (Celli et al., 2001). Examining the 
mechanism utilised by EPEC to subvert PI3K/AKT signalling will form the basis of this study. 
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The remainder of this report will focus on the role of EPEC and the effector proteins used to 
manipulate host cellular functions.  
 
1.5 Enteropathogenic E. coli (EPEC) 
EPEC is a gram-negative human pathogen of the small intestine. Identified in 1978 by Levine 
et al using the now prototypic strain E2348/69, EPEC pathogenesis contributes a significant 
risk to human health and disease, causing vomiting, fever and watery diarrhoea 
predominantly in infants and young children (Levine et al., 1978; Chen and Frankel, 2005). 
Although outbreaks are largely rare in economically developed nations, EPEC infection 
remains a persistent problem to developing countries accounting for at least 20% of 
reported diarrheal cases, which can often prove fatal (Gomes et al., 1991; Kaper et al., 2004; 
Ochoa et al., 2008). With E. coli infections implicated in approximately 2 million diarrhoeal 
related deaths per year, understanding the pathogenic mechanisms of E. coli strains such as 
EPEC has become of increasing importance (Chen and Frankel, 2005). Despite significant 
advances in cell biology, genetics and intestinal physiology that have improved the 
characterisation of EPEC pathogenesis, the mechanisms and bacterial proteins behind many 
of these clinical features remain largely unknown (Chen and Frankel, 2005; Dean and Kenny, 
2009). 
EPEC is a member of a family of diarrhoeagenic bacteria known as attaching effacing (A/E) 
pathogens, inducing the formation of characteristic histopathological structures termed A/E 
lesions (Figure 5) (Levine et al., 1978). This family of A/E pathogens also include the human 
pathogen enterohemorrhagic E. coli (EHEC), the mouse pathogen Citrobacter rodentium 
(CR), and the Rabbit pathogenic E. coli (RPEC). Caused by intimate attachment between the 
host plasma membrane and bacteria, A/E lesions can be observed at ultra-structural level on 
the apical surface of intestinal epithelial cells, known as enterocytes. These A/E lesions are 
characterised by the destruction of absorptive microvilli and significant cytoskeletal changes 
that include the accumulation of polymerized actin beneath adherent bacteria, known as 
pedestals (Figure 5) (Moon et al., 1983; Knutton et al., 1989). These pedestal structures 
protrude from the apical surface of enterocytes by as much as 10 m in vitro, cupping the 
individual bacteria (Rosenshine et al., 1996b). Although the functional significance of this 
structure remains incompletely understood, it is thought that pedestal formation may 
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promote EPEC’s extracellular lifestyle. The ability of these bacteria to induce A/E lesion 
formation is encoded on the highly conserved 35.6 kb pathogenicity island termed the locus 
of enterocyte effacement (LEE; Figure 6), which is both necessary and sufficient for EPEC to 
induce a number of subversive events including the formation of A/E lesions (McDaniel and 
Kaper, 1997). Acquired by horizontal gene transfer, the LEE region of EPEC (E2348/69) 
contains 41 genes organised into 5 polycistronic operons, which encode gene regulators, 
chaperones, EPEC secreted/signalling proteins (Esp) and components of the type 3 secretion 
system (T3SS) (Chen and Frankel, 2005).  
EPEC infection predominantly occurs by transmission through oral-faecal contact from 
contaminated hands or food (Bardiau et al., 2010). Once localised to the small intestine, the 
pathogenicity of EPEC infection is proposed to follow four main stages: (1) initial adherence 
and colonisation of the small intestine; (2) translocation of EPEC effector proteins into host 
cells; (3) formation of attaching effacing lesions; and (4) intimate attachment of EPEC to host 
cell membrane leading to pedestal formation and diarrhoea (Figure 7) (Clarke et al., 2003; 
Chen and Frankel, 2005). 
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Figure 5 EPEC induced attaching effacing lesions and actin rich pedestals.  
Representative images of EPEC induced infection characteristics. (A) The extensive 
effacement of microvilli on the apical surface of epithelial cells; revealed by scanning 
electron microscopy (SEM) after 4 h of infection with wild type EPEC, using a Caco-2 cell 
model. Taken from Dean et al., (Dean et al., 2006). (B) An SEM image of EPEC induced actin 
rich structures known as pedestals, using a HeLa cell model. These pedestal structures 
protrude from the apical surface, cupping individual bacteria. The image was artificially 
coloured to distinguish bacteria (purple) from HeLa cell (brown). Taken from Rosenshine et 
al., (Rosenshine et al., 1996b). 
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Figure 6 Schematic of the genetic organisation of the locus of enterocyte effacement.  
The locus of enterocyte effacement (LEE) is organised into 5 polycistronic operons, indicated 
LEE1-LEE5, encoding up to 41 known genes. These genes include those encoding: regulator 
proteins (Red); a T3SS, composed of E. coli secretion (Esc; Black) and secretion of EPEC 
proteins (Sep; Yellow); translocator proteins (Blue); chaperones (Purple); the outer 
membrane protein Intimin (eae; Green); effector proteins, termed EPEC secreted/signalling 
proteins (Esp; orange; that include Tir & Map); and other putative open reading frames (Orf; 
White). Taken from Wong et al., (Wong et al., 2011). 
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Figure 7 The four-stage model of EPEC infection.  
(1) EPEC infection requires the initial attachment of EPEC to the apical surface of 
eneterocytes. Expression of the adhesin BFP aids this attachment process, forming discrete 
EPEC microcolonies and a characteristic localised adherence pattern. (2) EPEC, now in close 
proximity to the host cell membrane, delivers a plethora of effector proteins into the host 
cell via a type-3 secretion system (T3SS). The T3SS in addition to 6 effectors and 3 translocon 
proteins (critical for effector translocation, of which one [EspB] has effector function) are 
encoded on the pathogenicity island termed the locus of enterocyte effacement (LEE). 
Effectors translocated into the host that are not encoded on the LEE region are mostly 
termed non-LEE encoded (Nle) effectors, with some named Esp (e.g. EspG2, EspL & EspJ). (3) 
Through the cooperative action of LEE and Nle effector proteins, EPEC subverts many 
functions, in addition to disrupting the host cytoskeleton. This is evident by the extensive 
loss of absorptive microvilli on the apical surface of enterocytes known as effacement. (4) 
The final stage of EPEC infection is characterised by the formation of actin rich pedestals; the 
intimate attachment between bacterium and host cell membrane; and the onset of watery 
diarrhoea through increased paracellular diffusion, disruption of tight junctions, loss of 
absorptive microvilli and altered transporter function. Intimate attachment is mediated 
through binding of outer membrane protein Intimin and the T3SS delivered translocated 
intimin receptor (Tir) effector, which is inserted into the host cell membrane. Adapted from 
Clarke et al., (Clarke et al., 2003). 
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1.5.1 EPEC Pathogenesis 
1.5.1.1 EPEC cell adherence and the bundle forming pilus 
The initial adherence of EPEC to intestinal epithelial cells is known to occur in discrete 
clusters, forming what is described as a localised adherence pattern (Knutton et al., 1987). 
This phenotype is rapidly promoted in vitro through pre-incubation of bacteria in tissue 
culture media (Vuopio-Varkila and Schoolnik, 1991). Formation of localised adherence is 
dependent on the expression of a number of EPEC genes encoded both on the chromosome 
and a plasmid subsequently named, EPEC adherence factor (EAF) (Baldini et al., 1983). 
Encoded on the EAF plasmid is a cell surface adhesion structure known as the bundle 
forming pili (BFP) that was first described by Giron et al in 1991 as a bundle of rope like 
filaments (Giron et al., 1991). Approximately 50-500 nm wide and extending from up to 14-
20 m long, the BFP filaments intertwine with those expressed on other localised EPEC 
forming a dense network that promotes microcolony formation (aggregation), stabilisation 
and non-intimate cell binding (Nataro and Kaper, 1998; Tobe and Sasakawa, 2001; Clarke et 
al., 2003). Once bound to the cell, the BFP is thought to retract thereby bringing the 
bacterium closer to the cell surface for the effective translocation of effector proteins 
(Zahavi et al., 2011). In addition to BFP, the EAF plasmid also encodes a cluster of regulatory 
genes known as plasmid encoded regulators A, B and C (perA, perB & perC) that regulate the 
expression of the BFP and other critical virulence factors including the T3SS via the LEE 
encoded regulator (LER) (Mellies et al., 1999). However, not all EPEC strains carry the EAF 
plasmid; with those strains that do not unable to demonstrate a localised adherence pattern 
in cell culture. EPEC strains have therefore been classified into those that carry and those 
that do not carry the EAF plasmid, commonly referred to as typical and atypical EPEC 
respectively (Trabulsi et al., 2002). Although atypical strains (EAF minus) are still capable of 
forming A/E lesions, these strains have been shown to be significantly delayed in lesion 
formation, inducing fewer cases of diarrhoea under human challenge (Levine et al., 1985; 
Chen and Frankel, 2005; Bueris et al., 2015). This suggests that expression of the BFP is not 
essential for full EPEC virulence, though may promote infection and EPEC colonisation. 
However, this has been challenged by studies in an intestinal ex vivo model, revealing the 
adhesion of EPEC strains lacking BFP (Hicks et al., 1998).  
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1.5.1.2 Effector translocation and the type 3 secretion system 
The T3SS is an important organelle common to many gram-negative bacteria, responsible for 
the delivery of effector proteins into host cells to subvert host cellular functions. Encoded on 
the LEE region, the T3SS of EPEC is a multi protein structure, composed of approximately 20 
proteins arranged into a ‘needle complex’ (Figure 8) (Coburn et al., 2007). These proteins 
named EPEC secretion (Esc) span both the inner and outer bacterial membrane. The inner 
membrane ring is composed of membrane spanning proteins EscR, EscS, EscT, EscU and 
EscV, whereas the outer membrane ring is formed from the subunit EscC. The two 
membrane rings are connected across the periplasmic space by the T3SS component EscJ. 
The external needle like structure is then formed from the secretion and polymerisation of 
the subunit EscF, which extends out from the outer membrane ring (EscC) a short distance 
(Garmendia et al., 2005). At the base of the T3SS is the cytoplasmic ATPase EscN, which is 
critical for effector translocation (Donnenberg et al., 1990). Hydrolysis of ATP to ADP by EscN 
is thought to provide the energy to release effector proteins from their chaperones, 
discussed below, prior to effector protein delivery (Akeda and Galan, 2005; Garmendia et al., 
2005).  
The T3SS is connected to the host cell membrane by a ‘translocon’ structure (Figure 8). 
Together, the T3SS needle complex and the translocon provides a continuous conduit for the 
translocation of effector proteins across the bacteria and host cell membrane and directly 
into the host cell cytosol. The translocon is composed of EPEC secreted/signalling proteins 
(Esp) EspA, EspB and EspD (Frankel et al., 1998). EspA is an important structural component 
of the secretion system, forming a hollow filamentous extension of the EscF needle structure 
(Knutton et al., 1998; Daniell et al., 2001). Transiently expressed at the bacterial cell surface, 
polymerised EspA can interact with the host cell membrane, prompting speculation it may 
contribute to initial bacterial-host cell adhesion. Pore forming components, EspB and EspD, 
are then secreted through the needle complex and EspA filament, before inserting 
themselves into the host cell membrane. The functionality of this membrane pore is 
indicated by its capacity to induce haemolysis of erythrocytes in an EspB/EspD dependent 
manner (Warawa et al., 1999; Shaw et al., 2001). Secretion of translocon proteins (EspA, 
EspB & EspD) and their collective interaction with the T3SS is therefore critical for successful 
translocation of effector proteins and EPEC virulence (Hartland et al., 2000; Luo and 
Donnenberg, 2011). Once fully formed, the T3SS promptly switches from the secretion of 
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translocator proteins to the secretion of EPEC effector proteins. This switch is controlled by 
cytoplasmic regulators SepD and SepL (Figure 8), though how this occurs is poorly 
understood. Indeed, mutations of SepD and SepL have been shown to cause the loss of 
effector secretion hierarchy and the hyper-secretion effector proteins through the T3SS 
(Deng et al., 2004; Deng et al., 2005). 
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Figure 8 Simplified schematic of the EPEC T3SS.  
The EPEC type 3 secretion system (T3SS) is a multiprotein complex comprised of E. coli 
secretion (Esc) and secretion of E. coli proteins (Sep). The T3SS needle complex is composed 
of proteins EscR, S, T, U and V, forming the inner membrane ring; EscJ, spanning the 
periplasmic space; EscC, spanning the outer membrane; and EscF, a short needle like 
structure extending away from the bacteria. This needle complex is connected to the host 
cell membrane via the translocaon. The translocon is formed of EspA, a long hollow 
filamentous structure, and membrane inserted proteins EspB and EspD, which are necessary 
for membrane pore formation. Together these proteins form continuous path for the 
delivery of effector proteins directly into the host cell cytosol, such as Tir and EspF. The 
bacterial cytosolic ATPase, EscN, provides the energy for this effector translocation through 
hydrolysis ATP to ADP. SepD, SepL and SepQ are proposed to regulate the switch from the 
secretion of translocator proteins to the secretion of EPEC effector proteins via the T3SS. 
Efficient translocation of most effector proteins is dependent on the chaperones CesF and 
CesT, though EspG, NleD and NleF are translocated independently of both chaperones. 
Adapted from Garmendia et al., (Garmendia et al., 2005). 
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1.5.1.3 EPEC effector proteins: LEE and Nle 
Among the 41 genes contained within the LEE region include those encoding for three 
translocator proteins (EspA, EspB & EspD), six effector proteins (EspG, EspH, mitochondrial 
associated protein [Map], Tir, EspF & EspZ) and the outer membrane protein Intimin (eae). 
The functions of these translocator proteins have already been discussed. However, of these 
translocator proteins only EspB is reported to possess some effector activity, increasing the 
number of known LEE encoded effector proteins from six to seven (Iizumi et al., 2007). Since 
Intimin is not delivered into host cells it is not considered to be a classical effector protein. 
However, the capacity of Intimin to trigger host cellular responses in both a Tir dependent 
and independent manner, through binding of host necleolin (Sinclair and O'Brien, 2002) and 
-integin (Frankel et al., 1996), highlights the importance of this virulent protein in EPEC 
pathogenesis (Liu et al., 1999a; Phillips et al., 2000; Dean and Kenny, 2004; Dean et al., 
2006).  
In addition to the LEE region, other pathogenicity islands encoded on prophages (PP) and 
integrative elements (IE) have been identified throughout EPEC’s genome; encoding up to 17 
known effector proteins (Figure 9). These proteins encoded outside of the LEE region are 
therefore termed non-LEE encoded effectors (Nle), though a few retain the ‘Esp’ 
nomenclature. Together, these effector proteins (LEE & Nle) act to subvert a number of host 
cellular functions. Functional studies examining the impact of LEE and Nle effector proteins 
during EPEC infection have highlighted their complex and multifunctional roles. This is 
demonstrated through the number of overlapping, cooperative and antagonistic activities of 
the translocated effector proteins, used to manipulate several host cellular activities 
(Schmidt, 2010; Shames and Finlay, 2012). Examples of this will be discussed later on. 
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Figure 9 Non-LEE effector encoding pathogenicity islands.  
Seventeen effector proteins are encoded outside of the LEE region. These effector proteins, 
termed non-LEE effector proteins (Nle), are encoded across three integrative elements (IE2, 
IE5 & IE6) and 4 prophages (PP2, PP3, PP4 & PP6) throughout EPEC’s genome. Genes and 
strand direction are indicated using individual arrows. (A) Representation of the 
pathogenicity islands IE3, IE5, IE6, PP2, PP4 and PP6; encoding fourteen effectors (Blue); in 
addition effectors LifA (IE6; Green) and EspC (IE4; Green). Taken from Dean and Kenny et al., 
(Dean and Kenny, 2009). (B) A simplified schematic of the prophage, PP3, encoding the most 
recently identified effector NleJ (Red). Taken from Deng et al., (Deng et al., 2012). 
 
 
Chapter 1 Introduction 
 28 
1.5.1.4 Chaperones and effector translocation 
Effector translocation into target cells is a highly complex and regulated process, dependent 
on a functional T3SS and ancillary proteins known as chaperones encoded on the LEE region. 
Whilst these chaperones do not form part of the T3SS itself, it is becoming increasingly 
apparent they play a critical role in the efficient secretion of virulence proteins. Chaperones 
are implicated to stabilise virulent proteins within the bacterial cytosol, regulate gene 
expression, mediate trafficking/docking with the T3SS at the inner membrane and induce a 
hierarchical release of effector proteins (Cornelis et al., 1998; Elliott et al., 1999; Creasey et 
al., 2003). EPEC encoded chaperones can be divided into three principal classes; those that 
bind effector proteins (Class I), those that bind translocon or pore forming proteins (Class II) 
and those that bind needle complex proteins (Class III). Class I type three secretion 
chaperones can be further divided into two categories, known as IA (single effector 
substrate binding) and IB (multiple effector substrate binding). EPEC encodes two Class I 
type three secretion chaperones on its LEE region (Figure 8); named chaperone of E. coli 
secreted Tir (CesT) and EspF (CesF) (Elliott et al., 1999). CesF is a Class IA T3SC, which is 
thought to bind a single effector protein EspF. In contrast, CesT is a Class IB T3SC, which is 
recognised to bind and regulate the efficient translocation of at least 12 effector proteins. 
These effector proteins are either fully dependent (Tir, EspZ, EspH, Map, EspJ, NleG, NleH1 & 
NleH2) or only partially dependent (NleB1, NleB2, NleC & NleA) on the chaperone CesT for 
translocation into host cells (Mills et al., 2013). The dependence of EspC, NleE1, NleE2 and 
EspL2 on both CesF and CesT chaperones has not been reported. Effector proteins NleD, 
NleF and EspG are translocated independently of CesF and CesT; however, whether the 
delivery of these effectors is indeed chaperone independent or dependent on a third as yet 
unknown Class I T3SC remains to be determined (Mills et al., 2013). 
The first EPEC effector protein delivered into host cells is Tir, followed by a temporal 
translocation order that demonstrates greater efficiency for LEE than most Nle encoded 
effector proteins (Mills et al., 2013). The early delivery of Tir and other LEE effectors 
suggests the establishment of intimate attachment and A/E lesion formation is the most vital 
task during early EPEC infection. This is supported by the sufficiency of the LEE region to 
induce A/E lesions when expressed in a non-pathogenic E. coli K12 strains (McDaniel and 
Kaper, 1997). In contrast, Nle effectors are increasingly recognised to promote EPEC 
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infection, targeting and subverting several host cell signalling pathways including those of 
cell survival and the inflammatory response (Krachler et al., 2011; Alto and Orth, 2012; 
Clements et al., 2012).  
 
1.5.2 Subverting host cellular functions by EPEC effector proteins 
1.5.2.1 Actin polymerisation and pedestal formation 
The intimate attachment of EPEC to host cell surface is mediated through the binding of the 
EPEC outer membrane protein Intimin with the translocated intimin receptor (Tir). Originally 
named Hp90, the bacterial protein Tir represents the first documented example of a 
bacterium inserting its own receptor into host cell membranes for virulence (Kenny et al., 
1997). Subsequent binding of Intimin to Tir triggers the clustering of Tir beneath the bound 
bacterium, forming a strong bond between the bacterium and the host cell cytoskeleton, 
termed intimate cell attachment (Kenny et al., 1997; Garmendia et al., 2005). Tir is inserted 
into the host cell membrane in a hairpin like conformation; possessing two transmembrane 
domains, an extracellular domain for binding Intimin and intracellular amino and carboxy-
termini. Once inserted into the host cell membrane, Tir is quickly phosphorylated by host 
kinases at several residues including Tyr474 within the carboxyl tail (Kenny, 1999; 
Campellone and Leong, 2005). This phosphorylation is reported to be mediated by Src family 
kinase c-fyn (SRK Fyn) (Phillips et al., 2004), with additional studies implicating Abl (Swimm 
and Kalman, 2008) and Tec family kinases (Bommarius et al., 2007). Phosphorylation of 
Tyr474 provides a docking site for the SH2 domain containing adaptor proteins Nck1 and 
Nck2 (Gruenheid et al., 2001). Binding of Nck then facilitates the recruitment of neural 
Wiskott-Aldrich syndrome protein (N-WASP) and the actin related protein (Arp)2/3 complex, 
resulting in the nucleation of actin formation of actin rich pedestals in vitro (Gruenheid et al., 
2001; Lommel et al., 2001). 
 
1.5.2.2 Mechanism of EPEC induced diarrhoea 
It is well established that EPEC infection induces severe watery diarrhoea, though the precise 
mechanism by which this occurs remains poorly defined. The onset of diarrhoea is likely 
dependent on the collective action of multiple effector proteins, disrupting enterocyte 
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cellular functions including: loss of absorptive microvilli (effacement), disruption of barrier 
function and alterations to ion/nutrient transporter activity (Figure 10). 
The gastrointestinal epithelium is composed of a tightly packed monolayer of epithelial cells 
(enterocytes) that play a critical role in the absorption of nutrients from the gut. Often 
termed the brush border region, the apical membrane of enterocytes is made up of a 
number of finger like projections (microvilli) that increase their surface area, aiding 
absorption. These microvilli are constructed from bundles of actin filaments that are 
dependent on myosin for their formation, maintenance and stability. Loss of microvilli is a 
key characteristic in the formation of A/E lesions and a major contributor to the reduced 
absorptive capacity of enterocytes post infection. EPEC induced loss of microvilli is said to 
follow a two step process, whereby adherent bacteria first ‘sink’ into the brush border 
membrane prior to inducing extensive loss of cell surface microvilli (Dean et al., 2006). The 
effacement of microvilli is linked to the cooperative actions of three LEE encoded effectors 
(Map, EspF & Tir) and the outer membrane protein Intimin (Figure 10) (Dean et al., 2006). 
Although the mechanism and the contributing roles of each effector remain to be fully 
defined, depolymerisation of actin filaments is thought to play a principal role (Dean et al., 
2006). EspB also contributes to this effacement process through disruption of actin-myosin 
interactions leading to destabilisation of the actin bundles and loss of microvilli structure 
(Iizumi et al., 2007). 
The reduced capacity of enterocytes to absorb nutrients is also modulated by EPEC at the 
level of transporter function. Since water moves to areas of high salt concentration, it is 
unsurprising that ion gradients are manipulated by diarrheagenic bacteria. EPEC disrupts ion 
gradients in part by decreasing the activity of the sodium hydrogen exchanger (NHE), 
resulting in the reduced uptake of sodium ions (Na+) from the gut lumen (Figure 10) (Hodges 
et al., 2008). This T3SS dependent decrease of NHE activity is induced by the LEE effector 
EspF (Hodges et al., 2008). Furthermore, decreased Na+ uptake is exacerbated through 
reduced expression of sodium glucose co-transporter (SGLT1) at the apical membrane; 
triggered through the cooperative actions of Map, EspF, Tir and Intimin (Figure 10) (Dean et 
al., 2006). In addition to sodium transport, EPEC can also reduce the uptake of chloride ions 
(CL-) through decreased surface expression of the chloride bicarbonate exchanger (CL-
/HCO3-) known as DRA (downregulated in adenoma). Dependent on effectors EspG and 
EspG2, this loss of DRA activity is mediated through disruption of microtubule networks 
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necessary for protein trafficking to the membrane (Figure 10) (Gill et al., 2007; Gujral et al., 
2015). EspG and EspF also contribute to the loss of water absorption through the 
redistribution of water channels (aquaporins) to intracellular compartments; away from the 
apical and lateral membrane (Figure 10) (Guttman et al., 2007). Recent reports have also 
suggested that EPEC infection can decrease function and expression of the apical sodium 
dependent bile acid transporter (ABST), responsible for bile acid reabsorption within the gut, 
which may have implications for the development of diarrhoea (Annaba et al., 2012). 
Together these effects likely contribute to the increase of water content within the gut 
lumen. 
In addition to absorption, enterocytes play a critical role in barrier function; separating the 
contents of the gut lumen from that of the underlying tissues. Intercellular tight junctions 
are critical to this function, maintaining cell-cell adhesion and restricting the flow of 
molecules between cells known as paracellular diffusion. Tight junctions are complex 
structures composed of several transmembrane proteins including claudins, occludins, 
zonula occluden (ZO) and the junction adhesion molecule (JAM). It is increasingly recognised 
that EPEC induces barrier dysfunction through the redistribution of junctional proteins 
leading to the loss of tight junction integrity (Simonovic et al., 2000; Guttman and Finlay, 
2009; Zhang et al., 2010). The mechanism by which this occurs is not understood, yet the 
activities of five LEE encoded proteins (Map, EspF, Tir, Intimin & EspG) and two Nle effectors 
(EspG2/Orf3 & NleA) have been implicated to play a significant role (Muza-Moons et al., 
2003; Dean and Kenny, 2004; Thanabalasuriar et al., 2010; Glotfelty and Hecht, 2012). These 
effectors are not thought to act directly on junctional proteins themselves, though may 
modulate their function and distribution through altered actin assembly, disruption of 
microtubule networks and dysfunctional protein trafficking that are collectively required to 
maintain tight junction structures (Peralta-Ramirez et al., 2008; Weflen et al., 2009; 
Thanabalasuriar et al., 2010; Glotfelty and Hecht, 2012). 
The combined impact of decreased absorption and loss of barrier function are believed to be 
the principal factors contributing the development of severe watery diarrhoea during EPEC 
infection. Although the precise role and mechanism of each effector protein remain to be 
defined, it is clear the activities of LEE encoded effectors are central to the onset of 
diarrhoea. 
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Figure 10 Disruption of cell absorption by EPEC effector proteins.  
EPEC infection disrupts the absorption of ions, water and nutrients in a multifactorial 
process, dependent on the collective action of translocated effector proteins. EPEC effectors 
disrupt absorption through the loss of absorptive microvilii (effacement), induced by the 
cooperative activities of effectors Map, EspF, Tir and the outer membrane protein Intimin. 
These effectors also contribute to the reduced surface expression of sodium glucose 
transporter (SGLT1) by re-distribution to intracellular vesicles. Decreased water transport is 
mediated through the redistribution of water channels (Aquaporins) away from the apical 
and basolateral membrane, dependent on effectors EspF and EspG. The primary route of 
sodium uptake (Na+) is the sodium hydrogen exchanger (NHE), which is disrupted by the 
effector EspF. Disruption of chloride (Cl-) absorption through the chloride bicarbonate 
(HCO3-) exchanger, known as downregulated in adenoma (DRA), is mediated by the 
effectors EspG and its Nle homolog EspG2. EspG and EspG2 disrupt the host cell 
microtubules, preventing protein trafficking, thus reducing DRA expression at the 
membrane. Adapted from Viswanathan et al., (Viswanathan et al., 2009). 
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1.5.2.3 EPEC inhibition of inflammation and the innate immune response 
Intestinal epithelial cells play a critical role in immune surveillance within the gut, prompting 
initiation of the pro-inflammatory response following the detection of pathogenic bacteria. 
EPEC is detected through the recognition of bacterial surface proteins, including LPS and 
flagella by PRR TLR4 and TLR5 respectively (Zhou et al., 2003; Edwards et al., 2011). These 
receptors are predominantly located on the basolateral membrane of polarised epithelial 
cells and are thus largely inaccessible to EPEC during the early stages of infection (Ruchaud-
Sparagano et al., 2007; Ruchaud-Sparagano et al., 2011). TLR agonist binding stimulates the 
activation of pro-inflammatory signalling pathways such as MAPK and NFB, leading to the 
initial increase of cytokines such as IL8. EPEC inhibits these signalling pathways soon after 
infection through the cooperative action of several T3SS dependent effector proteins, prior 
to the disruption of barrier function, thereby reducing the pro-inflammatory response to 
infection (Figure 11).  
EPEC effectors NleE and NleB are both reported to modulate the innate immune response by 
subverting the NFB signalling pathway. These effector proteins act by stabilising the 
interaction between NFB and its inhibitory subunit IB, by preventing the phosphorylation 
of the latter by associated kinase IKK (Figure 11) (Nadler et al., 2010; Newton et al., 2010). 
This step is necessary for the dissociation/degradation of the IB subunit, enabling the 
translocation of active NFB to the nucleus for transcription of pro-inflammatory genes. The 
capacity of NleE to inhibit NFB signalling is thought to depend on its S-adenosyl-L-
methionine-dependent methyltransferase (SAM) activity (Zhang et al., 2012). Upon TLR 
stimulation (Figure 11), the adaptor protein TNF receptor associated factor 6 (TRAF6) is 
recruited to the receptor complex, in addition to TGF-activated kinase 1 (TAK1) and TAK 
binding proteins 2 and 3 (TAB2/3). This interaction leads to the subsequent phosphorylation 
and activation of TAK1, which in turn recruits and activates the IKK complex (Takeda and 
Akira, 2005). NleE dependent methylation of TAB2/3 prevents the activation of IKK thereby 
inhibiting the phosphorylation and degradation of the IB subunit (Figure 11) (Zhang et al., 
2012). In contrast to NleE, NleB inhibits NFB signalling induced by TNF, but not IL-1, in a 
manner dependent on its N-acetyl-D-glucosamine (GlcNAc) transferase activity. NleB blocks 
TNF receptor associated factor 2 (TRAF2) but not TRAF6 dependent NFB activation; 
mediated through inhibition by GlcNAcylation of the TNF receptor (TNFR) adaptor protein, 
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known as TNFR1 associated death domain (TRADD) (Figure 11) (Li et al., 2013; Pearson et al., 
2013). 
Inhibition of the NFB signalling pathway has also been attributed to the activity of effectors 
NleH1 and NleH2. Although less potent than NleE or NleB, both NleH effectors have been 
found to inhibit the nuclear translocation of NFB for gene transcription. Royan et al, have 
demonstrated ectopic expression of NleH1 and NleH2 can supress IB degradation and NFB 
activation following stimulation with TNF (Royan et al., 2010). However, NleH1 and NleH2 
may differentially regulate NFB gene transcription through its interaction with cofactor, 
ribosomal protein s3 (RPS3). Necessary for the transcription of some NFB dependent genes, 
NleH1 but not NleH2 can inhibit RPS3 nuclear translocation, thus preventing transcription of 
pro-inflammatory genes (Figure 11) (Gao et al., 2009). 
Disruption to NFB signalling is further potentiated by the effector NleC, reported to inhibit 
translocation of NFB to the nucleus through cleavage of proteins p50 and c-Rel, with 
specificity for the p65 subunit (Figure 11) (Yen et al., 2010; Baruch et al., 2011; Ruchaud-
Sparagano et al., 2011; Giogha et al., 2015). This cleavage is dependent on the zinc-
metalloprotease activity of NleC. NleD also possess zinc-metalloprotease activity, though in 
contrast to NleC cleaves the MAPK signalling components p38 and JNK, thereby preventing 
activation of the pro-inflammatory transcription factor AP1 (Figure 11) (Baruch et al., 2011). 
Furthermore, the LEE effector Tir can also inhibit NFB induced inflammation through 
supressing TRAF2 and TRAF6 mediated signalling, which is independent of Intimin binding 
(Ruchaud-Sparagano et al., 2011). Interacting directly with TRAF2 and indirectly with TRAF6, 
via tyrosine phosphatases SHP1 and SHP2, Tir has been shown to inhibit their downstream 
activation of NFB and inhibit IL8 expression (Yan et al., 2012; Yan et al., 2013). 
The collective actions of these effector proteins effectively suppress the inflammatory 
response to EPEC infection. Interestingly, the EPEC effector protein NleF has been suggested 
to contribute to the activation of NFB and induction IL8 secretion during infection (Pallett 
et al., 2014). With the exception of Tir, it is interesting to note the prominent role of Nle 
effectors in manipulating MAPK/NFB signalling pathways. 
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1.5.2.4 EPEC manipulates host cell survival 
Apoptosis, also known as programmed cell death, is an important early host defensive 
strategy to infection; used to remove infected cells without emitting systemic alarm signals. 
Manipulating host cell survival mechanisms is an important feature of EPEC infection, 
necessary to promote colonisation and maintain an infective niche. EPEC infection is 
associated with early (altered membrane composition) but not late (cell shrinking, 
membrane blebbing & nuclear fragmentation) markers of apoptosis, suggesting a capacity to 
delay the onset of cell death (Santos and Finlay, 2015). This is achieved through the careful 
balance of pro- and anti-apoptotic effector proteins, delivered into host cells via the T3SS. 
LEE encoded effectors, Map and EspF, trigger the induction of cell death by similar 
mechanisms. Targeted to the mitochondria via their N-terminal sequence, Map and EspF 
disrupt the mitochondrial membrane potential triggering release of cytochrome c (Figure 11) 
(Nougayrede and Donnenberg, 2004; Ma et al., 2006; Papatheodorou et al., 2006). This leads 
to the formation of the apoptosome and activation of initiator caspase-9, which in turn 
activates the executioner caspases, -3 and -7, that cleaves cellular proteins resulting in cell 
death (Zou et al., 2003; Nougayrede and Donnenberg, 2004). In addition, EspF is also 
reported to target the ABC transporter AbcF2 for degradation that may contribute to the 
activation of caspases-9 and -3 (Nougayrede et al., 2007).  
EPEC effector proteins can also delay the onset of cell death to allow the establishment of 
infection, antagonising the activities of pro-apoptotic proteins. As described earlier, NleD 
can cleave JNK thus preventing the activation of transcription regulator AP1 and 
transcription of pro-apoptotic proteins (Figure 11) (Baruch et al., 2011). NleB is also 
proposed to prevent apoptosis through the inhibition of death receptor signalling, 
dependent on by its GlcNAc transferase activity. Ligand binding of death receptors, such as 
TNF-TNF receptor or FAS ligand-FAS receptor, triggers recruitment of death domain 
adaptor proteins including TRADD and Fas associated death domain (FADD) respectively 
(Figure 11). Both receptor pathways induce apoptosis through the activation of protein 
caspase cascade. NleB GlcNAcylates the death domains of TRADD and FADD, thereby 
preventing their recruitment and activation of pro-apoptotic signals (Li et al., 2013; Pearson 
et al., 2013). NleH1 and NleH2 are reported to inhibit apoptosis by reducing the levels of 
active caspase-3 (Figure 11). Furthermore, NleH1 has been shown to interact with the Bax 
inhibitor 1 (BI-1) thus inhibiting Bax mediated permeablisation of the mitochondrial 
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membrane, release of cytochrome c and activation of caspase-3 (Figure 11) (Hemrajani et 
al., 2010). NleF is also reported to play a role in preventing cell death through binding and 
inhibiting the catalytic activity of initiator caspase-9, thereby decreasing caspase-3 activation 
(Figure 11) (Blasche et al., 2013).  
Interestingly, the LEE effector EspZ is proposed to promote the survival of host cells by 
multiple mechanisms. EspZ has been shown to interact with the transmembrane protein 
CD98, promoting 1-integrin/FAK mediated host survival signals in addition to AKT 
phosphorylation (Figure 11) (Shames et al., 2010). However, recent reports have suggested 
this is likely an artefact of the cell line (HeLa) used, with the precise influence of EspZ on AKT 
phosphorylation remaining inconclusive (Roxas et al., 2012). Additionally, EspZ may also 
counteract the pro-apoptotic activities of effectors Map and EspF through its interaction 
with the mitochondrial membrane translocase Tim17b. Shames et al, have suggested this 
interaction with Tim17b stabilises the mitochondrial membrane potential, preventing the 
release of cytochrome c (Shames et al., 2011; Roxas et al., 2012). Moreover, EspZ is also 
proposed to regulate effector protein translocation into host cells via the T3SS through its 
interaction with EspD in the membrane pore (Berger et al., 2012). This regulation of effector 
protein delivery is thought to control the balance of pro- and anti-apoptotic effectors, thus 
delaying the onset of cell death.  
During the initial stages of EPEC infection, pro-survival signalling is also mediated through 
the cell surface EGFR receptor; stimulating the activation of the PI3K/AKT signalling pathway 
and expression of anti-apoptotic genes (Roxas et al., 2007). EGFR signalling is subsequently 
terminated by cleavage of the receptor after prolonged infection in a caspase dependent 
manner. This T3SS dependent degradation of the EGFR is dependent on the effector protein 
EspF; however, this activity is prevented during the early stages of infection by the effector 
EspZ (Roxas et al., 2014). The conflicting activities of these effector proteins manipulating 
host survival signalling highlights the complexities of the EPEC infection strategy. Whilst 
these antagonistic and overlapping functions are hard to reconcile, they may represent the 
hierarchy of effector translocation and timing of subversive activities. 
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1.5.2.5 EPEC Inhibition of phagocytosis 
Phagocytosis is a key innate immune mechanism responsible for the internalisation and 
degradation of invading pathogens. Phagocytosis is triggered either directly from recognition 
of bacterial structures known as cis-phagocytosis (TLR and Savenger receptor mediated 
detection of LPS) or indirectly through detection of attached immune opsonins known as 
trans-phagocytosis (Fc and complement receptor 3 [CR3] mediated detection of IgG and 
C3bi respectively). EPEC infection maintains a predominantly extracellular lifestyle whilst 
evading immune detection by preventing their uptake through intestinal microfold cells (M-
cells) and professional phagocytes such as macrophages. This inhibition is dependent on the 
collective action of effector proteins, targeting both the cis and trans phagocytosis signalling 
pathways. EspH has recently been identified as an inhibitor of both cis and trans mediated 
phagocytosis, likely mediated through its capacity to bind and inhibit the DH-PH domain of 
RhoGEFs (Dong et al., 2010). This prevents the activation of RhoGTPase, thereby preventing 
actin remodelling and phagosome formation. Interestingly, the Nle effector protein EspJ is 
recognised to inhibit trans-phagocytosis of both IgG and iC3b opsonised bacteria. This 
inhibition is proposed to occur through the inhibition of Src family kinases (SFK) by EspJ, 
preventing actin driven opsono-phagocytosis (Marches et al., 2008; Young et al., 2014). 
In addition to EspB’s critical role in T3SS effector translocation, this effector protein is also 
implicated in the inhibition EPEC phagocytosis. As discussed earlier, EspB can bind myosin 
motor domains of myosin family proteins (myosin-1c, -2, -5, -6 & -10), thus preventing their 
interaction with actin filaments (Iizumi et al., 2007). This disruption to actin dynamics 
therefore prevents pseudopod extension of the membrane, around the invading bacterium, 
and loss of myosin dependent closure of the phagocytic cup. Additionally, the effector 
protein EspF can also inhibit cis-phagocytosis by targeting the PI3K signalling pathway. EspF 
inhibits the activation but not the recruitment of PI3K to the membrane, which is thought to 
prevent actin cytoskeletal rearrangements necessary for phagosome formation and 
internalisation of the bacterium (Celli et al., 2001). This inhibition of PI3K activity was also 
correlated with the loss of AKT phosphorylation at Ser473. However, studies by Quitard et 
al., have since uncoupled the two events, indicating the loss of AKT phosphorylation occurs 
independently of EPEC manipulation of PI3K activity (Quitard et al., 2006). Whilst the 
mechanism by which EPEC inhibits PI3K activity is unknown, it has been shown this activity 
of EspF is dependent on the N-terminal region (101 residues) (Quitard et al., 2006). 
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Figure 11 Modulation of cell death and inflammatory signalling pathways by EPEC.  
The disruption of mitochondria or activation of TNF receptor (TNFR), FAS receptor (FASR) 
and toll like receptors (TLR) signalling triggers the onset of cell death and expression of pro-
inflammatory genes. EPEC effector proteins disrupt these inflammatory signalling pathways 
and delay host cell apoptosis by targeting multiple components of the MAPK (Tir & NleD), 
NFB (Tir, NleB, NleC, NleE & NleH1) and caspase (Tir, NleB, NleF & NleH1/2) signalling 
cascade. EPEC inhibits these signalling pathways through the cleavage of host proteins or 
inhibiting their activation by effector mediated post-translational modification (methylation 
or GlcNAcylation) as indicated. EPEC induces host cell death by apoptosis through disruption 
of mitochondria membrane potential (EspF & NleD). However, EPEC can antagonise this 
effector induced cell death through inhibition of mitochondria membrane disruption (EspZ & 
NleH1/2) or by promoting host cell survival signals (EspZ) triggered downstream of 1-
integrin and FAK mediated signalling. See text for further explanation. ER is endoplasmic 
reticulum and BI-1 is Bax inhibitor 1. Adapted from Wong et al., (Wong et al., 2011). 
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1.5.2.6 EPEC subverts phosphoinositide metabolism 
EPEC infection is increasingly recognised to involve the modulation of phosphoinositide 
metabolism to promote colonisation. As discussed earlier, phosphoinositides act as key 
signalling molecules (second messengers) by maintaining diverse lipid-protein and protein-
protein interactions. EPEC infection has been shown to induce the transient accumulation of 
PI[4,5]P2 and PI[3,4,5]P3 directly beneath its attachment site in a T3SS dependent manner 
(Sason et al., 2009). This accumulation of phosphoinositides is associated with the formation 
of cholesterol enriched lipid rafts, thought to promote effector translocation and pedestal 
formation. Indeed, PI[4,5]P2 has been associated with the recruitment of proteins key to 
pedestal formation, including Nck, WASP, Arp2/3, actinin, clathrin and dynamin (Sason et al., 
2009). The transient increase of PI[4,5]P2 suggests that EPEC induces an elimination phase, 
proposed to occur by two possible mechanisms: Tir-Intimin induced phosphorylation and 
activation of phospholipase C (PLC), converting PI[4,5]P2 to IP3; and/or Tir dependent 
activation of PI3K, triggering phosphorylation of PI[4,5]P2 to PI[3,4,5]P3 (Sason et al., 2009). 
Interestingly, Sason et al have shown that EPEC can recruit and activate of PI3K in a manner 
dependent on the phosphorylation of Tir residue Tyr454; likely mediated through binding of 
SH2 domains of PI3K regulatory subunit p85 (Sason et al., 2009). These results contradict 
previous reports supporting the ability of EPEC to inhibit PI3K activation in a manner 
dependent on the effector protein EspF (Celli et al., 2001; Quitard et al., 2006; Martinez-
Argudo et al., 2007). However, activation and recruitment of PI3K was correlated with the 
transient increase of PI[3,4,5]P3, thought to promote actin polymerisation and protrusion 
from the membrane (pedestal formation) (Sason et al., 2009). This elongation and 
polymerisation is then suggested to be terminated by the recruitment of SH2 domain 
containing inositol 5 phosphatase 2 (SHIP2) to Tir, inducing the dephosphorylation of 
PI[3,4,5]P3 to PI[3,4]P2 (Campellone, 2010). This recruitment is thought to occur through Tir 
associated immune receptor tyrosine based inhibition motifs (ITIMs), known to recruit SH2 
domain containing phosphatases (Smith et al., 2010). 
 
1.6 Summary and project aims 
Pathogenic bacteria such as EPEC employ a number of strategies to promote their 
colonisation and survival. The ability of EPEC to subvert host cellular functions is dependent 
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on its capacity to translocate up to 24 known effector proteins via a T3SS into target cells. 
These effector proteins subvert numerous cell signalling pathways, including those 
regulating the innate immune response and host cell survival. The mechanisms by which 
EPEC disrupts these signalling cascades is slowly being unravelled, providing valuable insight 
into the many components and complexity of these signalling pathways controlling the cell 
response. An interesting strategy identified during infection was the ability of EPEC to 
manipulate PI3K activity, phosphoinositide metabolism and AKT phosphorylation. Although 
effector proteins and mechanisms have been proposed through which EPEC targets and 
subverts PI3K activity, the precise mechanism for terminating AKT phosphorylation remains 
to be identified. AKT signalling is implicated in many cellular functions, including cell 
proliferation, apoptosis, transcription and metabolism. Understanding how EPEC disrupts 
AKT activity would provide greater understanding of the EPEC infection strategy and provide 
critical insight into the control of AKT signalling. This could prove useful in the development 
of agonists and/or antagonists where AKT signalling is overactive such as cancer.  
Due to the critical role of both LEE and Nle effector protiens to subvert host cell signalling 
pathways, it is hypothesised that one or more of these effectors may be required to disrupt 
AKT phosphorylation, and thus its activity. Therefore, the project aims are to examine the 
role of both LEE and Nle effector proteins, and to investigate the mechanism by which EPEC 
triggers the rapid decline of phosphorylated AKT. 
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2.1 Cell culture 
2.1.1 Bacterial strains and culture 
Bacterial strains used in this study are listed in Table 1. Bacteria cultures were streaked from 
-80˚C frozen culture stocks onto Luria-Bertani (LB) agar plates supplemented with 
antibiotic(s) (Nalidixic acid [50µg/ml], Carbenicillin [100µg/ml], Kanamycin [25µg/ml], 
Chloramphenicol [25µg/ml] and Tetracycline [12µg/ml] at final concentration) as 
appropriate for selection. For infection studies, single colonies were picked from LB agar 
plates and cultured in LB broth supplemented with selective antibiotic(s) and incubated 
overnight (16-18 h) at 37°C without shaking. For long-term storage, overnight LB broth 
cultured bacteria with antibiotic selection were diluted with 50% glycerol to a final 
concentration of 10% before storing at -80°C. 
On the day of experimentation, overnight bacterial cultures (37°C standing) were pre-
activated by dilution (1/10) in serum free Dulbecco’s minimal Eagles medium (DMEM; 
Sigma) supplemented, when needed, with antibiotic(s) for selection and incubated at 37°C 
with 5% CO2 for 3 h, unless otherwise indicated. The pre-activation of EPEC strains induces 
the synthesis of virulence proteins (including those of the T3SS), promoting rapid host cell 
binding and formation of characteristic disease phenotypes including A/E lesion formation, 
as described elsewhere (Rosenshine et al., 1996a). 
 
2.1.2 Mammalian cell culture 
Cell culture was performed under aseptic conditions in a Class 2 laminar flow hood (BioMat 
2). Cells were passaged in tissue culture flasks with a surface area of 25 cm2, 75 cm2 or 175 
cm2 (Corning) and maintained under sterile conditions in a humidified incubator at 37°C and 
5% CO2. J774.A1 macrophages (ATCC TIB-67) and HeLa cells (ATCC CCL-2) were cultured in 
DMEM, supplemented with 10% fetal calf serum (FCS; GIBCO). Cells were routinely cultured 
to ~80% confluence before passaging into a new tissue culture flask, at a 1:6 dilution. 
J774.A1 macrophages were isolated from tissue culture flasks using a rubber cell scraper 
following the replacement of cell culture media with fresh DMEM (5-15 ml). In contrast, 
HeLa cells were recovered from tissue culture flasks by trypsinisation (1 x Trypsin-EDTA 
[ethylenediamineacetic acid]; Sigma) for 10-15 min at 37°C and 5% CO2, following the 
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removal of media by washing cells with sterile 1x phosphate buffered saline (PBS; 137mM 
sodium chloride [NaCl], 2.7 mM potassium chloride [KCl], 10 mM disodium phosphate and 
1.8 mM monopotassium phosphate; pH 7.4). The resulting cell suspension of both cell lines 
were collected and the cell density determined by a 1:1 dilution in Trypan Blue (Sigma), with 
non-permeable and viable cells calculated by haemocytometer under a light microscope.  
Cell passage number was recorded, with cells passaged up to 30 times before cells were 
discarded. J774A.1 macrophage and HeLa cell stocks were prepared for long term storage in 
10% DMSO and 90% FCS at a concentration of 1x106/ml, before storing in liquid nitrogen. 
 
2.2 Molecular biology 
2.2.1 Plasmid extraction 
Bacteria carrying the plasmid for isolation were cultured overnight in 5 ml LB broth with 
appropriate antibiotic(s) for selection at 37°C shaking (~250 rpm). Bacteria were then 
harvested by centrifugation at 12,000 xg for 5 min at room temperature (RT) before isolating 
plasmid using the AccuPrep plasmid miniprep kit (Bioneer) according to manufacturer’s 
instructions. Concentration and purity of isolated plasmids was determined by using 
NanoDrop 100 spectrophotometer (Thermo Scientific). Concentration of the sample was 
measured using a reading at A260. Purity of the isolated plasmid was estimated by a ratio of 
A260:A230, with a value of ≥1.6 considered satisfactory. 
 
2.2.2 Preparation of electrocompetent bacteria 
Bacterial strains were cultured overnight at 37°C standing before diluting (1:100) in 100 ml 
LB broth with appropriate antibiotic(s) for selection at 37°C shaking (~250 rpm) for 2-4h, 
until an optical density (OD600) of 0.4-0.6. The resulting bacterial culture was centrifuged at 
12,000 xg for 15 min at 4°C before discarding the supernatant and re-suspending the 
bacterial pellet in ice cold 50 ml distilled H2O (d H2O). This bacterial cell suspension was 
again centrifuged at 12,000 xg 4°C for a further 15 min before repeating this wash step once 
more. Once complete, the resulting supernatant was discarded and remaining pellet re-
suspended in 20 ml sterile 10% glycerol and centrifuged at 12,000 xg and 4°C. Again, the 
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supernatant was discarded and pellet re-suspended in 100 μl of 10% glycerol before aliquots 
of 40 µl were ‘snap frozen’ in liquid nitrogen and stored at -80°C. All solutions were chilled to 
4°C and kept on ice between each step. 
 
2.2.3 Electroporation of bacteria 
Electrocompetent bacteria (40µl aliquots) were thawed on ice and incubated with 25-50 
ng/µl of plasmid DNA for 5-10 min, on ice. Bacteria-DNA suspension was then transferred to 
a 2 mm gap electroporation cuvette and electroporated at 2.5 kV, 200 Ω, 25 mF for 4.5 µs 
(GenePulser II; BioRad). Immediately after electroporation, transformed bacteria were re-
suspended in 1 ml super optimal broth with catabolite repression (SOC; 0.5% Yeast Extract, 
2% Tryptone, 10 mM NaCl, 2.5 mM KCl, 10 mM MgCl2, 10 mM MgSO4 & 20 mM Glucose) 
media pre-warmed to 37°C and incubated for a minimum of 1 h at 37°C. Post incubation, 50-
1000 µl of transformed bacterial suspension was plated onto LB agar plates with appropriate 
antibiotic(s) for the selection of plasmid(s) and incubated at 37°C overnight (16-18 h). Single 
colonies were picked and screened for expression of appropriate genes either by PCR and/or 
western blot analysis. Plasmids used in this study are listed in Table 2. 
 
2.2.4 PCR amplification of EPEC genes 
Oligonucleotide primers were designed using Clone Manager Professional Suite 8.0 
(Scientific and Educational Software) and are presented in Table 3. Colony PCR was 
performed using standard 25 µl PCR reactions prepared as follows: Template DNA (<1000 
ng), 1x Taq reaction buffer (New England Biolabs), dNTPs (200 µM; New England Biolabs), 
Taq DNA Polymerase (0.625 units; New England Biolabs) forward and reverse primers (0.2 
µM). Template bacterial DNA was obtained by boiling a single bacterial colony in 10 µl dH2O 
for 5 min at 100°C. Thermocycling was performed on a Veriti 96 well thermocycler (Applied 
Biosystems) using the cycling conditions listed in Table 4. 
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2.2.5 Agarose gel electrophoresis 
PCR reaction products were analysed by agarose gel electrophoresis, prepared with 0.7-1% 
w/v agarose in 1x TAE (40 mM Tris-acetate, 1 mM EDTA) buffer, supplemented with 
fluorescent nucleic acid stain GelRedTM (1:30,000; Biotium). DNA was mixed with 10x ficoll 
loading dye and loaded onto the gel alongside a 1 Kb DNA ladder (New England Biolabs). 
Samples were separated at 100 volts and products visualised using a UV transilluminator 
(Biorad) for image capture. 
 
2.3 Infection of mammalian cells 
2.3.1 Infection of J774.A1 macrophages 
2.3.1.1 Standard AKT phosphorylation assay with J774.A1 macrophages for protein 
extraction 
J774.A1 macrophages were seeded onto 6 well tissue culture plates at a density of 5x105 
cells per well 2 days prior to infection. Approximately 18 h before infection, cells were serum 
starved by replacing media with DMEM supplemented with 0.5% FCS, before starving cells in 
serum free DMEM for 1 h before infection. Where appropriate, cells were pre-treated with 
drugs at various concentrations (Table 5) in serum free DMEM for 1 h prior to infection and 
maintained in culture throughout the infection protocol. The OD600 of pre-activated bacterial 
cultures (see 2.1.1) were measured before infecting cells with bacterial strains (Table 1) at a 
multiplicity of infection (MOI) of 200:1 in a total volume of 2 ml and placed in an incubator 
with 5% CO2 at 37°C. Infections were stopped at various time points over a 2 h infection 
period by removing media and washing cells three times with chilled 1x PBS (4°C), to remove 
unbound bacteria, ready for isolation of protein extracts. 
 
2.3.1.2 Two-wave infection AKT phosphorylation assay with J774.A1 macrophages for 
protein extraction 
J774.A1 macrophages were seeded onto a 60 mm tissue culture dish at a density of 1.5x106 
cells per well 2 days prior to infection. Approximately 18 h before infection, cells were serum 
starved in DMEM supplemented with 0.5% FCS, before starving cells in serum free DMEM for 
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1 h before infection. The OD600 of pre-activated bacterial cultures (see 2.1.1) were measured 
before infecting cells with bacterial strains (Table 1) at an MOI of 200:1 in a total volume of 3 
ml and left to incubate in 5% CO2 at 37°C. Infections were stopped after 1 h by removing 
DMEM, washing cells with 1x PBS and incubating in 5% CO2 at 37°C with serum free DMEM 
supplemented with gentamicin (100 µg/ml; bactericidal levels) to kill extracellular bacteria, 
with or without inhibitors (when needed). After incubation, cells were again washed with 1x 
PBS and allowed to recover in fresh serum free DMEM for 1 h before infecting cells with the 
pre-activated EPEC strain, cfm-14, at an MOI of 100:1 in 5% CO2 at 37°C (Figure 12). 
Infections were stopped at various time points over a 1 h infection (15, 30 & 60 min) by 
removing media and washing cells three times with chilled 1x PBS (4°C) on ice, to remove 
unbound bacteria, ready for isolation of protein extracts. 
 
2.3.1.3 Phagocytosis Assay 
2.3.1.3.1 Single infection phagocytosis assay 
J774.A1 macrophages were seeded onto glass coverslips in a 24 well plate at a density of 
1.1x105 cells per well 2 days prior to infection. Approximately 1 h before infection, cells were 
incubated in fresh serum free DMEM. The OD600 of pre-activated bacterial cultures (see 
2.1.1) were measured before infecting cells with bacterial strains (Table 1) at an MOI of 
100:1 in a total volume of 1 ml and left to incubate in 5% CO2 at 37°C for 1 h. Infections were 
stopped by washing cells three times in 1x PBS and media replaced with fresh serum free 
DMEM supplemented with chloramphenicol (25 µg/ml; bacteriostatic levels) for 1 h to 
prevent further synthesis of EPEC effector proteins for T3SS dependent delivery into host 
cells. Cells were then washed three times in 1x PBS and fixed in 2.5% paraformaldehyde 
(PFA) for 20 min at RT and stored at 4°C prior to immunofluorescence staining. 
 
2.3.1.3.2 Two-wave infection phagocytosis assay 
J774.A1 macrophages were seeded onto glass coverslips in a 24 well plate at a density of 
1.1x105 cells per well 2 days prior to infection. Approximately 1 h before infection, cells were 
incubated in fresh serum free DMEM. The OD600 of pre-activated bacterial cultures (see 
2.1.1) were measured before infecting cells with bacteria strains (Table 1) at an MOI of 100:1 
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in a total volume of 1 ml and left to incubate in 5% CO2 at 37°C for 1 h. Infections were 
stopped by replacing media with fresh serum free DMEM supplemented with gentamicin 
(100 µg/ml; bactericidal levels) for 1h to kill extracellular bacteria. Cells were then washed 
with 1x PBS and left to recover in fresh DMEM supplemented with 10% FCS for 50 min, 
before replacing with serum free DMEM for a final 10 min incubation. After incubation, cells 
were infected with the pre-activated T3SS defective mutant carrying a plasmid encoding the 
green fluorescent protein (cfm-14/pGFP) in serum free DMEM at an MOI of 100:1 for 1 h, in 
a total volume of 1 ml, incubated in 5% CO2 at 37°C. Infections were stopped by washing 
cells three times in 1x PBS and media replaced with fresh serum free DMEM supplemented 
with chloramphenicol (25 µg/ml; bacteriostatic levels) for 1h to prevent further EPEC protein 
synthesis for T3SS dependent delivery of effector proteins into host cells. Cells were then 
washed three times in 1x PBS and fixed in 2.5% paraformaldehyde (PFA) for 20 min at RT and 
stored at 4°C prior to immunofluorescence staining (see 2.4). 
 
2.3.2 Cell viability 
2.3.2.1 Trypan blue assay 
J774A.1 macrophages were seeded onto 6 well plates and prepared for infection as 
described earlier (see 2.3.1.1). The OD600 of pre-activated bacterial cultures (see 2.1.1) were 
measured before infecting cells with bacterial strains (Table 1) at an MOI of 200:1 for 2 h in 
5% CO2 at 37°C. Infections were stopped by washing cells three times in 1x PBS before 
treating cells with a 1:1 mixture of trypan blue solution (Sigma) in 1x PBS and incubating in 
5% CO2 at 37°C for 5 min. Post incubation, cells were washed three times in 1x PBS before 
viewing by light microscope. Evaluation of cell viability and membrane integrity was assessed 
by visualising the permeability of cells to trypan blue dye. 
 
2.3.2.2 Lactate dehydrogenase (LDH) cytotoxicity assay 
The release of lactate dehydrogenase (LDH) from host cells was determined using the Pierce 
LDH Cytotoxicity Assay Kit (Thermo Fisher Scientific #88953); measuring the activity of LDH 
by formation of red Formazan product. Briefly, J774A.1 macrophages were seeded onto 24 
well plates and prepared for infection as described earlier (See section 2.3.1.3.1). The OD600 
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of pre-activated bacterial cultures (see 2.1.1) were measured before infecting cells with 
bacterial strains (Table 1) at an MOI of 200:1. Cells were left to incubate in 5% CO2 at 37°C 
before infections were stopped after 15, 30, 60, 90 and 120 min and supernatants collected. 
As per manufacturer’s instructions, uninfected cells were treated with a final concentration 
of 1x lysis buffer for 45 min prior to collecting supernatant for maximal LDH release. Sample 
supernatant was centrifuged at 250 xg for 3 min prior to transferring 50 µl to a flat bottomed 
96 well plate. Each sample was then mixed with 50 µl of reaction mixture (see 
manufacturer’s instructions) and left to incubate for 30 min protected from light. The 
reaction was stopped by the addition of 50 µl of stop solution before measuring the 
absorbance of the red reaction product Formazan at 490nm and 680nm using a FLUOstar 
opitma microplate reader (BMG Labtech). Percentage cell cytotoxicity induced by EPEC was 
calculated as follows: spontaneous release of LDH in uninfected cells is subtracted from that 
released in EPEC treated samples; this is then divided by maximum LDH activity (minus 
spontaneous LDH release) before multiplying by 100. Importantly, bacterial cell culture 
media did not alter the absorbance readings compared to DMEM alone. 
 
2.3.3 Infection of HeLa cells 
2.3.3.1 AKT phosphorylation assay with HeLa cells for protein extraction 
HeLa cells were seeded onto 24 well plates at a density of 2.5x105 cells per well 2 days 
before infection. Approximately 1 h prior to infection and/or treatment, cells were incubated 
in fresh serum free DMEM. Cells were either treated with epidermal growth factor (EGF; 100 
ng/ml final concnetration), Tumour necrosis factor α (TNFα; 10, 15 or 50 ng/ml final 
concentration) or infected with pre-activated EPEC strains in a total volume of 1 ml (Table 1). 
The OD600 of pre-activated bacterial cultures (see 2.1.1) were measured before infecting cells 
at a multiplicity of infection (MOI) of 100:1. Cells were left to incubate in 5% CO2 at 37°C for 
the indicated times before cells were washed three times in 1x PBS (4°C) on ice, ready for 
isolation of protein extracts.  
Alternatively, cells were left uninfected or infected with pre-activated EPEC strains at an MOI 
of 100:1 and left to incubate in 5% CO2 at 37°C for indicated times (1-5 h). Post incubation, 
cells were treated with agonists EGF (100 ng/ml) for 1 and/or 2 min before cells were 
washed three times in 1x PBS ready for isolation of protein extracts. 
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2.4 Immunofluorescence staining 
Following fixation of cells (2.5% paraformaldehyde) for 30 min, cells were washed three 
times in 1x PBS and probed for extracellular bacteria using appropriate primary antibodies 
against EPEC or E. coli (Table 6) for 1 h. Post incubation, cells were washed three times in 1x 
PBS and incubated with Alexa555 (Red) conjugated α-rabbit secondary antibody for 1 h. 
Again, cells were washed three times in 1x PBS and permeabilised in 1% Triton X-100 for 30 
min at RT, before incubating in appropriate primary antibody against EPEC or E. coli (Table 
6). Cells were then washed three times in 1x PBS before probing for total cell associated 
bacteria using Alexa488 (Green) α-rabbit secondary antibody. Host cellular and bacterial 
DNA was visualised by treating with the nuclear stain 4’6-diamidino-2-phenylinodole (DAPI; 
Blue). For two-wave infection studies, the total number of second-wave infected T3SS 
mutant bacteria (cfm-14) was determined by their expression of a plasmid encoded green 
fluorescent protein (pGFP; Green). Extracellular bacteria were labelled with anti-EPEC 
antibodies followed by Alexa 555 conjugated (Red) anti-rabbit antibodies. Coverslips were 
mounted onto glass slides using FluorSave reagent and imaged using Zeiss Axioskop 
epifluorescent microscope. The percentage of internalised bacteria was calculated by 
subtracting the number extracellular bacteria (labelled Red) from the total number of cell 
associated bacteria (labelled Green), divided by the total and then multiplied by 100. A total 
of 50 randomly selected cells per coverslip, each with a minimum of 20-30 cell-associated 
bacteria, were quantified in a semi-blind manner (identity of sample revealed post 
quantification). 
 
2.5 Protein analysis 
2.5.1 Isolation of cellular protein fractions 
Host cell proteins were isolated after appropriate infection protocols as described below. 
Using a cell scraper, total cellular protein extract was obtained by lysis of cells in 1X Laemmli 
sample buffer (60 mM Tris-HCl pH 6.8, 1% w/v SDS, 5% v/v glycerol, 5% v/v β-
mercaptoethanol & 0.01 % w/v bromophenol blue) for a concentration of ~10,000 cells/µl.  
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The isolation of host cellular protein fractions (cytoplasmic, membrane and insoluble 
proteins) was as previously described (Kenny et al., 1997; Kenny, 1999; Warawa and Kenny, 
2001). Briefly, cells were scraped into saponin lysis buffer (0.2% saponin, 1 mM PMSF, 1 mM 
NaF & 1 mM NaVO4 in ice cold 1x PBS) and centrifuged at 12,000 xg for 3 min at 4°C. The 
resulting cell supernatant, labelled host cytoplasmic proteins, was collected and stored on 
ice. The remaining cell pellet was washed in ice cold 1x PBS before re-suspending in Triton 
lysis buffer (1% Triton, 1 mM phenylmethylsulphonyl fluoride [PMSF], 1 mM sodium fluoride 
[NaF] & 1 mM sodium orthvanadate [NaVO4] in ice cold 1x PBS) and centrifuged at 12,000 xg 
for 3 min at 4°C. Again the resulting supernatant, labelled host membrane proteins, was 
isolated and stored on ice. The remaining cell pellet containing cell adherent bacteria, host 
nuclei and cytoskeletal proteins (insoluble proteins) was washed in 1x PBS 4°C before re-
suspending in 1X Laemmli sample buffer. Host cytoplasmic and membrane protein fractions 
were diluted in 5x Laemmli sample buffer for a final 1x concentration. Protein samples (total 
and fractionated proteins) were then boiled for 10 min at 100°C, before samples were 
vortexed and centrifuged at 13,000 xg at RT. All protein samples were stored at -20°C before 
subjecting to SDS-PAGE and western blot analysis. 
 
2.5.2 SDS-PAGE 
Isolated protein samples were denatured at 100°C for 10 min in Laemmli sample buffer and 
separated by polyacrylamide gel electrophoresis (SDS-PAGE). Protein samples of equal 
loading (derived from ~50,000 mammalian cells/well) were separated using a 10% 
polyacrylamide resolving gel (0.375 M Tris pH 8.8, 0.1% w/v SDS, 0.1% w/v ammonium 
persulfate & 0.1% v/v TEMED) and a 5% polyacrylamide stacking gel (0.125 M Tris-HCl pH 
6.8, 0.1% w/v SDS, 0.1% w/v ammonium persulfate & 0.1% v/v TEMED); all gels were 
prepared in dH2O. Polyacrylamide gels were loaded in to a vertical electrophoresis cell (Bio-
Rad) system, with electrophoresis performed using 1X SDS running buffer (25 mM Tris-HCl, 
192 mM glycine and 0.1 % w/v SDS; pH 8.3) for 1 h at 200 v. Once complete, gels were 
prepared for transfer to polyvinylidene fluoride (PVDF) membrane (GE Healthcare) for 
western blotting by tank (Wet) electrotransfer. 
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2.5.3 Western blot and quantification 
Transfer of proteins (separated by SDS-PAGE) onto PVDF membrane was performed in 1X 
transfer buffer (25 mM Tris & 192 mM glycine; pH 8.3) using the Mini Trans-Blot cell (Bio-
Rad) system for 60 min at 110 volts. Transfer success and gel loading levels was evaluated 
using Ponceau S, a staining solution designed for detecting proteins on nitrocellulose 
membranes (Sigma). Following transfer of proteins, PVDF membranes were removed of 
Ponceau S stain (1x PBS wash) and blocked in 5% (w/v) skimmed milk powder prepared in 
Tris buffered saline with Tween-20 (TBST; 150 mM NaCl, 10 mM Tris-HCl & 0.05% v/v Tween-
20; pH 7.5) for 1h at RT. PVDF membranes were removed from blocking buffer and washed 
3x 5 min washes in TBST, before incubating with primary antibody prepared in TBST with 5% 
(w/v) bovine serum albumin (BSA) overnight at 4°C. Primary antibodies and relevant 
dilutions used in this study are detailed in Table 6. Post incubation, membranes were 
removed and washed 3x 5min in TBST before incubating with appropriate HRP conjugated 
secondary antibody (Table 6) in TBST with 5% (w/v) skimmed milk powder for 1 h at RT, 
followed by a final wash step with 3x 5min in TBST. PVDF membranes were then exposed to 
ECL chemiluminesence substrate (Thermo Fisher Scientific) as per manufacturer’s 
instructions and imaged using a ChemiDoc imaging system (Bio-Rad). Quantification of 
protein signal, identified by western blot, was performed by densitometry analysis. 
Protein(s) identified by chemiluminescent signal of bound HRP-conjugated antibodies was 
quantified using Image Lab software (BioRad; V5.2.1), measuring the signal intensity of each 
protein band, adjusted for background signal and labelled as arbitrary units. The signal 
intensity of query/target protein was then normalised against a protein loading control 
(actin) before calculating as a fold change against uninfected control cells (unless otherwise 
stated). 
 
2.6 Statistical analysis 
Statistical analysis was performed using GraphPad Prism V6.0 (GraphPad software) to 
analyse data sets using a one-way or two-way analysis of variance (ANOVA) with additional 
Dunnett’s (*) or Sidaks (#) post-tests, as indicated respectively. P-values of p<0.05 were 
considered significant. 
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Figure 12 EPEC two-wave infection model.  
An illustration for the two-wave infection of the J774A.1 macrophage cell model to examine 
the impact of cells pre-infected with EPEC to trigger AKT phosphorylation or the 
phagocytosis of the T3SS mutant (cfm-14) following a second infection. (1) J774A.1 
macrophages are infected with selected EPEC strains. (2) Infections are stopped and 
extracellular bacteria killed by gentamicin treatment. (3) Cells are allowed to recover in cell 
culture media. (4) Cells pre-infected with EPEC strains are challenged with the T3SS defective 
mutant (cfm-14 ± pGFP) before analysing for AKT phosphorylation or percentage of bacteria 
uptake. 
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Bacterial Strain Description Antibiotic 
Selection 
Reference 
Wild-type (WT) EPEC 
E2348/69 (0127:H6) 
Prototypical EPEC strain. NalR (Levine et al., 
1985) 
Δcfm-14 Transposon-disrupted escN gene. 
Lacks functional Type 3 secretion 
system. 
NalS/KmR (Donnenberg and 
Kaper, 1991) 
ΔsepB (CVD452) 
E2348/69 
Lacks functional sepB gene. Type-
3-secretion system defective 
strain. 
NalR (Jarvis et al., 
1995) 
Class5 30-5-1(3) 
E2348/69 
Transposon-disruption which 
inactivates the Type 3 secretion 
system. 
KmR (Donnenberg et 
al., 1990) 
ΔespA (UMD872) Lacks EspA translocator protein 
(can’t deliver effector proteins). 
NalR (Kenny et al., 
1996) 
ΔespB (UMD864) Lacks EspB translocator protein 
(can’t deliver effector proteins). 
NalR (Donnenberg et 
al., 1993) 
ΔespD (UMD870) Lacks EspD translocator protein 
(can’t deliver effector proteins). 
NalR (Lai et al., 1997) 
ΔcesF Lacks EspF chaperone, CesF (cesF 
gene disrupted by introduced 
kanamycin cassette). 
NalR/KmR Kenny Lab, 
provided by B. 
Kenny 
(unpublished) 
ΔcesT::km Lacks chaperone, CesT (cesT gene 
disrupted by introduced 
kanamycin cassette) that 
promotes the delivery of many 
effectors. 
NalR/KmR Kenny Lab, 
provided by B. 
Kenny 
(unpublished) 
Δquad 
E2348/69 
Lacks Map, EspF, Tir effectors and 
Intimin (eae gene) surface protein 
NalR (Quitard et al., 
2006) 
Δmfzgorf3eh::km Lacks EspG, Orf3/EspG2, Map, 
EspF, EspZ, EspH effectors plus 
Intimin (eae gene) surface 
protein. espH gene disrupted by 
introduced gene encoding 
Kanamycin resistance. 
NalR/KmR Kenny Lab, 
provided by 
Azzeldin Madkour 
(unpublished) 
Δcore::km Lacking LEE region (replaced with 
kanamycin cassette) encoding 3 
effectors (EspH, Map, Tir) 2 
chaperones (CesT, CesF) and 
Intimin (eae gene) surface 
protein. 
NalR/KmR (Dean et al., 
2010) 
gorf3Δcore::km Δcore::km mutant also lacking 
another two effectors (EspG and 
NalR/KmR (Ruchaud-
Sparagano et al., 
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Bacterial Strain Description Antibiotic 
Selection 
Reference 
its homologue Orf3/EspG2). 2007) 
ΔespZ Lacks the EspZ effector. NalR Kenny Lab, 
provided by B. 
Kenny 
(unpublished) 
WT EPEC Japan 
E2348/69 (0127:H6)  
Prototypical EPEC strain provided 
by Tobe et al. 
Nals (Yen et al., 2010) 
TOE A1 Lack PP2 effector gene cluster. Nals (Yen et al., 2010) 
TOE A2 Lack PP2 & IE2 effector gene 
clusters. 
Nals (Yen et al., 2010) 
TOE A3 Lack PP2, IE2 & PP4 effector gene 
clusters. 
Nals (Yen et al., 2010) 
TOE A4 Lack PP2, IE2, PP4 & IE6 gene 
clusters. 
Nals (Yen et al., 2010) 
TOE A5 Lack PP2, IE2, PP4, IE6 & PP6 gene 
clusters. 
Nals (Yen et al., 2010) 
TOE A6 Lack PP2, IE2, PP4, IE6, PP6 & IE5 
gene clusters. 
Nals (Yen et al., 2010) 
TOE A7 Lack PP2, IE2, PP4, IE6, PP6, IE5 
gene clusters and LEE espG gene. 
Nals (Yen et al., 2010) 
TOE A7_Δcore::km Lacking genes espH, cesF, map, tir, 
cesT & eae [Intimin] from a TOEA7 
strain. 
NalS/KmR Kenny Lab, 
provided by B. 
Kenny 
(unpublished) 
TOB01 (E. coli K12) E. coli K12 strain carrying the 
pTOK-01 plasmid, encoding the 
bfp operon and perABC regulatory 
genes. All EPEC genes encoded on 
the plasmid originate from the 
EPEC B171-8 strain. 
KmR/CmpR (Yen et al., 2010) 
TOBO2 (E. coli K12) E. coli K12 carrying plasmids 
pTOK-01, encoding the bfp operon 
and perABC regulatory gene; and 
pTOK-02 encoding the LEE region. 
All EPEC genes encoded on 
plasmids originate from the EPEC 
B171-8 strain. 
KmR/CmpR (Yen et al., 2010) 
DH10B (E. coli K12) Innocuous E. coli K12 strain. NA Thermo Fisher 
Scientific 
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Table 1 Bacterial strains used in this study.  
Bacteria strains and their selective antibiotics: Nalidixic acid (NalR), Kanamycin (KmR), 
Carbenicillin (CarbR) and Chloramphenicol (CmpR). 
 
Plasmid Description Antibiotic 
Selection 
Reference 
pLG-HcFM 
(pHcFM) 
Carrying LEE genes espH, cesF & 
map. 
CarbR Kenny Lab, provided 
by B. Kenny 
(unpublished) 
pACYC-TcT (pTcT) Carrying LEE genes tir & cesT. CmpR Kenny Lab, provided 
by B. Kenny 
(unpublished) 
pGFP Carrying gfp gene. CarbR Kenny Lab, provided 
by B. Kenny 
(unpublished) 
 
Table 2 Plasmids used in this study.  
Plasmids used in this study (unpublished) were provided by B. Kenny. Antibiotic selection is 
indicated; Carbenicillin (CarbR) and Chloramphenicol (CmpR). 
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Name Oligonucleotide sequence 5’-3’ 
espH Forward Primer CCCTTTGGCAACCGTAAAGC 
espH Reverse Primer AAATATCGTCCCCAGAACAG 
espF Forward Primer ATGGAATTAGTAACGCTGCTTCTACAC 
espF Reverse Primer TTGGTTACCCTTTCTTCGATTGCTCATAG 
espG Forward Primer ACAAAAACTATGGCTGACGCATCAC 
espG Reverse Primer TTCAGCGCATGACATCTCATCCCAG 
espG2/orf3 Forward Primer TAGGTATAACCCTATGCCTGTGTTC 
espG2/orf3 Reverse Primer AACAAATTCAGGCTGACACAGTACC 
nleE1 Forward Primer CCAGTATGTATACCAGCAGTTCATGGTAAG 
nleE1 Reverse Primer ATTGGGCGTTTTCCGGATATAACTG 
nleD Forward Primer GCTTTATTATCGGGTTTGGTGACCGCCTTG 
nleD Reverse Primer AATAAGAGCTGAGTCGTGCGGGTAG 
nleE2 Forward Primer TTATTTCCACAGGCATGTAG 
nleE2 Reverse Primer TCCTGTTACTAATACTCAGGG 
espJ Forward Primer AAATAACCACCACTCCCACACCAGCGAAAC 
espJ Reverse Primer ATACCAAATGCGTTTTTTTGTGGGTTATAC 
nleF Forward Primer AAGGGGGTTTTGATATGTTACCAACAAGTG 
nleF Reverse Primer CCACGAGGCATTTCATTGCTCGTAG 
 
 
Table 3 Oligonucleotides used in this study.  
List of oligonucleotides designed in this study for confirmation of functional genes by PCR 
analysis. 
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Stage Temperature Time Cycles 
Initial denaturation 95°C 30 sec 1 
Denaturation 
Annealing 
Extension 
95°C 
56-68°C 
68°C 
30 sec 
60 sec 
60 sec 
 
30 
Final Extension 68°C 5 min 1 
 
 
Table 4 PCR Thermocycling conditions.  
Routine thermocycling conditions used for colony PCR analysis of genes. 
 
Inhibitor Description Working 
concentration 
Source 
Calyculin A Selective inhibitor of 
serine/threonine protein 
phosphatases, PP1 and 
PP2A. 
5-100 nM Calbiochem; 
#208851 
Okadaic Acid Selective inhibitor of 
serine/threonine protein 
phosphatases, PP2A. 
100-400 nM Sigma; # O-7885 
 
Table 5 Serine/Threonine phosphatase inhibitors used in this study.  
List of inhibitors and used in this study with respective working concentrations. 
 
Antibody Target Origin Dilution 
(IF) 
Dilution 
(WB) 
Company & 
Catalogue # 
Primary Antibodies 
EPEC 0127 Rabbit 1/100 NA Statens Serum Institute 
‘E. coli OK127 
monospecific OK rabbit 
antiserum; #44305 
E. coli (polyclonal) Rabbit 1/100 NA AMS Biotech; # 
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Antibody Target Origin Dilution 
(IF) 
Dilution 
(WB) 
Company & 
Catalogue # 
B65001R 
Tir Rabbit NA 1/5000 Kenny Lab 
EspF Rabbit NA 1/2000 Kenny Lab 
β-Actin Rabbit NA 1/2000 Sigma; A2066 
p-AKTser473 Rabbit NA 1/500 Cell Signalling; #4060 
p-AKTThr308 Mouse NA 1/500 Cell Signalling; #13038 
AKT (Pan isoforms 1, 2 & 
3) 
Rabbit NA 1/1000 Cell Signalling; #4691 
AKT1 Rabbit NA 1/1000 Cell Signalling; #2938 
AKT2 Rabbit NA 1/1000 Cell Signalling; #3063 
AKT3 Rabbit NA 1/1000 Cell Signalling; #8018 
p-PDK1Ser241 Rabbit NA 1/1000 Cell Signalling; #3438 
p-PTENSer380 Rabbit NA 1/1000 Cell Signalling; #9551 
p-C-RafSer259 Rabbit NA 1/1000 Cell Signalling; #9421 
p-GSK3βSer9 Rabbit NA 1/1000 Cell Signalling #5558 
EGFR Rabbit NA 1/200 Santa Cruz 
Biotechnology; #sc-03 
LDH Mouse NA 1/200 Abcam; #ab54288 
Secondary Antibodies 
Anti Rabbit IgG-HRP Goat NA 1/5000 Jackson Immuno 
Research; #111-035-
003 
Anti Mouse IgG-HRP Goat NA 1/5000 Jackson Immuno 
Research; #111-035-
003 
Anti Rabbit Alexa Fluor 
555 
Goat 1/200 NA Molecular Probes; 
#A11008 
Anti Rabbit Alexa Fluor 
488 
Goat 1/200 NA Molecular Probes; 
#A21428 
Nuclear Stain 
DAPI NA 1/1000 NA Invitrogen; #D1306 
 
Table 6 Antibodies for western blot or immunofluorescence analyses.  
List of antibodies selected in this study and their respective dilutions. 
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Chapter 3 Screening for the EPEC effectors required 
to trigger the rapid decline of phosphorylated AKT 
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3.1 Introduction 
3.1.1 The EPEC effector repertoire 
The importance of EPEC effector proteins to promote colonisation and subvert host cell 
function has become increasingly recognised over the past 2 decades (Dean et al., 2005). 
The first effector proteins identified were those encoded on the pathogenicity island known 
as LEE, which is highly conserved amongst A/E pathogens. In addition, effector proteins have 
been identified that are encoded outside the LEE region, known as non-LEE encoded (Nle) 
effectors, though some have retained the nomenclature ‘Esp’ (Elliott et al., 2001; Gruenheid 
et al., 2004; Dean and Kenny, 2009). The complete genome sequence of the prototypic EPEC 
strain (E2348/69) in 2009 led to the recognition of 21 effector proteins (7 LEE & 14 Nle) 
(Iguchi et al., 2009). Since then the EPEC effector repertoire has expanded further with the 
identification of additional effectors EspC (Vidal and Navarro-Garcia, 2008), NleJ and LifA 
(Deng et al., 2012). Furthermore, studies within the Kenny lab have identified 6 additional 
experimentally supported effectors (Dean et al., unpublished), suggesting the full EPEC 
effector repertoire is yet to be identified. 
Although the functions of many LEE and Nle effector proteins have been reported, full 
characterisation of effector activity and their role in EPEC pathogenesis remains to be 
defined (Dean and Kenny, 2009; Santos and Finlay, 2015). EPEC effector proteins function in 
a carefully orchestrated manner, exhibiting many examples of antagonistic actions, 
overlapping function (functional redundancy) and cooperative activity to subvert host 
cellular functions (Dean and Kenny, 2009; Schmidt, 2010; Santos and Finlay, 2015). This is 
exemplified by the cooperative and redundant activities of 3 effectors (Tir, Map & EspF) and 
the outer membrane protein Intimin to induce the effacement of absorptive microvilli of 
enterocytes (Dean et al., 2006). This not only highlights the complexity of host pathogen 
interactions but also demonstrates the difficulty in defining the contribution of specific 
effectors to subvert host cellular pathways. 
 
3.1.2 EPEC anti-phagocytosis 
EPEC inhibition of phagocytosis was initially identified using the rabbit form of EPEC (RDEC-
1); revealing the capacity of these bacteria to inhibit their uptake by intestinal microfold cells 
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(M-cells) (Inman and Cantey, 1983; Siebers and Finlay, 1996). Studies examining this 
mechanism of inhibition have predominantly utilised macrophages (J774A.1 & RAW264.7) as 
a more convenient and simplistic model to examine the interaction of EPEC with phagocytic 
cells (Law et al., 2013). These studies demonstrated that EPEC has the ability to inhibit its 
phagocytosis by the PI3K mediated pathway, dependent on a functional T3SS (Goosney et 
al., 1999). This inhibition of PI3K mediated phagocytosis was correlated with the rapid 
decrease of phosphorylated AKT (Ser473), routinely used as a marker of PI3K activity (Celli et 
al., 2001). However, the identification of EspF as the effector protein responsible for 
inhibiting PI3K dependent phagocytosis has uncoupled these two signalling events (Quitard 
et al., 2006). Quitard et al., were the first to identify the critical role of EspF, revealing EPEC 
strains lacking the EspF effector are unable to inhibit their uptake by the PI3K mediated 
pathway. These results were later supported by two independent studies in a macrophage 
(Tahoun et al., 2011) and M-cell model (Martinez-Argudo et al., 2007). Crucially, strains 
lacking EspF retained the capacity to induce the rapid loss of phosphorylated AKT. This latter 
finding suggests that EPEC induced inhibition of PI3K mediated phagocytosis and the rapid 
decrease of phosphorylated AKT (Ser473) are triggered by independent mechanisms. 
It is hypothesised that the rapid decline of infection-induced phosphorylated AKT is 
dependent on one or more of the 24 known EPEC effectors translocated into host cells. 
Therefore, to identify the critical virulence factors necessary to subvert AKT 
phosphorylation, bacterial strains that express or lack specific EPEC virulence factors were 
examined for their ability to decrease infection-induced phosphorylated AKT.  
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3.2 Results 
3.2.1 EPEC triggers a rapid T3SS dependent loss of phosphorylated AKT 
EPEC induced loss of AKT phosphorylation at Ser473 (p-AKTser473) is reported to be 
dependent on a functional T3SS (Celli et al., 2001; Quitard et al., 2006). Prior to screening for 
EPEC virulence factors responsible for this rapid decrease, it was first necessary to re-
establish this infection model. Thus, J774A.1 macrophages were left uninfected or infected 
with the pre-activated T3SS defective mutant, cfm-14 (unable to translocate effectors) or WT 
EPEC strain at an MOI of 200:1, before isolating total cell extracts over a 120 min infection 
period and processed for western blot analysis (see Materials and Methods).  
Infection with the cfm-14 mutant induced a strong increase in AKT phosphorylation (Figure 
13A). Increased levels of p-AKTser473 were detected at 15 min post infection and maintained 
above the level of uninfected control over the 120 min infection period (Figure 13A). In 
contrast, infection with WT EPEC strain induced only a transient increase in phosphorylated 
AKT, triggering the rapid decrease of p-AKTser473 signal at 60 min post infection (Figure 13B). 
These results are consistent with previous studies (Celli et al., 2001; Quitard et al., 2006). 
Total AKT and Actin (loading control) remained constant throughout the 120 min infection 
period with the cfm-14 mutant and WT EPEC strain (Figure 13A & Figure 13B). This sustained 
increase of p-AKTser473 levels over the 120 min infection period was also evident using 
alternative T3SS defective mutant’s ∆sepB (CVD452) and class5 mutant (Appendix Figure 1).  
The LEE effector Tir was used as a marker of T3SS effector protein translocation, 
representing the first and most abundantly delivered EPEC effector into target cells (Mills et 
al., 2008). Tir delivered into host cells undergoes modification by host cell kinases resulting 
in a shift in Mw from its unmodified (T0; 78 kDa) to modified form (T’’; 90 kDa) (Kenny et al., 
1997). As expected (Kenny et al., 1997), both forms of Tir (T0 & T’’) were detected in cells 
infected with the WT EPEC strain, with only the unmodified form evident post infection with 
the T3SS mutants: cfm-14, ∆sepB (CVD452) and class 5 (Figure 13 & Appendix Figure 1). The 
host modified form of Tir (T’’) was detected after 60 min of infection with the WT EPEC 
strain and correlated with the rapid loss of p-AKTser473 signal (Figure 13B). Comparison of 
these strains reveals the detection of the unmodified form of Tir (T0) by 15-30 min post 
infection with nalidixic acid sensitive (NalS) EPEC strains (cfm-14 & class5), in contrast to 60-
90 min of infection with nalidixic acid resistant (NalR) strains (WT EPEC & ∆sepB). The delay 
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in detection of the unmodified form of Tir (T0) with the WT EPEC and ∆sepB mutant was 
associated with a comparatively slower rate of growth (data not shown); linked to the 
acquired resistance to the antibiotic nalidixic acid (Nisa et al., 2013). This faster growth of 
NalS EPEC strains presumably accelerates the formation of stable EPEC-macrophage 
interactions, enabling the early detection of Tir (T0). For the remainder of this study all 
strains examined were of NalR genetic background, unless stated otherwise. 
To support the development of a reproducible and quantifiable method of analysing AKT 
phosphorylation (Ser473), western blots from multiple independent experiments were 
subjected to densitometry analysis; quantifying changes in p-AKTser473 signal, normalised to 
loading control (Actin) and calculated as a fold change of uninfected cells (see Materials and 
Methods). Actin, and not total AKT, was selected as a loading control to ensure 
normalisation of p-AKTser473 signal within the same blot; avoiding complications of comparing 
separate blots, or the stripping and re-probing of the same blot which can lead to loss or 
variable protein signal. Densitometry analysis supports the T3SS dependent decrease of 
phosphorylated AKT, revealing a significant increase of p-AKTser473 above the level uninfected 
control throughout the 120 min infection period with the cfm-14 mutant (Figure 13C). In 
contrast, this significant increase of p-AKTser473 signal is lost at 60 min post infection with the 
WT EPEC strain (Figure 13C). Furthermore, comparison of results reveals significantly 
reduced levels of p-AKTser473 at 30, 60, 90 and 120 min post infection with the WT EPEC 
strain than induced by the cfm-14 mutant (Figure 13C). Although not obvious from western 
blots, quantification data indicates a subtle decrease of p-AKTser473 levels towards latter 
stages of infection with the cfm-14 mutant (Figure 13C). This gradual decrease may 
represent the natural host mediated down regulation of phosphorylated AKT, possibly due 
to internalisation of the activating receptor (e.g. TLR, RTK, etc) (Husebye et al., 2006; Sorkin 
and von Zastrow, 2009) and/or dephosphorylation of AKT by protein phosphatases (Hers et 
al., 2011). This decrease of p-AKTser473 signal has previously been demonstrated over a 
similar time course following LPS stimulated AKT phosphorylation in macrophages (McGuire 
et al., 2013).  
Taken together, these results support the re-establishment of a robust and re-producible 
model to study the EPEC induced T3SS dependent loss of phosphorylated AKT. 
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Figure 13 EPEC induced loss of phosphorylated AKT requires a functional T3SS.  
(A & B) J774A.1 macrophages were left uninfected (0) or infected (MOI 200:1) with pre-
activated WT EPEC or T3SS mutant (cfm-14) strains. Total cell extracts were isolated (1x SDS 
sample buffer) at 15, 30, 60, 90 and 120 min post infection. Protein samples were separated 
by SDS-PAGE (10%) for western blot analysis probing for anti-p-AKTser473, anti-pan-AKT 
(detect all 3 isoforms), anti-Tir and anti-Actin (loading control) antibodies. Host kinase 
mediated modification of Tir, dependent on its T3SS delivery into host cells, is indicated by 
an apparent increase in molecular mass from its unmodified (T0) to its fully modified form 
(T’’) (Kenny et al., 1997). Where appropriate, immunoblots were cropped and moved for 
presentation purposes, indicated by a dashed line. (C) Densitometry analysis of western 
blots was performed using ImageLab software, with values representing a fold change in p-
AKTser473 signal, normalised to Actin (loading control) and calculated as relative change to 
uninfected control (0) cells. Quantification data are from a minimum of three independent 
experiments, with values shown being the mean ± SD. Statistical analysis was performed by 
two-way ANOVA followed by Dunnett’s post-test for comparison against uninfected control 
cells (****p<0.0001, ***p<0.001. **p<0.01 and *p<0.05) or by Sidak’s post-test for 
comparison of values at each corresponding time point (####p<0.0001, ###p<0.001, 
##p<0.01 and #p<0.05).  
 
 
Chapter 3 Results I 
 66 
3.2.2 The T3SS dependent loss of phosphorylated AKT requires functional 
translocator proteins 
In addition to the T3SS, effector protein translocation into host cells is dependent on 3 
translocator proteins, EspA, EspD and EspB; of which only EspB has known effector functions 
(Iizumi et al., 2007). To confirm the assumption that translocator proteins are critical for 
EPEC induced loss of phosphorylated AKT, J774A.1 macrophages were left uninfected or 
infected with the pre-activated ∆espB (lacking EspB) mutant at an MOI of 200:1 before 
isolating total protein extracts over a 120 min infection period and processed for western 
blot analysis (see Materials and Methods).  
Infection with the ∆espB mutant induced a robust increase in p-AKTser473 signal over the 120 
min infection period (Figure 14A), similar to that induced by the cfm-14 strain (Figure 13A). 
Lack of effector protein delivery with the ∆espB mutant was supported by detection of only 
the unmodified form of Tir (T0) in infected cell extracts (Figure 14A). Similar results were 
obtained with the additional translocator mutants, ∆espA and ∆espD (lacking EspA & EspD 
respectively), revealing a sustained increase in p-AKTser473 signal above the level of 
uninfected control over the 120 min infection period (Appendix Figure 2). Both strains were 
positive for the detection of the unmodified form of Tir only (T0) (Appendix Figure 2). 
Quantification analysis revealed the significant increase of p-AKTser473 levels at 60, 90 and 
120 min post infection with the ∆espB strain (Figure 14B). Furthermore, this increase of p-
AKTser473 levels were significantly greater than that induced by the WT EPEC strain after 60, 
90 and 120 min of infection. This p-AKTser473 profile was similar to that induced by the cfm-14 
mutant (Figure 13C), though notably more variable (note error bars); possibly due to the 
variability of cell binding with the ∆espB strain.  
This work reveals a critical role for translocator proteins in EPEC induced rapid loss of p-
AKTser473 signal, supporting the requirement for a functional effector delivery system for 
effector protein translocation into host cells. Collectively these findings suggest that one or 
more T3SS/translocator dependent effector protein(s) may affect AKT phosphorylation. 
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Figure 14 EPEC requires a functional effector delivery system to decrease phosphorylated 
AKT.  
(A) J774A.1 macrophages were left uninfected (0) or infected (MOI 200:1) with the pre-
activated ∆espB (lacking EspB translocator protein) strain. Total cell extracts were isolated 
(1x SDS sample buffer) at 15, 30, 60, 90 and 120 min post infection. Protein samples were 
separated by SDS-PAGE (10%) for western blot analysis probing for anti-p-AKTser473, anti-Tir 
and anti-Actin (loading control) antibodies. Host kinase mediated modification of Tir, 
dependent on its T3SS delivery into host cells, is indicated by an apparent increase in 
molecular mass from its unmodified (T0) to its fully modified form (T’’) (Kenny et al., 1997). 
(B) Densitometry analysis of western blots was performed using ImageLab software, with 
values representing a fold change in p-AKTser473 signal, normalised to Actin (loading control) 
and calculated as relative change to uninfected control (0) cells. Quantification data are from 
a minimum of three independent experiments, with values shown being the mean ± SD. 
Values for p-AKTser473 levels from WT EPEC infected cell extracts are taken from Figure 13. 
Statistical analysis was performed by two-way ANOVA followed by Dunnett’s post-test for 
comparison against uninfected control cells (****p<0.0001, ***p<0.001. **p<0.01 and 
*p<0.05) or by Sidak’s post-test for comparison of values at each corresponding time point 
(####p<0.0001, ###p<0.001, ##p<0.01 and #p<0.05). 
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3.2.3 EPEC induced loss of phosphorylated AKT is independent of 6 LEE effectors, 
the outer membrane protein Intimin and non-LEE effector EspG2/Orf3 
Studies by Quitard et al., have previously demonstrated the rapid loss of p-AKTser473 using 
the EPEC ∆quad mutant (lacks 3 LEE effectors [Map, EspF & Tir] & the outer membrane 
protein Intimin), similar to that of the WT EPEC strain (Quitard et al., 2006). To examine the 
role of LEE effector proteins, it was important to re-establish these results using the ∆quad 
mutant prior to screening the recently generated more complex LEE effector deficient strain, 
∆mfzgorf3eh::km (lacks the Nle effector EspG2/Orf3 & all known LEE effectors except Tir and 
EspB; Figure 15). Thus, J774A.1 macrophages were left uninfected or infected with the pre-
activated ∆quad or ∆mfzgorf3eh::km mutant at an MOI of 200:1 before isolating total 
protein extracts over a 120 min infection period and processed for western blot analysis (see 
Materials and Methods).  
 
 
Figure 15 Schematic of the complex LEE effector ∆quad and ∆mfzgorf3eh::km mutants.  
An illustration of the LEE region encoding T3SS dependent effector proteins (Blue), T3SS 
effector chaperones (Green), translocator proteins (Orange) and the outer membrane 
protein Intimin (Brown). Also presented is the non-LEE encoded (Nle) effector EspG2/Orf3 
encoded on the pathogenicity island IE5. EPEC strains ∆quad (Quitard et al., 2006) and 
∆mfzgorf3eh::km (A. Madkour et al., unpublished) were created by the disruption of LEE 
effector genes in addition to espG2/orf3; these strains and corresponding disrupted genes 
are indicated with a ‘x’. 
 
As reported (Quitard et al., 2006), infection with ∆quad mutant induced a transient increase 
in AKT phosphorylation (Figure 16A), similar to that of the WT EPEC strain (Figure 16B). 
Increased p-AKTser473 levels were detected at 15 and 30 min post infection, followed by a 
rapid decrease below uninfected control after 60 min of infection (Figure 16A). 
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Quantification analysis supports the significant increase of p-AKTser473 levels at 15 min post 
infection only (Figure 16B). Unexpectedly, this increase was significantly greater than that 
induced by the WT EPEC strain at 15 min post infection (Figure 16B). Importantly, infection 
with the ∆mfzgorf3eh::km mutant displayed a similar capacity to rapidly decrease the level 
of p-AKTser473 below uninfected control by 60 min post infection (Figure 16C). As a result, it 
was decided further repeat experiments were not required for quantification analysis to 
support this WT EPEC like p-AKTser473 profile. Detection of both the unmodified (T0) and 
modified form of Tir (T’’) was evident in cells infected with the ∆mfzgorf3eh::km, but not 
∆quad mutant, supporting the loss of a functional tir gene in the latter strain only (Figure 
16A & Figure 16C). The ∆mfzgorf3eh::km strain genotype was supported by PCR analysis for 
the disruption of the appropriate genes (Madkour et al., data not shown). For example, 
Figure 16D reveals the increase in size of the espH gene product by PCR analysis for the 
∆mfzgorf3eh::km, but not the ∆quad, strain. This supports the disruption of the espH gene 
by insertion of a kanamycin antibiotic cassette (Figure 16D). 
This work supports the non-essential roles (cooperative or individual) for 5 LEE effectors 
(EspZ, EspH, Map, EspF & EspG), the outer membrane protein Intimin and the Nle effector 
EspG2/Orf3, for EPEC to induce the rapid loss of phosphorylated AKT. Crucially, these strains 
do not discount a role for the LEE effector EspB, individually or in cooperation with Tir; 
maintained in the strain as a marker of T3SS functionality. 
 
Chapter 3 Results I 
 70 
 
 
  Chapter 3 Results I 
71 
Figure 16 EPEC strains lacking a subset of LEE encoded effector proteins do not prevent the 
rapid decrease of AKT phosphorylation.  
(A & C) J774A.1 macrophages were left uninfected (0) or infected (MOI 200:1) with pre-
activated EPEC Δquad (lacking LEE genes espF, map, tir & eae [intimin]) or Δmfzgorf3eh::km 
(lacking LEE genes eae [Intimin], map, espF, espZ, espH, espG & the EspG homologue 
espG2/orf3) mutant strains. Total cell extracts were isolated (1x SDS sample buffer) at 15, 
30, 60, 90 and 120 min post infection. Protein samples were separated by SDS-PAGE (10%) 
for western blot analysis probing for anti-p-AKTser473, anti-Tir and anti-Actin (loading control) 
antibodies. Host kinase mediated modification of Tir, dependent on its T3SS delivery into 
host cells, is indicated by an apparent increase in molecular mass from its unmodified (T0) to 
its fully modified form (T’’) (Kenny et al., 1997). Western blots presented are representative 
of three (A; Δquad) and one (C; Δmfzgorf3eh::km) independent experiment, with 
immunoblots (where appropriate) cropped and moved for presentation purposes, indicated 
by a dashed line. (B) Densitometry analysis of western blots was performed using ImageLab 
software, with values representing a fold change in p-AKTser473 signal, normalised to Actin 
(loading control) and calculated as relative change to uninfected control (0) cells. Values 
shown are the mean ± SD. Values for p-AKTser473 levels from WT EPEC infected cell extracts 
are taken from Figure 13. Statistical analysis was performed by two-way ANOVA followed by 
Dunnett’s post-test for comparison against uninfected control cells (****p<0.0001, 
***p<0.001. **p<0.01 and *p<0.05) or by Sidak’s post-test for comparison of values at each 
corresponding time point (#p<0.05). (D) PCR analysis of the EPEC Δquad and 
Δmfzgorf3eh::km mutants, probing for the disruption (by kanamycin gene; km) of the espH 
gene, indicated by a larger PCR gene product. PCR products were separated by agarose gel 
(1%) electrophoresis, stained with Gel Red and imaged by UV illumination. 
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3.2.4 E.coli K12 bacteria carrying the LEE region can inhibit PI3K mediated 
phagocytosis 
The effector activity of EspB cannot be distinguished from its critical role in effector 
translocation by a gene deletion strategy. To examine the effector activity of EspB and 
possible redundant activities of all LEE effectors, the ability of the LEE region to trigger the 
rapid loss of p-AKTser473 signal was examined using the E. coli K12 strain carrying the LEE 
region on a plasmid (Yen et al., 2010). This strategy has previously confirmed the sufficiency 
of the LEE region to induce A/E lesion formation (McDaniel and Kaper, 1997) and barrier 
disruption (Simonovic et al., 2000). The ability of the LEE region to rapidly reduce p-AKTser473 
levels was interrogated using the available strains TOB02, TOB01 and DH10B. As described 
(Yen et al., 2010), the TOB02 strain carries two plasmids, one encoding the LEE region (pLEE) 
and the other (pBFP_Per) encoding the bfp operon (coding for the bundle forming pilus) and 
perABC regulatory genes (encoding regulatory genes for BFP and LEE transcription) (Mellies 
et al., 1999; Mellies et al., 2007). In contrast, the TOB01 strain carries the plasmid pBFP_Per 
only (Yen et al., 2010), while the E. coli K12 strain (DH10B) is lacking of both these plasmids. 
Before interrogating the impact of LEE carrying TOB02 on AKT phosphorylation, it was first 
necessary to confirm whether this strain could induce a rapid LEE effector dependent 
subversive event. This was achieved by examining the ability of the TOB02 (K12/pLEE + 
pBFP_Per) strain to inhibit its uptake (phagocytosis) by J774A.1 macrophages. This inhibition 
of phagocytosis by the PI3K mediated pathway is linked to the activities of 3 LEE effector 
proteins, EspF (Quitard et al., 2006), EspH (Dong et al., 2010) and EspB (Iizumi et al., 2007). 
Thus, J774A.1 macrophages were infected with pre-activated WT EPEC, cfm-14, DH10B 
(K12), TOB01 (K12/pBFP_Per) or TOB02 (K12/pLEE + pBFP_Per) strains for 1 h at an MOI of 
100:1. Infections were stopped by the removal of bacteria and treated with chloramphenicol 
for 1 h, to prevent further effector protein delivery and ensure sufficient time for cell bound 
bacteria to be internalised. Following treatment, cells were fixed and stained using a 
differential fluorescence based antibody assay, distinguishing extracellular (Red) from total 
(Green) bacteria (Figure 17A), to determine the percentage of intracellular bacteria (see 
Materials and Methods). As reported (Goosney et al., 1999; Celli et al., 2001; Quitard et al., 
2006), the T3SS defective mutant (cfm-14) was readily internalised by J774A.1 macrophages 
with approximately 74.9% (±1.7%) of bacteria internalised (Figure 17A & B). In contrast, only 
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35.0% (± 6.2%) of WT EPEC bacteria were internalised, significantly less than the cfm-14 
mutant (p<0.0001; Figure 17B). Infection with LEE deficient K12 strains (DH10B & TOB01) led 
to a similar percentage uptake to the cfm-14 mutant, with 77.8% (±6.5%; p>0.9) and 77.4% 
(±8.2%; p>0.9) of bacteria internalised respectively (Figure 17A & B). Like the WT EPEC 
strain, infection with the TOB02 (K12/pLEE + pBFP_Per) strain led to significantly fewer 
bacteria being internalised than the cfm-14 mutant (46.8% ± 0.8%; p<0.001; Figure 17A & B). 
No significant difference in the percentage of uptake was identified between infections with 
the WT EPEC or TOB02 (K12/pLEE + pBFP_Per) strain. This work reveals, for the first time, the 
ability of the plasmid encoded LEE region to inhibit the uptake of E. coli by J774A.1 
macrophages. This confirms the capacity of the TOB02 (K12/pLEE + pBFP_Per) strain to 
induce a rapid LEE dependent subversive event. 
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Figure 17 LEE carrying TOB02 can inhibit PI3K mediated phagocytosis.  
(A) J774A.1 macrophages were infected for 1 h with pre-activated WT EPEC, cfm-14 (non-
functional T3SS), DH10B (E. coli K12), TOBO1 (E. coli K12 carrying plasmid encoding the bfp 
and perABC regulatory genes) or TOBO2 (TOB01 strain carrying plasmid encoding the LEE 
region) bacteria. Infections were stopped by washing of cells to remove non-adherent 
bacteria before treating with chloramphenicol [25 µg/ml] for 1 h to prevent further effector 
delivery and allow adherent bacteria time to be internalised. Post incubation, cells were 
fixed and examined by differential fluorescence antibody labelling. Cells were probed with 
anti-EPEC or anti-E. coli antibodies and detected using Alexa Fluor 555 anti-rabbit (Red; 
Extracellular bacteria). These cells were then permeablised (1% Triton X-100), probed with 
anti-EPEC or anti-E. coli antibodies and detected using Alexa Fluor488 anti-rabbit (Green; 
Total bacteria). Bacterial and host DNA was labelled with Dapi (Blue). (B) A total of 50 
randomly selected cells per experiment, with between 20-50 cell-associated bacteria, were 
quantified in a semi blind manner (strain identity revealed post-counting). Percentage of 
internalised bacteria was calculated by subtracting the number of extracellular bacteria 
(Red) from the total number of cell associated bacteria (Green), divided by the total (Green) 
and multiplied by 100. Data are from of three independent experiments, with values being 
the mean ± SD. Statistical analysis was performed by one-wave ANOVA followed by 
Dunnett’s post-test (****p < 0.0001, ***p < 0.001). 
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3.2.5 E. coli K12 bacteria carrying the LEE region cannot induce the rapid loss of 
phosphorylated AKT 
Having demonstrated the ability of the LEE carrying TOB02 strain to inhibit phagocytosis, the 
role of the LEE region to trigger the rapid loss of phosphorylated AKT was examined. Thus, 
J774A.1 macrophages were infected with pre-activated WT EPEC, TOB02 (K12/pLEE + 
pBFP_Per), TOB01 (K12/pBFP_Per) or DH10B (K12) strains at an MOI of 200:1, before 
isolating total protein extracts over a 120 min infection period and processed for western 
blot analysis (see Materials and Methods).  
As before (Figure 13B), infection with WT EPEC induced a transient increase in AKT 
phosphorylation (Figure 18A). This phosphorylation was visibly greater than uninfected 
control at 15 min post infection before rapidly decreasing to background levels after 60 min 
of infection (Figure 18A). In contrast, infection with strains DH10B (K12), TOB01 
(K12/pBFP_Per) and TOB02 (K12/pLEE + pBFP_Per) led to an increase in AKT phosphorylation 
at 15 min post infection that was maintained at/or above the level of uninfected control 
over the 120 min infection period (Figure 18A-D), similar to the T3SS defective mutant cfm-
14 (Figure 13A). However, it should be noted that not in all cases was this increase in p-
AKTser473 signal supported to be statistically significant by quantification. 
Bacterial strain genotypes were supported by the absence (DH10B & TOB01) or presence 
(WT EPEC & TOB02) of LEE encoded effector proteins EspF and Tir (Figure 18A-D). Detection 
of the host kinase modified form of Tir (T’’) supported a functional T3SS with the WT EPEC 
and TOB02 strain. Interestingly, detection of modified form of Tir (T’’) coincided with the 
rapid loss of p-AKTser473 in cells infected with the WT EPEC (detected at 60 min post infection; 
Figure 18A), but not TOB02 (detected at 90 min post infection; Figure 18D), strain. 
Microcolony formation was evident with the TOB01 (K12/pBFP_Per), TOB02 (K12/pLEE + 
pBFP_Per) and WT EPEC, but not DH10B (K12), strains supporting the functionality of 
plasmid encoding the adhesion protein BFP (Tobe and Sasakawa, 2001) (data not shown).  
Quantification analysis confirms a transient p-AKTser473 profile induced by the WT EPEC 
strain, revealing the loss of significantly increased p-AKTser473 at or below the level of 
uninfected control after 60 min of infection (Figure 18E). By contrast, this rapid loss of p-
AKTser473 signal was absent from cell extracts infected with the DH10B (K12), TOB01 
(K12/pBFP_Per) or TOB02 (K12/pLEE + pBFP_Per) strain; revealing a sustained increase of p-
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AKTser473 signal with a subtle decline towards background levels similar to the cfm-14 mutant 
(Figure 18E & Figure 13C). This decline of p-AKTser473 levels was greater for DH10B (K12) than 
TOB01 (K12/pBFP_Per) strain at 90 and 120 min post infection, which may indicate a factor 
on TOB01 (BFP) to promote AKT phosphorylation. Comparison of results against the WT 
EPEC strain reveals significantly greater levels of p-AKTser473 with the DH10B (60 min post 
infection) and TOB01 (60 & 90 min post infection), but not the TOB02, strain (Figure 18E). 
However, p-AKTser473 levels induced by the TOB02 strain were significantly lower than those 
induced with the TOB01 strain at 90 min post infection (Figure 18E). Together this suggests 
the TOB02 strain may have a weak capacity to stimulate/reduce the levels of p-AKTser473. 
This work suggests that E. coli strains with or without plasmids encoding the LEE region 
and/or BFP operon/perABC regulatory genes (DH10B, TOB01 & TOB02) do not stimulate a 
rapid loss of p-AKTser473, unlike the WT EPEC strain. Though able to inhibit phagocytosis 
(Figure 17), these results argue against the role for LEE encoded factors, alone, to induce the 
rapid loss of phosphorylated AKT. The latter finding implies that factors/effectors necessary 
to trigger the rapid decrease of p-AKTser473 are encoded outside the LEE region (non-LEE). 
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Figure 18 The LEE region does not encode the necessary factors to induce a rapid decrease 
in AKT phosphorylation.  
(A-D) J774A.1 macrophages were left uninfected (0) or infected (MOI 200:1) with pre-
activated WT EPEC, DH10B (E. coli K12), TOBO1 (E. coli K12 carrying plasmid encoding the 
bfp and perABC regulatory genes) or TOB02 (TOB01 strain carrying plasmid encoding the LEE 
region) bacteria. Total cell extracts were isolated (1x SDS sample buffer) at 15, 30, 60, 90 and 
120 min post infection. Protein samples were separated by SDS-PAGE (10%) for western blot 
analysis probing for anti-p-AKTser473, anti-EspF, anti-Tir and anti-Actin (loading control) 
antibodies. Host kinase mediated modification of Tir, dependent on its T3SS delivery into 
host cells, is indicated by an apparent increase in molecular mass from its unmodified (T0) to 
its fully modified form (T’’) (Kenny et al., 1997). Where appropriate, immunoblots were 
cropped and moved for presentation purposes, indicated by a dashed line. (E) Densitometry 
analysis of western blots was performed using ImageLab software, with values representing 
a fold change in p-AKTser473 signal, normalised to Actin (loading control) and calculated as 
relative change to uninfected control (0) cells. Quantification data are from a minimum of 
three independent experiments, with values shown being the mean ± SD. Statistical analysis 
was performed by two-way ANOVA followed by Dunnett’s post-test for comparison against 
uninfected control cells (****p<0.0001, ***p<0.001. **p<0.01 and *p<0.05) or by Sidak’s 
post-test for comparison of values at each corresponding time point (####p<0.0001, 
###p<0.001, ##p<0.01 and #p<0.05). 
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3.2.6 Pre-infection of cells with EPEC can prevent AKT phosphorylation stimulated 
by T3SS mutant (cfm-14) 
A possible problem identified with the established infection model was the unsynchronised 
infection of cells. This may lead to sub-populations of cells at early time points having none, 
few or many cell-associated bacteria to inhibit AKT phosphorylation, therefore accounting 
for subtle variations in the p-AKTser473 profile. To resolve this, a two-wave infection protocol 
was designed to examine the capacity of cells pre-infected with EPEC to stimulate AKT 
phosphorylation following a second infection with the T3SS mutant (cfm-14). Thus, J774A.1 
macrophages were left uninfected or infected with pre-activated WT EPEC or cfm-14 mutant 
(1st wave infection) strains for 1 h at an MOI of 200:1. Infections were stopped by treatment 
of cells with gentamicin (kill extracellular bacteria) for 1 h, followed by a 1 h recovery period 
in fresh DMEM. Cells were then infected post recovery with the cfm-14 strain (2nd wave 
infection) at an MOI of 100:1. Cell extracts were isolated after the initial EPEC infection (post 
recovery in DMEM) and after 15, 30 and 60 min of infection with the cfm-14 mutant (2nd 
wave infection). The T3SS defective mutant (cfm-14) was selected for the second-wave 
infection due to its robust stimulation of AKT phosphorylation (Figure 13A). 
Analysis of 1st wave infections only (post gentamicin/recovery) revealed the increase in AKT 
phosphorylation, above the level of uninfected control, after infection with the cfm-14, but 
not the WT EPEC, strain (Figure 19A). A second infection of cells (2nd wave) pre-infected with 
the T3SS mutant (cfm-14) led to a robust increase in AKT phosphorylation after 15, 30 and 60 
min of infection with the cfm-14 strain (Figure 19A). In contrast, cells pre-infected with the 
WT EPEC strain led to only a weak increase of p-AKTser473 signal after 15, 30 and 60 min of 
infection with the cfm-14 mutant (Figure 19A). EPEC strain genotype was supported by the 
detection of the host kinase modified form of Tir (T’’) in cell extracts infected with the WT 
EPEC, but not cfm-14, strain (Figure 19A). Quantification analysis supports the robust 
increase in p-AKTser473 signal after a second infection with the cfm-14 mutant in cells pre-
infected with the cfm-14, but not WT EPEC, strain (Figure 19B). This reveals that the capacity 
of J774A.1 macrophages to induce AKT phosphorylation is prevented if cells are pre-infected 
with WT EPEC strain. 
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This work illustrates that pre-infection of cells for 1 h with EPEC can prevent the 
phosphorylation of AKT in a T3SS dependent manner, stimulated by a second infection with 
the cfm-14 mutant. 
 
3.2.7 Pre-infection of cells with LEE carrying E. coli K12 bacteria does not prevent 
AKT phosphorylation stimulated by T3SS mutant (cfm-14) 
To interrogate the suggested weak capacity of the LEE carrying TOB02 strain to prevent or 
decrease the levels of p-AKTser473 (Figure 18D), the capacity to stimulate AKT 
phosphorylation was examined in cells pre-infected with the TOB02 (K12/pLEE + pBFP_Per) 
strain in a 2-wave infection model. Thus, J774A.1 macrophages were left uninfected or 
infected with the DH10B (E. coli K12), TOB01 (K12/ pBFP_Per) or TOB02 (K12/pLEE + 
pBFP_Per) strain for 2 h at an MOI of 200:1 (1st wave infection). Infections were stopped by 
treatment of cells with gentamicin (kill extracellular bacteria) for 1 h, followed by a 1 h 
recovery period in fresh DMEM. Cells were then infected post recovery with the cfm-14 
strain (2nd wave infection) at an MOI of 100:1. Cell extracts were isolated after the initial 
EPEC infection (post recovery in DMEM) and after 15, 30 and 60 min of infection with the 
cfm-14 mutant (2nd wave infection). 
The analysis of 1st wave infections (post gentamicin/recovery) revealed the level of p-
AKTser473 is similar to that of uninfected control after infection with the DH10B (K12) or 
TOB02 (K12/pLEE + pBFP_Per) strain (Figure 20). In contrast, the 1st wave infection with 
TOB01 (K12/pBFP_Per) strain induced a notable increase in p-AKTser473 signal above 
background levels (Figure 20). A second infection of cells (2nd wave) pre-infected with strains 
DH10B (K12), TOB01 (K12/pBFP_Per) or TOB02 (K12/pLEE + pBFP_Per) led to an increase in 
p-AKTser473 signal above background levels after 15, 30 and 60 min of infection with the cfm-
14 mutant (Figure 20). However, quantification analysis reveals this increase of p-AKTser473 
signal after the second-wave infection is, though subtle, overall greater in cells pre-infected 
with the DH10B (K12) and TOB01 (K12/pBFP_Per), than TOB02 (K12/pLEE + pBFP_Per) strain 
(Figure 20B). Again, this may tentatively suggest that the TOB02 (K12/pLEE + pBFP_Per) 
strain/LEE encoded factor has some capacity to decrease the level of phosphorylated AKT or 
a reduced capacity to induce AKT phosphorylation. 
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Bacteria strain genotype was supported by detection of the host kinase modified form of Tir 
(T’’) in cells infected with the TOB02 but not DH10B or TOB01 strains (Figure 20A). The 
unmodified form of Tir (T0) is detected in all cells infected with the cfm-14 mutant as part of 
the 2-wave infection strategy (Figure 20A). As both the DH10B or TOB01 strain do not 
encode the effector Tir, detection of a band similar to the Mw of its unmodified form (T0) in 
1st wave infected cell extracts is likely due to a contamination of the sample or the non-
specific detection of an E. coli K12 protein (Figure 20A). 
This work suggests that pre-infection of cells with the TOB02 strain does not prevent the 
phosphorylation of AKT in a 2-wave infection model. However, the comparatively weak 
increase of p-AKTser473 levels in cells pre-infected with the TOB02 strain may indicate a weak 
capacity to decrease phosphorylated AKT or that this strain poorly stimulates AKT 
phosphorylation. This would support findings that the critical factors necessary to 
prevent/trigger a rapid decline of phosphorylated AKT are encoded outside the LEE region. 
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Figure 19 Infection triggered AKT phosphorylation is inhibited in a T3SS dependent manner 
in a two-wave infection model.  
(A) J774A.1 macrophages were left uninfected (Ctrl) or infected (MOI 200:1) for 1 h with pre-
activated WT EPEC or T3SS mutant (cfm-14) strains. Cells were washed to remove non-
adherent bacteria before treating with gentamicin [100µg/ml] for 1 h to kill extracellular 
bacteria, followed by a second wash step and final incubation in fresh DMEM for 1 h to allow 
for cell recovery. Post recovery, cells were left uninfected or infected with the cfm-14 strain 
(2nd infection; MOI 100:1) for 15, 30 and 60 min. Total cell extracts were isolated after the 
first infection (post gentamicin treatment and recovery) or following a 2nd infection with the 
cfm-14 strain. Protein samples were separated by SDS-PAGE (10%) for western blot analysis 
probing for anti-p-AKTser473, anti-Tir and anti-Actin (loading control) antibodies. Host kinase 
mediated modification of Tir, dependent on its T3SS delivery into host cells, is indicated by 
an apparent increase in molecular mass from its unmodified (T0) to its fully modified form 
(T’’) (Kenny et al., 1997). (B) Densitometry analysis of western blots was performed using 
ImageLab software, with values representing a fold change in p-AKTser473 signal, normalised 
to Actin (loading control) and calculated as relative change to uninfected control (Ctrl) cells. 
Data represent a single experiment. 
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Figure 20 LEE expressing E. coli K12 strain (TOB02) cannot inhibit AKT phosphorylation 
stimulated by second-wave infection with the T3SS mutant (cfm-14).  
(A) J774A.1 macrophages were left uninfected (Ctrl) or infected (MOI 200:1) for 2 h with pre-
activated DH10B (E. coli K12), TOBO1 (E. coli K12 carrying plasmid encoding the bfp and 
perABC regulatory genes) or TOB02 (TOB01 strain carrying plasmid encoding the LEE region) 
bacteria. Cells were washed to remove non-adherent bacteria before treating with 
gentamicin [100µg/ml] for 1 h to kill extracellular bacteria, followed by a second wash step 
and final incubation in fresh DMEM for 1 h to allow for cell recovery. Post recovery, cells 
were left uninfected or infected with the cfm-14 strain (2nd infection; MOI 100:1) for 15, 30 
and 60 min. Total cell extracts were isolated after the first infection (post gentamicin 
treatment and recovery) or following a 2nd infection with the cfm-14 strain. Protein samples 
were separated by SDS-PAGE (10%) for western blot analysis probing for anti-p-AKTser473, 
anti-Tir and anti-Actin (loading control) antibodies. Host kinase mediated modification of Tir, 
dependent on its T3SS delivery into host cells, is indicated by an apparent increase in 
molecular mass from its unmodified (T0) to its fully modified form (T’’) (Kenny et al., 1997). 
(B) Densitometry analysis of western blots was performed using ImageLab software, with 
values representing a fold change in p-AKTser473 signal, normalised to Actin (loading control) 
and calculated as relative change to uninfected control (Ctrl) cells. Data represent a single 
experiment. 
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3.2.8 The T3SS dependent loss of phosphorylated AKT is independent of 14 Nle 
effector proteins 
The EPEC effector repertoire consists of up to 17 known Nle effector proteins, implicated to 
inhibit a number of cell signalling pathways including the innate inflammatory response 
(Iguchi et al., 2009; Santos and Finlay, 2015). To investigate the requirement of 14 of the 
most studied Nle effector proteins to induce the rapid loss of p-AKTser473 signal, cells were 
infected with available EPEC strains TOEA1-A7 (Yen et al., 2010), lacking subsets or all 14 Nle 
effectors (Table 7). EPEC strains TOEA1-A7 carry additive deletions of effector gene clusters 
from three prophages (PP2, PP4 & PP6), three integrative elements (IE2, IE4 & IE5) and the 
LEE region in a NalS EPEC (WT EPEC Japan; E2348/69) strain background (Yen et al., 2010). 
EPEC Japan strain genotype was supported by PCR screening for the presence or absence of 
effector genes from each of the six genomic islands and/or LEE region (Figure 21), indicated 
in Table 7. The TOEA7 strain was the most complex mutant available, lacking functional 
genes for all effectors examined but the for LEE encoded espF gene (positive control; Figure 
21). Thus, J774A.1 macrophages were left uninfected or infected with pre-activated WT 
EPEC Japan or strains TOEA1-A7 at an MOI of 200:1 before isolating total protein extracts 
over a 120 min infection period and processed for western blot analysis (see Materials and 
Methods). 
Infection of cells with the WT EPEC Japan (NalS) strain induced a transient increase in AKT 
phosphorylation (Figure 22A), similar to that of our WT EPEC (NalR) strain (Figure 22B). 
Detection of the host-modified form of Tir (T’’) was again correlated with decreasing p-
AKTser473 signal at approximately 60 min post infection (Figure 22A). Quantification analysis 
supports this transient p-AKTser473 profile, revealing the significant increase of p-AKTser473 
levels at 15 and 30 min post infection before declining to background levels after 60 min of 
infection. (Figure 22B). Importantly, no significant difference in p-AKTser473 levels stimulated 
by the WT EPEC Japan or WT EPEC strain was identified over the 120 min infection period 
(Figure 22B). Furthermore, this transient p-AKTser473 profile was also identified in cells 
infected with the TOEA7 and TOEA6-A1 strains, revealing maximal phosphorylation at 15 min 
post infection (Figure 22C-D). Again, quantification analysis supported this transient increase 
of p-AKTser473 levels, revealing no significant difference between strains TOEA2-A7 over the 
120 min infection period (Figure 22D). 
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This work demonstrates that the 14 Nle effector proteins examined (Table 7) do not play 
critical roles (individual or cooperative) in the EPEC induced rapid decline of phosphorylated 
AKT. This would implicate the requirement for other non-LEE T3SS dependent factors, such 
as NleJ, LifA and/or EspC. 
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Table 7 Representation of the effector gene clusters deleted from TOEA1-A7 strains.  
EPEC Japan strains TOEA1-A7 carry deletions of effector gene clusters present on three 
prophages (PP2, PP4 & PP6), three integrative elements (IE2, IE5 & IE6) and the LEE region 
from a Nalidixic Acid sensitive (Nals) EPEC strain (WT EPEC Japan; E2348/69 background). 
Effector gene clusters were deleted in additive fashion indicated by a red box with missing 
genes indicated with a (-). The 14 functional Nle-encoding and two of the LEE effector genes 
are indicated by Red and Blue text respectively. 
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Figure 21 PCR analysis supports the strain genotype of TOEA1-A7 strains through absence 
of the appropriate effector genes.  
EPEC Japan strains TOEA1-A7 and WT EPEC Japan were screened by colony PCR to confirm 
the presence or absence of appropriate effector genes (Table 7). The effector genes selected 
for analysis represent one of the genes from each of the gene clusters deleted from each of 
the 3 prophages (PP2, PP4 & PP6), 3 integrative elements (IE2, IE5 & IE6) and the LEE region. 
Genes selected were: espF (LEE), espG (LEE), espG2/orf3 (IE5), nleF (PP6), nleE1 (IE6), nleD 
(PP4), nleE2 (IE2) and espJ (PP2). PCR products were separated by agarose gel (1%) 
electrophoresis, stained with Gel Red and imaged by UV illumination. Size of PCR products 
are indicated. 
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Figure 22 The T3SS dependent decrease of phosphorylated AKT is independent of 14 Nle 
effectors and the LEE effector EspG.  
(A & C) J774A.1 macrophages were left uninfected (0) or infected (MOI 200:1) with pre-
activated WT EPEC Japan or its derivative strains (TOEA1-A7; lacking subsets or all 14 Nle 
effector proteins & LEE effector EspG). Total cell extracts were isolated (1x SDS sample 
buffer) at 15, 30, 60, 90 and 120 min post infection. Protein samples were separated by SDS-
PAGE (10%) for western blot analysis probing for anti-p-AKTser473, anti-Tir and anti-Actin 
(loading control) antibodies. Host kinase mediated modification of Tir, dependent on its T3SS 
delivery into host cells, is indicated by an apparent increase in molecular mass from its 
unmodified (T0) to its fully modified form (T’’) (Kenny et al., 1997). Where appropriate, 
immunoblots were cropped and moved for presentation purposes, indicated by a dashed 
line. (B & D) Densitometry analysis of western blots was performed using ImageLab 
software, with values representing a fold change in p-AKTser473 signal, normalised to Actin 
(loading control) and calculated as relative change to uninfected control (0) cells. 
Quantification data is from 4 (WT EPEC Japan & TOEA7), 3 (TOEA6 & A4), 2 (TOEA3 & A2) 
and 1 (TOEA1) independent experiment, with values shown being the mean ± SD. Values for 
p-AKTser473 levels from WT EPEC NalR infected cell extracts are taken from Figure 13. 
Statistical analysis was performed by two-way ANOVA followed by Dunnett’s post-test for 
comparison against uninfected control cells (****p<0.0001, ***p<0.001. **p<0.01 and 
*p<0.05). Sidak’s post-test for comparison of values at each corresponding time point did 
not identify any statistically significant differences (#p<0.05). 
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3.2.9 EPEC strains lacking the central ‘core’ LEE region display a defect in 
stimulating the rapid loss of phosphorylated AKT 
The efficient translocation of most effector proteins (LEE & Nle) is dependent on the LEE 
encoded effector chaperones CesF and CesT (EspF, Tir, EspZ, EspH, Map, EspJ, NleG, NleH1, 
NleH2, NleB1, NleB2, NleC & NleA) (Mills et al., 2013). To help identify the effector(s) 
responsible for the rapid loss of phosphorylated AKT, studies interrogated whether this 
subversive event requires the T3SS effector chaperones CesF and CesT. This was investigated 
using the available chaperone defective mutant, ∆core::km (lacks LEE region that encodes 
EspH, Map, Tir, Intimin, CesF & CesT; Figure 23). Thus, J774A.1 macrophages were left 
uninfected or infected with the pre-activated EPEC ∆core::km strain at an MOI of 200:1 
before isolating total protein extracts over a 120 min infection period and processed for 
western blot analysis (see Materials and Methods). 
 
 
Figure 23 The EPEC ∆core::km mutant lacks the central core region of the LEE pathogenicity 
island.  
Illustration of the LEE region encoding: (1) T3SS dependent effector proteins (Blue), (2) T3SS 
chaperones (Green), (3) translocator proteins (Orange) and (4) the outer membrane protein 
Intimin [eae] (Brown). The EPEC ∆core:km strain lacks the central ‘core’ region highlighted in 
a red box (replaced by the kanamycin antibiotic gene). This strain no longer has functional 
espH, cesF, map, tir, cesT and eae [Intimin] genes.  
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Infection with the ∆core::km mutant induced a robust increase in AKT phosphorylation at 15 
min post infection (Figure 24A). This increase in p-AKTser473 signal was sustained above 
uninfected control cells before dramatically decreasing to background levels at the last (120 
min) time point (Figure 24A); correlating with significant levels of cell detachment (data not 
shown). This prolonged increase in AKT phosphorylation was likened to that induced by the 
T3SS defective mutant, cfm-14 (Figure 13A). The ∆core::km strain genotype was supported 
by the absence of Tir (T0/T’’) and the low levels of EspF in cell extracts (Figure 24A); the latter 
due to the absence of CesF chaperone (Elliott et al., 2002). Quantification analysis confirms a 
significant increase in p-AKTser473 above the level of uninfected control at 15, 30, 60 and 90 
min post infection before a dramatic decrease to background levels by 120 min post 
infection (Figure 24B). AKT phosphorylation induced by the ∆core::km mutant was 
significantly greater than that induced by the WT EPEC strain at 60 and 90 min post infection 
(Figure 24B). Similar results were obtained using an alternative ∆core-like strain, 
gorf3∆core::km (lacks the LEE effector EspG, its Nle homologue EspG2/Orf3, as well as 
proteins encoded on the central core LEE region; see Figure 23) (Appendix Figure 3). 
This work suggests that EPEC strains lacking the central ‘core’ LEE region are defective in 
their ability to induce a rapid loss of phosphorylated AKT; except for dramatic loss at the 120 
min time point, linked to cell detachment. Having discounted a role for the outer membrane 
protein Intimin and three LEE effectors (EspH, Map & Tir; Figure 15 & Figure 16) lacking in 
the ∆core::km mutant, this work implicates a requirement for chaperones CesF and/or CesT. 
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Figure 24 The EPEC ∆core::km strain displays a T3SS mutant-like phenotype, but for the 
dramatic loss of phosphorylated AKT at the final time point.  
(A) J774A.1 macrophages were left uninfected (0) or infected (MOI 200:1) with the pre-
activated ∆core:km (lacking LEE genes espH, cesF, map, tir, cesT & eae [Intimin]) strain. Total 
cell extracts were isolated (1x SDS sample buffer) at 15, 30, 60, 90 and 120 min post 
infection. Protein samples were separated by SDS-PAGE (10%) for western blot analysis 
probing for anti-p-AKTser473, anti-EspF, anti-Tir and anti-Actin (loading control) antibodies. 
Host kinase mediated modification of Tir, dependent on its T3SS delivery into host cells, is 
indicated by an apparent increase in molecular mass from its unmodified (T0) to its fully 
modified form (T’’) (Kenny et al., 1997). Where appropriate, immunoblots were cropped and 
moved for presentation purposes, indicated by a dashed line. (B) Densitometry analysis of 
western blots was performed using ImageLab software, with values representing a fold 
change in p-AKTser473 signal, normalised to Actin (loading control) and calculated as relative 
change to uninfected control (0) cells. Quantification data is from a minimum of three 
independent experiments, with values shown being the mean ± SD. Values for p-AKTser473 
levels from WT EPEC infected cell extracts are taken from Figure 13. Statistical analysis was 
performed by two-way ANOVA followed by Dunnett’s post-test for comparison against 
uninfected control cells (****p<0.0001, ***p<0.001. **p<0.01 and *p<0.05) or by Sidak’s 
post-test for comparison of values at each corresponding time point (####p<0.0001, 
###p<0.001, ##p<0.01 and #p<0.05). 
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3.2.10 EPEC strains unable to express or deliver EspZ induce increased host cell 
cytotoxicity 
The LEE effector protein EspZ plays a critical role in maintaining cell viability by preventing 
host cell cytotoxicity, apoptosis and cell detachment (Shames et al., 2011; Berger et al., 
2012; Roxas et al., 2012). Translocation of the effector EspZ into host cells is dependent on 
the LEE encoded chaperone CesT (Mills et al., 2013), which is absent form the ∆core::km 
strain. To support observations of significant cell detachment with the ∆core::km mutant 
and to help explain the dramatic loss of p-AKTser473 signal by 120 min post infection, cell 
viability was examined by the trypan blue exclusion assay (Strober, 2001). Thus, cells were 
left uninfected or infected with the WT EPEC, cfm-14 (T3SS defective), or ∆core::km mutant 
(lacking genes of the central core LEE region) strains at an MOI of 200:1 for 2 h. Non-
adherent bacteria were removed by washing cells before treating cells with trypan blue 
(0.2% in 1x PBS) and analysing the uptake of trypan blue by microscopy. Cells infected with 
the ∆core::km mutant revealed a significant reduction in cell density in comparison WT EPEC, 
cfm-14 or uninfected cells (Figure 25). Moreover, comparison of strains reveals a notably 
greater number of cells permeable to the trypan blue following infection with the ∆core::km 
mutant than WT EPEC, cfm-14 or uninfected cells (Figure 25). The latter findings suggest that 
a considerable number of cells infected with the ∆core::km mutant for 2 h are non-viable. 
Thus, the rapid decrease of p-AKTser473 after 2 h after of infection with the ∆core::km mutant 
may be due to a loss of cell viability.  
The loss of cell viability and high levels of cell detachment with the ∆core::km mutant was 
hypothesised to be caused by increased host cell cytotoxicity, due to the absence of 
chaperone CesT; thus preventing delivery of EspZ into host cells (Mills et al., 2013). To 
support the requirement of T3SS delivered EspZ to maintain host cell viability, J774A.1 
macrophages were infected with pre-activated WT EPEC, cfm-14 (T3SS defective), ∆core::km 
(lacks genes of the central core LEE region) or the ∆espZ (lacks a functional espZ gene) 
mutant at an MOI of 200:1. Cell culture supernatant was then sampled over a 120 min 
infection period for the release of cytosolic LDH (marker of cell toxicity) (Fotakis and 
Timbrell, 2006).  
As reported (Shames et al., 2010), infection with the cfm-14 mutant induced minimal host 
cell cytotoxicity, with <10% (p<0.05) of LDH released into the cell culture media at 120 min 
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post infection (Figure 26). In contrast, cells infected with the WT EPEC strain displayed a 
significant time dependent increase in LDH release at 60, 90 and 120 min post infection, with 
a maximal release of 27% (± 5%) at the final (120 min) time point (Figure 26). This increase in 
LDH release was significantly greater than that induced with the cfm-14 mutant after 90 or 
120 min of infection (Figure 26). Similar results were obtained with the ∆core::km and ∆espZ 
mutant, leading to a maximum release of 33% (± 9%) and 42% (± 9%) of total LDH 
respectively at 120 min post infection (Figure 26). Importantly, LDH release by the ∆core::km 
(90 & 120 min post infection) and ∆espZ (120 min post infection) mutant was significantly 
greater than that induced by the WT EPEC strain at corresponding times post infection 
(Figure 26). 
This work suggests that increased cell detachment and loss of cell viability identified in cells 
infected with the ∆core::km mutant is linked to the loss of CesT chaperone dependent 
translocation of the effector EspZ. This may have important implications for the rapid loss of 
p-AKTser473 signal at 120 min post infection. 
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Figure 25 The EPEC ∆core::km strain induces increased cell detachment and permeability 
to trypan blue.  
J774A.1 macrophages were left uninfected or infected (MOI 200:1) for 2 h with pre-activated 
WT EPEC, cfm-14 (non-functional T3SS) or ∆core::km (lacking LEE genes espH, cesF, map, tir, 
cesT & eae [Intimin]) strains. Cell viability was assessed post infection by trypan blue 
exclusion assay, with uptake of dye indicating a damaged/permeable cell membrane. Images 
are representative of two independent experiments taken by light microscope at 10x the 
objective. 
 
  Chapter 3 Results I 
99 
 
Figure 26 EPEC ∆core::km and ∆espZ mutants induce significantly greater host cell toxicity 
than WT EPEC strain.  
J774A.1 macrophages were infected (MOI 200:1) with pre-activated WT EPEC, cfm-14 (non-
functional T3SS), ∆core::km (lacking LEE genes espH, cesF, map, tir, cesT & eae [Intimin]) or 
∆espZ (lacking LEE effector EspZ) strains. Cell supernatants were isolated at 15, 30, 60, 90 
and 120 min post infection and LDH release quantified (see Materials and Methods). Values 
shown are the mean ± SD from a minimum of three independent experiments. Statistical 
analysis was performed by two-way ANOVA followed by Dunnett’s post-test for comparison 
against values at 15 min post infection (****p<0.0001, ***p<0.001. **p<0.01 and *p<0.05) 
or by Sidak’s post-test for comparison of values at each corresponding time point 
(####p<0.0001, ###p<0.001. ##p<0.01 and #p<0.05). 
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3.2.11 EPEC induced loss of phosphorylated AKT requires the LEE encoded CesT 
chaperone and/or effector Tir 
To identify the gene products whose absence from the ∆core::km mutant compromised the 
strains ability to rapidly decrease phosphorylated AKT, complementation studies were 
undertaken using the available constructs pHcFM (encoding genes espH, cesF & map) and 
pTcT (encoding genes tir & cesT). Thus, J774A.1 macrophages were left uninfected or 
infected with the pre-activated EPEC strains ∆core::km/pHcFM, ∆core::km/pTcT or 
∆core::km/pHcFM + pTcT at an MOI of 200:1 before isolating total protein extracts over a 
120 min infection period and processed for western blot analysis (see Materials and 
Methods). 
Infection with the ∆core::km/pHcFM strain induced a ∆core::km-like p-AKTser473 profile 
(Figure 27A & Figure 24A), with a significant increase of p-AKTser473 signal detected at 15, 30 
and 60 min post infection, before a dramatic decrease to background levels at the final (120 
min) time point (Figure 27A & Figure 27D). In contrast, infection with both the 
∆core::km/pTcT and ∆core::km/pHcFM+pTcT strains induced a transient increase in p-
AKTser473 levels (Figure 27B & Figure 27C), similar to that of the WT EPEC strain (Figure 13B). 
Both the ∆core::km/pTcT and ∆core::km/pHcFM+pTcT strains stimulated the increase of p-
AKTser473 signal above the level of uninfected control at 15 and 30 min post infection before 
decreasing rapidly to background levels thereafter (Figure 27B-D). Surprisingly, this infection 
induced increase of p-AKTser473 levels by the ∆core::km/pHcFM+pTcT strain was not found to 
be statistically significant (Figure 27D). Comparison of data against the WT EPEC strain 
revealed significantly greater levels of p-AKTser473 with the ∆core::km/pHcFM (60 min post 
infection) and ∆core::km mutant (60 & 90 min post infection) only (Figure 27D). Conversely, 
comparison against the ∆core::km mutant reveals significantly lower levels of p-AKTser473 at 
60 min post infection with the ∆core::km/pTcT and ∆core::km/pHcFM+pTcT strains.  
Strain complementation was supported by the presence of the pHcFM (encoding genes 
espH, cesF & map) and pTcT (encoding genes tir & cesT) plasmids being associated with 
greater levels of EspF (provides the EspF chaperone, CesF) and Tir (provides the Tir 
chaperone, CesT) respectively (Figure 27A-C). Detection of the host modified form of Tir (T’’) 
with the ∆core::km/pTcT and ∆core::km/pHcFM+pTcT strains was correlated with decreasing 
p-AKTser473 signal at approximately 60 min post infection respectively (Figure 27B & Figure 
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27C). Significant cell detachment was evident for cells infected with the ∆core::km and 
∆core::km/pHcFM, but not the ∆core::km/pTcT and ∆core::km/pHcFM + pTcT, strains over 
the 120 min infection period (data not shown). This supports the premise that the cell 
detachment phenotype is associated with the absence of the CesT chaperone, necessary for 
the translocation of EspZ into host cells. 
This work suggests reintroducing genes for CesT chaperone and/or the effector Tir restores 
the capacity of the ∆core::km strain to induce the rapid loss of p-AKTser473 signal and reduce 
significant cell detachment during infection. This suggests the effector(s) responsible for the 
rapid loss of p-AKTser473 signal is/are likely to be CesT chaperone dependent. 
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Figure 27 Re-introducing LEE genes tir and cesT restores the capacity of the ∆core::km 
mutant to rapidly decrease phosphorylated AKT.  
(A-C) J774A.1 macrophages were left uninfected (0) or infected (MOI 200:1) with the pre-
activated EPEC ∆core::km strain carrying plasmids pHcFM (encoding LEE genes espH, cesF & 
map) and/or pTcT (encoding LEE genes tir & cesT). Total cell extracts were isolated (1x SDS 
sample buffer) at 15, 30, 60, 90 and 120 min post infection. Protein samples were separated 
by SDS-PAGE (10%) for western blot analysis probing for anti-p-AKTser473, anti-EspF, anti-Tir 
and anti-Actin (loading control) antibodies. Host kinase mediated modification of Tir, 
dependent on its T3SS delivery into host cells, is indicated by an apparent increase in 
molecular mass from its unmodified (T0) to its fully modified form (T’’) (Kenny et al., 1997). 
Where appropriate, immunoblots were cropped and moved for presentational purposes, 
indicated by a dashed line. (D) Densitometry analysis of western blots was performed using 
ImageLab software, with values representing a fold change in p-AKTser473 signal, normalised 
to Actin (loading control) and calculated as relative change to uninfected control (0) cells. 
Quantification data is from a minimum of three independent experiments, with values 
shown being the mean ± SD. Values for p-AKTser473 levels from WT EPEC and ∆core::km 
infected cell extracts are taken from Figure 13 and Figure 24 respectively. Statistical analysis 
was performed by two-way ANOVA followed by Dunnett’s post-test for comparison against 
uninfected control cells (****p<0.0001, ***p<0.001. **p<0.01 and *p<0.05) or by Sidak’s 
post-test for comparison of values at each corresponding time point (####p<0.0001, 
###p<0.001, ##p<0.01 and #p<0.05). 
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3.2.12 EPEC strain lacking the CesT chaperone induces a ‘core’ mutant-like 
sustained increase of phosphorylated AKT 
To support this CesT dependent decrease of phosphorylated AKT, studies examined the 
impact of EPEC strains lacking only the CesT (∆cesT) or CesF (∆cesF) chaperones. Thus, 
J774A.1 macrophages were left uninfected or infected with the pre-activated WT EPEC, cfm-
14, ∆cesF or ∆cesT strains at an MOI of 200:1 before isolating total cell extracts after 15, 30, 
45, 60 and 90 min of infection and processed for western blot analysis (see Materials and 
Methods). The infection time course was reduced from 120 min to limit complications of 
significant cell detachment identified with strains lacking the CesT chaperone (Figure 25 & 
Figure 26).  
As expected, infection with the cfm-14 mutant induced a sustained increase in p-AKTser473 
levels over the 90 min infection period; contrasting with that of the transient p-AKTser473 
profile triggered by the WT EPEC strain (Figure 28A, B & E). This transient increase of p-
AKTser473 signal was also evident for the ∆cesF, but not ∆cesT, strain (Figure 28C & D). The 
latter illustrating a more sustained increase of p-AKTser473 signal before dramatically 
decreasing below background levels at 90 min post infection (Figure 28D & E) linked to 
increased host cell detachment (data not shown). Again, this cell detachment was associated 
with the absence of CesT chaperone dependent delivery of the effector EspZ into host cells. 
Crucially, these results were supported by quantification analysis indicating a transient (WT 
EPEC & ∆cesF) and sustained (cfm-14 & ∆cesT) increase of phosphorylated AKT respectively 
(Figure 28E). However, it should be noted this increase of p-AKTser473 signal stimulated by the 
∆cesF strain was not found to be significantly greater than uninfected controls throughout 
the infection period. Furthermore, this work was unable to identify any statistically 
significant differences in the levels of phosphorylated AKT induced by ∆cesF or ∆cesT strains, 
or when compared  with WT EPEC. Intriguingly, the p-AKTser473 profile induced by the ∆cesT 
strain was similar to that induced by ∆core::km mutant (Figure 24). EPEC strain genotype 
was supported by the absence (cfm-14 & ∆cesT) or presence (WT EPEC & ∆cesF) of the host 
modified form of Tir (T’’), in addition to the strong (cfm-14, WT EPEC & ∆cesT) and weak 
(∆cesF) detection of the effector EspF in respective cell extracts (Figure 28A-E). These 
findings support the requirement for an unknown CesT dependent effector to induce the 
rapid T3SS dependent decrease of phosphorylated AKT. 
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Figure 28 EPEC strains lacking the CesF, but not CesT, chaperone induce a WT EPEC-like 
decrease of phosphorylated AKT.  
(A-D) J774A.1 macrophages were left uninfected (0) or infected (MOI 200:1) with pre-
activated WT EPEC, T3SS mutant (cfm-14), ∆cesF (lacking LEE chaperone CesF) or ∆cesT 
(lacking LEE chaperone CesT) strains. Total cell extracts were isolated (1x SDS sample buffer) 
at 15, 30, 45, 60 and 90 min post infection. Protein samples were separated by SDS-PAGE 
(10%) for western blot analysis probing for anti-p-AKTser473, anti-EspF, anti-Tir and anti-Actin 
(loading control) antibodies. Host kinase mediated modification of Tir, dependent on its T3SS 
delivery into host cells, is indicated by an apparent increase in molecular mass from its 
unmodified (T0) to its fully modified form (T’’) (Kenny et al., 1997). Where appropriate, 
immunoblots were cropped and moved for presentation purposes, indicated by a dashed 
line. (E) Densitometry analysis of western blots was performed using ImageLab software, 
with values representing a fold change in p-AKTser473 signal, normalised to Actin (loading 
control) and calculated as relative change to uninfected control (0) cells. Quantification data 
is from a minimum of three independent experiments, with values shown being the mean ± 
SD. Statistical analysis was performed by two-way ANOVA followed by Dunnett’s post-test 
for comparison against uninfected control cells (****p<0.0001 and *p<0.05) or by Sidak’s 
post-test for comparison of values at each corresponding time point (#p<0.05). 
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3.2.13 The EPEC TOEA7Δcore::km mutant does not induce a rapid loss of 
phosphorylated AKT 
The recently generated TOEA7∆core::km mutant was the most complex EPEC mutant 
available (lacks 14 Nle effectors [Table 7] and the central ‘core’ LEE genes [Figure 23]); 
defective in the efficient delivery of up to 20 of the 24 known T3SS dependent effector 
proteins. This strain was examined with the expectation of a defect in the loss of 
phosphorylated AKT, similar to the ∆core::km mutant. Thus J774A.1 macrophages were 
infected with the pre-activated EPEC TOEA7∆core::km strain at an MOI of 200:1 before 
isolating total protein extracts over a 120 min infection period and processed for western 
blot analysis (see Materials and Methods). 
Infection with the TOEA7∆core::km mutant induced a robust and sustained increase in AKT 
phosphorylation (Figure 29A). This increase of p-AKTser473 levels was significantly greater 
than uninfected control throughout the 120 min infection period (Figure 29B), similar to that 
of the T3SS mutant, cfm-14 (Figure 13A). Furthermore, the levels of p-AKTser473 stimulated by 
the TOEA7∆core::km mutant was significantly greater than corresponding values triggered 
by the WT EPEC strain at 15, 30, 60, 90 and 120 min post infection (Figure 29B). In contrast 
to the ∆core::km mutant (Figure 24), no dramatic decrease of p-AKTser473 levels was evident 
by 120 min post infection (Figure 29A). Furthermore, no significant cell detachment was 
observed over the 120 min infection period (data not shown); linked to loss of CesT 
chaperone dependent delivery of EspZ into target cells. Strain genotype was supported by 
the absence of Tir (T0/T’’) and only weak detection of EspF in cell extracts infected with the 
TOEA7∆core::km mutant (Figure 29A). 
This work supports the requirement for the LEE encoded chaperone CesT to trigger the rapid 
loss of phosphorylated AKT. Furthermore, these findings suggest that the cell detachment 
identified with strains lacking CesT and/or EspZ requires one or more of the 14 Nle effectors 
lacking in the TOEA7∆core::km mutant. 
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Figure 29 The TOEA7∆core::km mutant displays a T3SS mutant-like (cfm-14) p-AKTser473 
profile.  
(A) J774A.1 macrophages were left uninfected (0) or infected (MOI 200:1) with the pre-
activated TOEA7∆core:km (lacking 14 Nle effectors [EspG2, NleA, NleB1, NleB2, NleC, NleD, 
NleE1, NleE2, NleF, NleG, NleH1, NleH2, EspJ & EspL], LEE effector EspG & proteins of the 
central core LEE region [EspH, Map Tir, CesF, CesT & Intimin]) strain. Total cell extracts were 
isolated (1x SDS sample buffer) at 15, 30, 60, 90 and 120 min post infection. Protein samples 
were separated by SDS-PAGE (10%) for western blot analysis probing for anti-p-AKTser473, 
anti-EspF, anti-Tir and anti-Actin (loading control) antibodies. Host kinase mediated 
modification of Tir, dependent on its T3SS delivery into host cells, is indicated by an 
apparent increase in molecular mass from its unmodified (T0) to its fully modified form (T’’) 
(Kenny et al., 1997). Where appropriate, immunoblots were cropped and moved for 
presentation purposes, indicated by a dashed line. (B) Densitometry analysis of western 
blots was performed using ImageLab software, with values representing a fold change in p-
AKTser473 signal, normalised to Actin (loading control) and calculated as relative change to 
uninfected control (0) cells. Quantification data is from a minimum of three independent 
experiments, with values shown being the mean ± SD. Values for p-AKTser473 levels from WT 
EPEC infected cell extracts are taken from Figure 13. Statistical analysis was performed by 
two-way ANOVA followed by Dunnett’s post-test for comparison against uninfected control 
(****p<0.0001, ***p<0.001. **p<0.01 and *p<0.05) or by Sidak’s post-test for comparison 
of values at each corresponding time point (####p<0.0001, ###p<0.001, ##p<0.01 and 
#p<0.05). 
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3.3 Discussion 
EPEC inhibition of PI3K mediated phagocytosis was previously correlated with the rapid loss 
of infection induced phosphorylated AKT in J774A.1 macrophages (Celli et al., 2001). This 
relationship has been uncoupled by the discovery of EspF deficient EPEC strains unable to 
inhibit PI3K dependent phagocytosis, yet inducing an EPEC-like rapid decline of 
phosphorylated AKT (Quitard et al., 2006). This study aimed to identify the T3SS dependent 
effector(s) responsible for EPEC to trigger the rapid decrease of phosphorylated AKT 
(Ser473). Screening of bacterial strains lacking or expressing subsets of EPEC effector 
proteins suggests that EPEC induced T3SS dependent decrease of phosphorylated AKT 
(Ser473) is independent of 7 LEE and 14 examined Nle effectors; implicating roles for other 
Nle effectors EspC (Guignot et al., 2015), NleJ, LifA (Deng et al., 2012), six putative effectors 
(experimentally supported effectors; Dean et al., unpublished) and/or other effectors not 
yet identified. Furthermore, this study suggests the effector(s) responsible for the rapid 
decline of phosphorylated AKT is dependent on the effector chaperone CesT. 
The initial aim of this chapter was to re-establish a robust J774A.1 macrophage cell model to 
study the impact of EPEC infection on AKT activity. Using this model, this study confirmed an 
EPEC induced T3SS dependent transient increase of phosphorylated AKT (Ser473) over an 
extended 120 min infection period; consistent with the literature over a 90 min infection 
time course (Celli et al., 2001; Quitard et al., 2006). The quantification of p-AKTser473 levels by 
densitometry analysis of western blots confirmed the reproducibility of these results for the 
first time. This analysis supported the rapid T3SS dependent decrease of infection-induced 
AKT phosphorylation (Ser473) to background levels after 60 min of infection with the WT 
EPEC strain, but not T3SS mutant (cfm-14). This defect in capacity to trigger a rapid decrease 
of phosphorylated AKT was also evident with strains lacking either of the three translocator 
proteins, EspA, EspB and EspD, which are critical for effector translocation into target cells. 
Thus, this work confirmed the previously assumed roles for translocator proteins to induce 
the rapid T3SS dependent decrease of p-AKTser473 signal, implicating the requirement for one 
or more T3SS/Esp translocon-dependent EPEC effector proteins. 
In this study, the effector protein Tir was used as a marker for cell adherence in total cell 
extracts, with detection of its host modified form (T’’) supporting a functional T3SS (Kenny et 
al., 1997). Indeed, Tir is the first and most abundantly delivered effector into target cells 
(Mills et al., 2008; Mills et al., 2013). Interestingly, detection of the host-modified form of Tir 
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(T’’) was correlated with the rapid T3SS dependent decrease of p-AKTser473 signal in this 
model at 60 min post infection with the WT EPEC strain. Since the requirement of Tir to 
trigger a rapid decrease of p-AKTser473 signal has previously been discounted (Celli et al., 
2001; Quitard et al., 2006), the decline of phosphorylated AKT was therefore linked to the 
T3SS translocation of other effectors into host cells.  
The mechanism of EPEC induced AKT phosphorylation in this macrophage model has not 
previously been examined, though this presumably requires the engagement of cell surface 
receptors, such as toll-like receptors (TLR). Whilst this mechanism was not investigated, it is 
interesting to note that infection induced AKT phosphorylation was evident before detection 
of the effector Tir (T0/T’’) in WT EPEC infected cell extracts, at 15 and 60 min post infection 
respectively. This suggests that EPEC induced AKT phosphorylation in this model is triggered 
by either: 1) a transient/early interaction of EPEC with macrophages (too few bacteria bound 
to detect with sensitive anti-Tir antibodies), likely involving cell surface proteins such as BFP 
and/or flagella; or 2) a diffusible factor such as LPS, a known stimulant of AKT 
phosphorylation in macrophages (McGuire et al., 2013). This infection induced increase of p-
AKTser473 is consistent with previous reports, indicating that EPEC cell contact and not cell 
uptake is responsible for PI3K dependent AKT phosphorylation (Celli et al., 2001). Future 
experiments could look to identify the responsible factor(s) by the treatment of cells with 
sterile EPEC culture supernatant, purified BFP, flagella and/or LPS. 
To investigate the role of LEE-encoded effectors in the rapid loss of phosphorylated AKT, 
studies re-examined a ∆quad mutant (lacks 3 LEE effectors [Map, EspF & Tir] & Intimin) and a 
more recently generated complex mutant ∆mfzgorf3eh::km (lacks all LEE effectors except for 
Tir [marker of T3SS functionality] & EspB [critical for effector delivery]). Consistent with 
studies by Quitard et al., using the ∆quad strain (Quitard et al., 2006), this study confirmed 
the infection induced transient increase of phosphorylated AKT, revealing the loss of p-
AKTser473 signal by 60 min post infection. Furthermore, this rapid decline of p-AKTser473 signal 
was also triggered by infection with the ∆mfzgorf3eh::km mutant. Collectively, this work 
discounted a role (individual or cooperative) for all LEE encoded effectors, except for EspB 
individually or in cooperation with Tir. 
EspB is the only translocator protein with known effector function (Iizumi et al., 2007); 
however, distinguishing this activity from its critical role in effector protein translocation is 
not possible using a gene deletion strategy. To interrogate the requirement for EspB effector 
Chapter 3 Results I 
 112 
activity (plus other LEE encoded factors), this study took an indirect approach to examine the 
ability of the LEE carrying E. coli K12 strain (TOB02/pLEE + pBFP_Per) to trigger the rapid 
decrease of infection induced phosphorylated AKT. Importantly, this strain was found to 
encode the necessary information to enable E. coli K12 to inhibit its uptake by macrophages; 
a rapid T3SS dependent phenotype linked to the activity of LEE effectors EspF (Quitard et al., 
2006), EspH (Dong et al., 2010) and EspB (Iizumi et al., 2007). This finding demonstrates, for 
the first time, the ability of the LEE region to inhibit phagocytosis in a manner linked to the 
inhibition of PI3K activity (Celli et al., 2001); an event upstream of AKT phosphorylation. 
However, whether this inhibiton of EPEC phagocytosis is indeed LEE sufficient, or dependent 
on the presence of the plasmid encoding BFP and Per regulatory genes (pBFP_Per) cannot be 
confirmed here. Resolving this question would require additional work, preferably using a 
TOB02 strain without plasmid encoding BFP and Per. Nevertheless, this work thus expands 
the number of known LEE dependent subversive events (McDaniel and Kaper, 1997; 
Simonovic et al., 2000).  
Analysing the infection with TOB02 (K12/pLEE + pBFP_Per) strain revealed the host modified 
form of Tir (T’’) at 90 min post infection; however, unlike the WT EPEC strain, this was not 
correlated with a dramatic loss of p-AKTser473 signal. Whilst a transient p-AKTser473 profile was 
not evident with the TOB02 (K12/pLEE + pBFP_Per) strain over the 120 min infection period, 
the levels of p-AKTser473 were notably weaker in comparison to the LEE negative controls 
TOB01 (K12/pBFP_Per) and DH10B (K12). This suggested two possibilities: 1) TOB02 is a poor 
stimulant of AKT phosphorylation, caused by poor cell binding (linked to weak detection of 
Tir [T0/T’’]) or reduced levels of p-AKTser473 stimulant (e.g. BFP); or 2) TOB02 has a weak 
capacity to reduce p-AKTser473 levels, implicating the need for other key factors encoded 
outside the LEE region (e.g. Nle effector proteins) to induce the rapid decline of 
phosphorylated AKT. Intriguingly, the greater levels of phosphorylated AKT with the TOB01 
(K12/pBFP_Per) than DH10B (K12) strain at 90 and 120 min post infection, supports the 
requirement for BFP to sustain the infection induced increase of p-AKTser473 signal. However, 
it should be noted that TOB0 strains were created using an E. coli K12 derivative of DH10B, 
known as EPI300 (unavailable at the time of experiment) (Yen et al., 2010). Further work is 
therefore required to confirm the p-AKTser473 profile with this plasmid free TOB0 strain 
(cured of pBFP_Per plasmid) to ensure there is no notable difference in ability to 
stimulate/sustain AKT phosphorylation. 
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The ability of the LEE region to induce the rapid decrease of p-AKTser473 signal was further 
interrogated in this study through the development of a two-wave infection model; an 
approach previously used to illustrate the capacity of EPEC to inhibit innate immune 
signalling (Ruchaud-Sparagano et al., 2007). This strategy illustrated, for the first time, the 
ability of EPEC to prevent AKT phosphorylation stimulated by second-wave infection with 
T3SS mutant (cfm-14). Importantly, this inhibition of AKT phosphorylation was dependent on 
a functional T3SS and was stable for at least 3 h (time between 1st & 2nd wave infections). 
Crucially, this capacity to inhibit AKT phosphorylation was not identified in cells pre-infected 
with the DH10B (K12), TOB01 (K12/pBFP_Per) or TOB02 (K12/pLEE + pBFP_Per) strain. 
However, it is interesting to note the levels of p-AKTser473 stimulated in cells pre-infected 
with the TOB02 (K12/pLEE + pBFP_Per) strain were again comparatively reduced. These 
results support the premise of a weak capacity of LEE region to prevent/reduce AKT 
phosphorylation. Though, as this work is from a single experiment, further work is required 
to confirm these observations and support the reproducibility of these results. 
It is important to note that the LEE, BFP and Per loci carried by the TOB0 strains were cloned 
from the alternative prototypic EPEC strain, B171-8 (Yen et al., 2010). Whilst there exists 
some divergence between the LEE effectors of EPEC B171-8 and our EPEC E2348/69 strain 
(e.g. 66% Tir, 66% EspB & 77% EspF protein identity), both LEE regions have demonstrated 
the capacity to translocate effector proteins (EspB dependent), induce intimate cell 
attachment (Tir dependent) (McDaniel and Kaper, 1997; Simonovic et al., 2000; Yen et al., 
2010) and inhibit phagocytosis (EspF, EspB & EspH dependent; this study); thus supporting 
the comparative function of both sets of LEE effectors. Nevertheless, whether this EPEC 
B171-8 strain has the capacity to induce a rapid loss of phosphorylated AKT has not 
previously been examined. Additional work is therefore required to determine the ability of 
the EPEC B171-8 strain and/or whether the sufficiency of the EPEC E2348/69 LEE region 
expressed in an E. coli K12 bacteria can prevent/reduce infection induced AKT 
phosphorylation.  
The examination of EPEC strains lacking most LEE effectors and the LEE carrying TOB02 
(K12/pLEE + pBFP_Per) strain, had argued the need for additional factors encoded outside 
the LEE region to trigger the dramatic loss of p-AKTser473 signal. In addition to the LEE region, 
the effector repertoire of EPEC includes up to 17 known Nle effector proteins (E2348/69). 
The requirement for 14 of the most studied Nle effectors was interrogated in this study 
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using the available strains TOEA1-A7. Created from a NalS EPEC background (WT EPEC 
Japan), assessment of this parental strain revealed the near identical loss p-AKTser473 signal as 
our WT EPEC NalR strain over the 120 min infection period. This decrease was characterised 
by the rapid decline of p-AKTser473 signal to background levels by 60 min post infection. 
Investigations with the complex Nle effector deficient strains (TOEA1-A7) supported this 
transient increase of phosphorylated AKT, with no obvious defect in capacity to decrease the 
p-AKTser473 signal. Crucially, this work discounted a key role (individual or cooperative) for 
the 14 examined Nle effectors (NleA, NleB1, NleB2, NleC, NleD, NleE1, NleE2, NleF, NleG 
NleH1, NleH2, EspJ, EspL & EspG2) and the LEE effector EspG. This implied that other T3SS 
dependent substrates, such as EspC (Guignot et al., 2015), LifA, NleJ (Deng et al., 2012), 6 
experimentally supported effectors (Dean et al., unpublished) and/or other effectors yet to 
be identified are required to trigger the rapid decline of phosphorylated AKT. 
The LEE encoded chaperones CesF and CesT are critical for the efficient translocation of up 
to 13 effector proteins (5 LEE & 8 Nle); with EspG, NleD and NleF the only known effectors 
translocated independently of both chaperones (Mills et al., 2013). To gain insight into the 
T3SS dependent factors responsible for inducing the rapid loss of phosphorylated AKT, an 
alternative approach was taken to examine the requirement for LEE encoded effector 
chaperones, CesF and CesT. This was initially investigated using the available, complex 
double chaperone mutant ∆core::km (lacks 3 LEE effectors: EspH, Map & Tir; 2 chaperones: 
CesF & CesT; and Intimin), revealing a T3SS mutant-like increase of p-AKTser473 levels, except 
for a dramatic loss of p-AKTser473 signal at 120 min post infection. This loss of p-AKTser473 
signal was associated with increased cell detachment, linked to the absence of the effector 
EspZ translocation into target cells (delivery is CesT dependent) (Shames et al., 2010; Berger 
et al., 2012; Roxas et al., 2012). This premise was supported by the significantly greater 
levels of LDH release (marker of cell cytotoxicity) at 90 and 120 min post infection with 
∆core::km and ∆espZ (lacks EspZ) mutant, than WT EPEC and cfm-14 strains. These results 
are consistent with previous reports (Shames et al., 2010; Berger et al., 2012). Importantly, 
re-introduction of genes encoding CesT and Tir, but not EspH, Map and CesF, on a plasmid 
restored the capacity of the ∆core::km mutant to trigger the rapid decline of p-AKTser473 
signal at 60 min post infection, similar to the WT EPEC strain. Furthermore, this had the 
added effect of preventing the significant increase of cell detachment identified at latter 
time points with the ∆core::km mutant when carrying plasmid encoding CesT and Tir (data 
  Chapter 3 Results I 
 115 
not shown). Having previously discounted a role for Tir and other LEE encoded CesT 
dependent effectors (EspZ, EspH & Map); this work suggested a key role for CesT chaperone 
to mediate the rapid decline of phosphorylated AKT. Thus, this suggests the effector(s) 
responsible is/are likely to be a CesT dependent Nle effector other than the 14 previously 
discounted. Indeed, the finding that infection with EPEC strains lacking the CesF, but not 
CesT, chaperone led to the WT EPEC-like decrease of phosphorylated AKT supported this 
assumption. 
Interestingly, studies using the recently generated complex effector mutant TOEA7∆core::km 
(lacks all known Nle effectors except EspC, LifA & NleJ, in addition to being theoretically 
unable to express or deliver all LEE effectors, except EspB), revealed a T3SS mutant-like (cfm-
14) sustained increase of phosphorylated AKT throughout the 120 min infection period. 
Importantly, the absence of a ‘core’ mutant-like (∆core::km & gorf3∆core::km) dramatic loss 
of p-AKTser473 signal at 120 min post infection was associated with the lack of significant cell 
detachment with this complex mutant (data not shown). This suggests that increased cell 
detachment/cytotoxicity identified with the ∆core::km mutant is dependent on one or more 
of the 14 Nle effector proteins absent from the TOEA7∆core::km strain. This may include one 
of the several Nle effector proteins with pro-apoptotic activities, such as NleD (Baruch et al., 
2011), NleB (Pearson et al., 2013), NleH (Hemrajani et al., 2010) and NleF (Blasche et al., 
2013). Deletion of the central core LEE region from the TOEA1-A6 strains should enable 
identification of the responsible effector(s) to mediate cell detachment and how/if they 
promote cell cytotoxicity associated loss of p-AKTser473 signal. Crucially, this work supports 
requirement for the CesT chaperone to trigger the rapid decline of phosphorylated AKT. 
However, this would require confirmation by the re-introduction of genes (CesT; CesT & Tir; 
and/or the core LEE region) on a plasmid to determine the capacity to restore the rapid loss 
of p-AKTser473 signal, similar to WT EPEC strain. 
As a consequence of increased host cell detachment triggered by EPEC strains lacking the 
CesT chaperone, there was a greatly reduced population of cells at the end of the 
experiment available for protein extraction and subsequent analysis. Whilst it is assumed all 
cells are infected equally (MOI 200:1) in this assay, it is possible that those cells remaining 
after infection with CesT deficient EPEC strains are not representative of the whole cell 
population, due to low and/or no evidence of infection. To corroborate our findings of a 
T3SS and CesT dependent decrease of p-AKTser473 signal, additional work could thus look to 
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examine the level of phosphorylated AKT in both the detached and adherent cells post 
infection by western blot analysis. Furthermore, antibody labelling of EPEC on remaining 
cells post-infection could support or not whether these cells are indeed infected and to what 
level. Alternatively, single cell analysis of those cells remaining could provide a more 
accurate interpretation of the level of AKT phosphorylation in those cells that are left post 
infection. 
In summary, this study has demonstrated the development of a reproducible and 
quantifiable model to examine the impact of EPEC infection on AKT phosphorylation. This 
work supports the literature of a T3SS dependent decrease of phosphorylated AKT and 
extends these observations to discount a key role for all known LEE and the 14 examined Nle 
effectors. Importantly, whilst the LEE region was shown for the first time to encode the 
necessary factors to inhibit PI3K mediated phagocytosis, it does not contain the necessary 
factors to trigger the rapid loss of p-AKTser473 signal; though it may have some capacity to 
prevent/reduce infection induced AKT phosphorylation. Furthermore, this study provides 
evidence to suggest the T3SS dependent loss of phosphorylated AKT requires a functional 
CesT chaperone, implicating roles for an unknown CesT dependent effector(s). These may 
include effectors EspC, LifA, NleJ, 6 putative effectors (identified T3SS substrates by 
bioinformatic analysis; Dean et al., unpublished) and/or other unknown Nle effectors. 
Though, whether there exists cooperative activity between LEE and Nle effectors to reduce 
phosphorylated AKT cannot be discounted here. This would indicate a need to examine 
strains lacking all LEE (except translocation critical EspB) and all 14 Nle effectors, in addition 
to EspC, NleJ, LifA and other candidate effector proteins. 
Crucially, further work is required to support and extend these findings to enable 
identification of the responsible CesT dependent effector(s) needed promote the rapid loss 
of p-AKTser473 signal. Future studies should therefore continue to optimise this J774A.1 
macrophage cell model to overcome the identified limitations; such as the infection induced 
EspZ linked cell detachment/cytotoxicity and the associated loss of p-AKTser473 signal. This 
could include the transfection of the EspZ effector into host cells prior to EPEC infection, 
though this is notably difficult in the macrophage cell model. 
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Chapter 4 Investigating the T3SS dependent 
decrease of phosphorylated AKT in a HeLa cell 
model 
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4.1 Introduction 
AKT signalling is stimulated downstream of receptor tyrosine kinase (RTK) and G-protein 
coupled receptor (GPCR) in a class I PI3K dependent manner. RTK family proteins include the 
cell surface epidermal growth factor receptor (EGFR), activated following the detection of 
the ligand epidermal growth factor (EGF). Although PI3K is the predominant mode of AKT 
activation, several studies have reported alternative PI3K independent mechanisms of AKT 
activation. These include the direct phosphorylation of AKT by host kinases such as activated 
CDC42 kinase 1 (ACK1) (Mahajan and Mahajan, 2010), Src kinase (Jiang and Qiu, 2003), IB 
kinase  (IKK) (Guo et al., 2011), and TANK-binding kinase (TBK1) (Joung et al., 2011). 
Indeed, the activation of these kinase and AKT signalling has been demonstrated 
downstream of TNFR and TLR activation, stimulated by detection of agonists TNFα and 
PAMPs (e.g. LPS) respectively (Jiang and Qiu, 2003; Pincheira et al., 2008; Guo et al., 2011; 
Cheung et al., 2015). 
EPEC infection targets the epithelial cells of the small intestine (enterocytes and M-cells). 
These cells are polarised with distinct apical and basolateral membranes, and are routinely 
studied in vitro using cell lines such as Caco-2 (polarised intestinal cell model), sometimes in 
co-culture with Raji B-lymphocytes (phagocytic M-cell model), or using J774A.1 macrophages 
as a simplistic model of phagocytic cells (M-cell like). However, non-polarised epithelial cell 
lines (HeLa cells) have also been extensively used to study EPEC pathogenesis (Law et al., 
2013). For example, HeLa cells have proved useful to characterise and dissect many aspects 
of EPEC infection, including pedestal formation (Knutton et al., 1989), T3SS dependent 
effector translocation hierarchy (Mills et al., 2013), as well as the functional analysis of 
delivered effector proteins such as Tir (Nieto-Pelegrin and Martinez-Quiles, 2009).  
In addition to macrophages (J774A.1), EPEC infection has previously been shown to reduce 
AKT phosphorylation in epithelial cell models, including non-polarised HeLa (Shames et al., 
2010) and polarised Caco-2 (Ruchaud-Sparagano et al., 2007) cells. HeLa cells offer particular 
advantages over polarised epithelial cell models (e.g. Caco-2, TC7 & T84) and J774A.1 
macrophages, including their ease of transfection and greater resistance to EPEC induced 
cell detachment (Kenny et al., unpublished data). HeLa cells may therefore provide an 
alternative, robust, stable and more amenable (transfection) model to interrogate the 
effectors responsible for EPEC to trigger the rapid decline of phosphorylated AKT; avoiding 
some of the limitations identified in J774A.1 macrophages.  
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Using HeLa cells, it was therefore hypothesised this model would support observations of a 
T3SS dependent decrease of phosphorylated AKT, aiding identification of the virulence 
factors required to subvert the AKT signalling pathway. The aim of this chapter was thus to 
develop a HeLa cell model to investigate the impact of EPEC infection on AKT 
phosphorylation. 
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4.2 Results 
4.2.1 EPEC does not stimulate AKT phosphorylation in HeLa cells under the 
conditions examined 
EPEC is reported to influence AKT phosphorylation in a number of cell models, including 
macrophages (J774A.1 & RAW 264.7), polarised (MDCK & Caco-2) and non-polarised 
epithelial (HeLa) cells (Roxas et al., 2007; Ruchaud-Sparagano et al., 2007; Sason et al., 2009; 
Shames et al., 2010; Roxas et al., 2012). Indeed, EPEC infection has been shown to decrease 
phosphorylated AKT in a HeLa cell model; however, previous work within the Kenny group 
has failed to recapitulate this result (Kenny et al., unpublished). To determine the capacity of 
EPEC to stimulate AKT phosphorylation in HeLa cells, cells were left uninfected or infected 
with the EPEC T3SS defective mutant (cfm-14) or WT EPEC strain at an MOI of 100:1 over a 
standard 120 min infection period before isolating total cell extracts at indicated times for 
western blot analysis. Samples infected with the cfm-14 mutant revealed no induction of 
AKT phosphorylation above the levels of uninfected control cells at all time points (Figure 
30A). Lack of infection induced AKT phosphorylation with cfm-14 mutant was not due to 
notable changes in levels of total AKT or Actin (loading control; Figure 30A). Similar results 
were found following infection with WT EPEC strain, revealing no induction of p-AKTser473 
signal or changes in total AKT and Actin (Figure 30B). As expected (Kenny et al., 1997), EPEC 
strain genotype was supported by the detection of the host kinase modified form of Tir (T’’) 
in WT EPEC but not cfm-14 mutant infected cells (Figure 30). This work indicates that EPEC 
strains do not induce AKT phosphorylation in this HeLa cell model under the conditions 
examined. Thus, to examine the impact of EPEC infection on AKT activity would require a 
robust stimulus of AKT phosphorylation. 
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Figure 30 EPEC infection does not induce AKT phosphorylation in HeLa cells.  
(A & B) HeLa cells were left uninfected (0) or infected (MOI 100:1) with the pre-activated 
T3SS defective mutant (cfm-14) or WT EPEC strain for indicated times (min) over a 2 h 
infection before infections were stopped. Total cell extracts were isolated (1x SDS sample 
buffer) and protein samples separated by SDS-PAGE (10%) for western blot analysis, probing 
for anti-p-AKTser473, anti-pan-AKT (detect isoforms 1, 2 & 3), anti-Tir and anti-Actin (loading 
control) antibodies. Host kinase mediated modification of Tir, dependent on its T3SS delivery 
into host cells, is indicated by an apparent increase in molecular mass from its unmodified 
(T0) to its fully modified form (T’’) (Kenny et al., 1997). Western blots represent a signle 
experiment, with immunoblots (where appropriate) cropped and moved for presentation 
purposes, indicated by a dashed line. 
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4.2.2 TNFα induces AKT phosphorylation in HeLa cells 
AKT phosphorylation at residue Ser473 in response to treatment with TNFα has previously 
been reported in a number of cell models, including HeLa cells (Ozes et al., 1999; Osawa et 
al., 2001; Kettritz et al., 2002; Wang et al., 2013). To re-establish the appropriate conditions 
for TNFα induced AKT phosphorylation, HeLa cells were left untreated or treated with TNFα 
using a range of concentrations (10, 15 & 50 ng/ml) over a 20 min time course before 
isolating total cell extracts at indicated times for western blot analysis. Untreated HeLa cells 
reveal weak background levels of p-AKTser473. Treatment with TNFα induced a time 
dependent increase in AKT phosphorylation for all concentrations examined (Figure 31A). 
Maximum stimulation of p-AKTser473 was achieved at concentrations of 15 ng/ml and 50 
ng/ml, reaching an approximate 5 fold increase in comparison to uninfected control cells 
after 10 and 5 min of stimulation respectively (Figure 31B). This work supports TNFα as a 
stimulus of AKT phosphorylation in HeLa cells, indicating a weak transient p-AKTser473 profile 
at the concentrations examined (Figure 31). To achieve a stronger induction of AKT 
phosphorylation in comparison to basal levels of untreated cells, alternative agonists were 
examined. 
 
4.2.3 EGF is a strong inducer of AKT phosphorylation in HeLa cells 
EGF stimulation of the EGFR/PI3K/AKT signalling pathway induces a rapid and transient 
increase in AKT phosphorylation in HeLa cells (Steele-Mortimer et al., 2000; Cooper et al., 
2011). To confirm these findings in our HeLa cell clone, cells were left untreated or treated 
with EGF (100 ng/ml) over a 20 min time course before isolating total cell extracts at 
indicated times for western blot analysis. Untreated HeLa cells displayed very week (poorly 
detected) basal levels of phosphorylated AKT (Figure 32A). Treatment with EGF induced a 
strong increase in AKT phosphorylation, detected after treatment for 1, 2 and 5 min with 
EGF before decreasing rapidly to background levels after 10 and 20 min (Figure 32A). This 
observed increase in p-AKTser473 signal with EGF treatment, at all time points, was not due to 
notable changes in total AKT (Figure 32A). Quantification analysis of the p-AKTser473 signal, 
normalised to Actin (loading control) and calculated as a relative change to untreated cells, 
reveals a clear transient increase in AKT phosphorylation, indicating an approximate 600 fold 
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increase in p-AKTser473 after 2 min of EGF treatment (Figure 32B). This work supports the use 
of EGF as a suitable agonist for the strong induction of AKT phosphorylation in HeLa cells. 
 
 
Figure 31 TNFα stimulates AKT phosphorylation in HeLa cells.  
(A) HeLa cells were left untreated (0) or treated with TNFα over a range of concentrations 
(10, 15 & 50 ng/ml) for the indicated times (min) before isolating total cell extracts (1x SDS 
sample buffer). Protein samples were separated by SDS-PAGE (10%) for western blot 
analysis; probing for anti-p-AKTser473 and anti-Actin (as loading control) antibodies. Western 
blots represent a single experiment, with immunoblots (where appropriate) cropped and 
moved for presentation purposes, indicated by a dashed line. (B) Densitometry analysis was 
performed using ImageLab software, with values representing a fold change in p-AKTser473 
signal, normalised to Actin (loading control) and calculated as a relative change to uninfected 
control (0) cells.  
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Figure 32 EGF induces a strong transient increase in AKT phosphorylation.  
(A) HeLa cells were left untreated (0) or treated with EGF (100 ng/ml) for the indicated times 
(min) before isolating total cell extracts (1x SDS sample buffer). Protein samples were 
separated by SDS-PAGE (10%) for western blot analysis; probing for anti-p-AKTser473, anti-
pan-AKT (detect isoforms 1, 2 & 3) and anti-Actin (as loading control) antibodies. Western 
blots represent a single experiment, with immunoblots (where appropriate) cropped and 
moved for presentation purposes. (B) Densitometry analysis was performed using ImageLab 
software, with values representing a fold change in p-AKTser473 signal, normalised to Actin 
(loading control) and calculated as a relative change to uninfected control (0) cells.  
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4.2.4 EPEC infection prevents EGF induced AKT phosphorylation in a T3SS 
dependent manner 
Having established EGF as an appropriate agonist for the strong induction of AKT 
phosphorylation, studies were undertaken to examine the ability of EPEC to prevent, in a 
T3SS dependent manner, EGF induced AKT phosphorylation. Thus, HeLa cells were left 
uninfected or infected with the EPEC T3SS defective mutant (cfm-14) or WT EPEC strain at an 
MOI of 100:1 for 1, 2 or 3 h prior to stimulating cells with EGF (100 ng/ml) for 2 min before 
isolating total cell extracts for western blot analysis. As expected, infection with the T3SS 
mutant (cfm-14) did not induce AKT phosphorylation at 3 h post infection (Figure 33A). In 
contrast, stimulation of uninfected cells with EGF induced strong levels of p-AKTser473 (Figure 
33A). Furthermore, EGF treatment of cells pre-infected with the cfm-14 mutant for 1, 2 or 3 
h led to the robust stimulation of AKT phosphorylation (Figure 33A). Like the cfm-14 mutant, 
infection with WT EPEC alone did not induce AKT phosphorylation (Figure 33A). However, 
treatment of EGF to WT EPEC infected cells led to a strong induction of AKT phosphorylation 
for cells pre-infected for 1 h, but not 2 or 3 h (Figure 33A). Observed changes in AKT 
phosphorylation, post infection, with the cfm-14 mutant or WT EPEC strain (± EGF) were not 
linked to alterations in levels of total AKT (Figure 33A). Quantification analysis of p-AKTser473 
signal, normalised to Actin (loading control) and calculated as a relative change to uninfected 
EGF treated cells, demonstrated the clear capacity of EGF to induce strong levels of AKT 
phosphorylation in cells pre-infected with the cfm-14 mutant, but not WT EPEC strain, after 
2 h of infection (Figure 33B). Effector protein delivery in WT EPEC infected cells was 
supported by the detection of the host modified form of Tir (T’’) after 1, 2 and 3 h post 
infection, which was absent from samples infected with the T3SS defective mutant, cfm-14 
(Figure 33A). These results illustrate the ability of the WT EPEC strain to prevent EGF from 
inducing AKT phosphorylation in a T3SS dependent manner. 
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Figure 33 EPEC prevents EGF induced AKT phosphorylation in a T3SS dependent manner.  
(A) HeLa cells were left uninfected (0) or infected (MOI 100:1) with the pre-activated T3SS 
defective mutant (cfm-14) or WT EPEC strain for 1, 2 & 3 h, before treating cells with EGF 
agonist (100 ng/ml) for 2 min. Total cell extracts were isolated (1x SDS sample buffer) and 
protein samples separated by SDS-PAGE (10%) for western blot analysis, probing for anti-p-
AKTser473, anti-pan-AKT (detect isoforms 1, 2 & 3), anti-Tir and anti-Actin (loading control) 
antibodies. Host kinase mediated modification of Tir, dependent on its T3SS delivery into 
host cells, is indicated by an apparent increase in molecular mass from its unmodified (T0) to 
its fully modified form (T’’) (Kenny et al., 1997). Western blots represent a single experiment, 
with immunoblots (where appropriate) cropped and moved for presentation purposes. (B) 
Densitometry analysis was performed using ImageLab software, with values representing a 
fold change in p-AKTser473 signal, normalised to Actin (loading control) and calculated as a 
relative change to uninfected EGF treated (0) cells.  
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4.2.5 The outer membrane protein Intimin is not essential to prevent EGF induced 
AKT phosphorylation in HeLa cells 
Although crucial for EPEC mediated intimate attachment with host cells and other host cell 
subversive events (Knutton et al., 1989; Dean and Kenny, 2004; Dean et al., 2006), Intimin 
has previously been discounted in EPEC induced loss of phosphorylated AKT in macrophages 
(Quitard et al., 2006) and polarised Caco-2 (Ruchaud-Sparagano et al., 2007) cells. To 
examine the requirement of Intimin to prevent EGF induced AKT phosphorylation in HeLa 
cells initial experiments focused on the EPEC ∆eae mutant over an extended 5 h infection. 
Thus, HeLa cells were left uninfected or infected with the EPEC T3SS defective mutant (cfm-
14), WT EPEC strain or ∆eae mutant at an MOI of 100:1 for 2, 3, 4 and 5 h prior to 
stimulating cells with EGF (100 ng/ml) for 2 min and isolating total cell extracts for western 
blot analysis. Stimulation of uninfected cells with EGF demonstrated the robust induction of 
AKT phosphorylation (Figure 34A). Moreover, EGF treatment of cfm-14 infected cells 
revealed the strong stimulation of AKT phosphorylation at 2, 3, 4 and 5 h post infection 
(Figure 34A). In contrast, infection with the WT EPEC strain revealed reduced levels of EGF 
induced AKT phosphorylation at all time points post infection (2, 3, 4 & 5 h; Figure 34B), 
consistent with earlier findings (Figure 33). Similar results were obtained following EGF 
treatment of EPEC ∆eae mutant pre-infected cells, revealing low levels of p-AKTser473 at 2, 3, 
4 and 5 h post infection (Figure 34C); though notably greater than p-AKTser473 levels in WT 
EPEC infected samples over the same time course (Figure 34B). Quantification analysis of p-
AKTser473 signal, normalised to Actin (loading control) and calculated as a relative change to 
uninfected EGF treated cells, supports the capacity of EGF to induce strong levels of AKT 
phosphorylation in cells pre-infected with the cfm-14 mutant, but not WT EPEC or the ∆eae 
mutant (Figure 34D). EPEC strain genotype was supported by the detection of the host 
kinase modified form of Tir (T’’) in WT EPEC and the ∆eae strain, but not cfm-14 mutant 
infected cell extracts (Figure 34A-C). It should be noted some cell detachment was observed 
with the WT EPEC and ∆eae mutant, but not cfm-14 strain, at approximately 5 h post 
infection in this model. These results suggest that Intimin (∆eae) is not essential for EPEC to 
prevent EGF induced AKT phosphorylation. 
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Figure 34 The EPEC Intimin mutant has a delayed capacity to prevent EGF induced AKT 
phosphorylation.  
(A-C) HeLa cells were left uninfected (0) or infected (MOI 100:1) with the pre-activated T3SS 
defective mutant (cfm-14), WT EPEC, or Δeae (lacking outer membrane protein Intimin) 
strains for 2, 3, 4 & 5 h, before treating cells with EGF agonist (100 ng/ml) for 2 min. Total 
cell extracts were isolated (1x SDS sample buffer) and protein samples separated by SDS-
PAGE (10%) for western blot analysis, probing for anti-p-AKTser473, anti-Tir and anti-Actin 
(loading control) antibodies. Host kinase mediated modification of Tir, dependent on its T3SS 
delivery into host cells, is indicated by an apparent increase in molecular mass from its 
unmodified (T0) to its fully modified form (T’’) (Kenny et al., 1997). Western blots represent 
a single experiment, with immunoblots (where appropriate) cropped and moved for 
presentation purposes, indicated by a dashed line. (D) Densitometry analysis was performed 
using ImageLab software, with values representing a fold change in p-AKTser473 signal, 
normalised to Actin (loading control) and calculated as a relative change to uninfected EGF 
treated (0) cells.  
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4.2.6 The capacity of EPEC to prevent EGF induced AKT phosphorylation is 
independent of Intimin, 5 LEE effectors (EspZ, EspH, Map, EspF & EspG) and 
the Nle effector EspG2/Orf3 
To investigate the virulence factor(s) required for EPEC to prevent EGF induced AKT 
phosphorylation in HeLa cells, initial studies focused on examining the role of LEE effector 
proteins using the available complex EPEC ∆mfzgorf3eh::km mutant (lacking Intimin, 5 LEE 
effectors [EspZ, EspH, Map, EspF & EspG] and Nle effector EspG2/Orf3). This 
∆mfzgorf3eh::km strain still encodes LEE effectors Tir and EspB. Thus, HeLa cells were left 
uninfected or infected with the ∆mfzgorf3eh::km strain at an MOI of 100:1 for 2, 3, 4 and 5 h 
prior to stimulating cells with EGF (100 ng/ml) for 2 min and isolating total cell extracts for 
western blot analysis. Treatment with EGF in uninfected cells demonstrated the robust 
stimulation of AKT phosphorylation (Figure 35). In contrast, treatment with EGF to 
∆mfzgorf3eh::km infected cells failed to induce AKT phosphorylation at all time points post 
infection (2, 3, 4 & 5 h), with the p-AKTser473 signal below the level of detection (Figure 35). It 
should be noted infection with this complex mutant (∆mfzgorf3eh::km) resulted in high 
levels of cell detachment after 3 h of infection (data not shown), supported by decreasing 
levels of actin over the infection period (Figure 35); linked to the absence of EspZ delivery 
into host cells (Shames et al., 2010; Berger et al., 2012; Roxas et al., 2012). EPEC strain 
genotype was supported by the detection of the host kinase modified form of Tir (T’’; Figure 
35) and PCR analysis for the appropriate disruption of genes (A. Madkour et al., data not 
shown). This work suggests the outer membrane protein Intinim, 5 LEE effectors (EspZ, EspH, 
Map, EspF & EspG) and the Nle effector EspG2/Orf3 are not required to prevent EGF induced 
AKT phosphorylation, similar to results identified in the J774A.1 macrophage cell model. 
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Figure 35 EPEC's capacity to prevent EGF induced AKT phosphorylation is independent of 5 
LEE effectors (Map, EspH, EspZ, EspG & EspH), Intimin and the Nle effector EspG2/Orf3.  
HeLa cells were left uninfected (0) or infected (MOI 100:1) with the pre-activated EPEC 
mutant Δmfzgorf3eh::km (lacking the outer membrane protein Intimin, LEE effectors EspH, 
Map, EspF, EspZ, EspG and its Nle homolog EspG2/Orf3) for 2, 3, 4 & 5 h before treating cells 
with EGF agonist (100 ng/ml) for 2 min. Total cell extracts were isolated (1x SDS sample 
buffer) and protein samples separated by SDS-PAGE (10%) for western blot analysis, probing 
for anti-p-AKTser473, anti-Tir and anti-Actin (loading control) antibodies. Host kinase mediated 
modification of Tir, dependent on its T3SS delivery into host cells, is indicated by an apparent 
increase in molecular mass from its unmodified (T0) to its fully modified form (T’’) (Kenny et 
al., 1997). Western blots represent a single experiment, with immunoblots (where 
appropriate) cropped and moved for presentation purposes, indicated by a dashed line. 
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4.2.7 The EPEC strain lacking the central ‘core’ LEE region prevents EGF induced 
AKT phosphorylation 
LEE encoded chaperones CesF and CesT are required for the efficient translocation of up to 
13 known LEE and Nle effector proteins into host cells (Mills et al., 2013). To examine 
whether the virulence factor(s) required to prevent EGF induced AKT phosphorylation are 
dependent on these chaperones (CesF & CesT) and to determine the requirement of the 
effector protein Tir, p-AKTser473 levels were examined in cells infected with the available EPEC 
∆core::km mutant. This ∆core::km strain lacks the central ‘core’ LEE region encoding Intimin; 
3 LEE effectors, EspH, Map and Tir; and 2 chaperones, CesF and CesT. HeLa cells were left 
uninfected or infected with the ∆core::km strain at an MOI of 100:1 for 2, 3, 4 and 5 h prior 
to stimulating cells with EGF (100 ng/ml) for 2 min and isolating total cell extracts for 
western blot analysis. As expected, EGF treatment of uninfected cells revealed strong levels 
of p-AKTser473 (Figure 36). However, EGF treatment of cells infected with the ∆core::km 
mutant revealed weak stimulation of AKT phosphorylation at 2 and 3 h post infection, with 
p-AKTser473 signal undetected at 4 and 5 h post infection (Figure 36). Again, high levels of cell 
detachment were observed with this strain after 3 h of infection (data not shown), 
supported by decreasing levels of actin over the infection period (Figure 36). Absence of host 
kinase modified (T’’) and unmodified (T0) forms of Tir (Figure 36), in addition weak levels of 
EspF (data not shown) supports EPEC ∆core::km strain genotype. This result tentatively 
suggests that the EPEC virulence factor(s) necessary to prevent EGF induced AKT 
phosphorylation in HeLa cells do not require the effector protein Tir or effector chaperones 
CesF and/or CesT; thus differing from a CesT dependent phenotype identified in J774A.1 
macrophages. However, due to notable levels of infection induced cell detachment, linked to 
increased cell cytotoxicity (Shames et al., 2010; Berger et al., 2012; Roxas et al., 2012), it 
remains to be determined whether these cells are capable of responding to EGF induced AKT 
phosphorylation. 
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Figure 36 The EPEC ∆core::km mutant prevents EGF induced AKT phosphorylation.  
HeLa cells were left uninfected (0) or infected (MOI 100:1) with pre-activated EPEC mutant 
Δcore::km (lacking LEE proteins EspH, Map, CesF, Tir, CesT and Intimin [Figure 23]) for 1, 2, 3, 
4 & 5 h before treating cells with EGF agonist (100 ng/ml) for 2 min. Total cell extracts were 
isolated (1x SDS sample buffer) and protein samples separated by SDS-PAGE (10%) for 
western blot analysis, probing for anti-p-AKTser473, anti-Tir and anti-Actin (loading control) 
antibodies. Host kinase mediated modification of Tir, dependent on its T3SS delivery into 
host cells, is indicated by an apparent increase in molecular mass from its unmodified (T0) to 
its fully modified form (T’’) (Kenny et al., 1997). Western blots represent a single experiment, 
with immunoblots (where appropriate) cropped and moved for presentation purposes, 
indicated by a dashed line. 
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4.2.8 EPEC inhibition of EGF induced AKT phosphorylation is independent of 6 LEE 
and 14 known Nle effector proteins 
Using the most recently generated complex EPEC effector mutant, TOEA7core::km, studies 
were undertaken to examine the ability of this strain prevent EGF-induced AKT 
phosphorylation. Crucially, this strain is unable to express and/or deliver all known LEE 
effectors (except EspB), all Nle effectors (except EspC, LifA & NleJ), two effector chaperones 
(CesF & CesT) and the outer membrane protein Intimin. Thus, this strain is theoretically 
unable to translocate up to 20 of 24 known effector proteins into host cells. HeLa cells were 
left uninfected or infected at an MOI of 100:1 for 2, 3, 4 and 5 h prior to stimulating cells 
with EGF (100 ng/ml) for 2 min and isolating total cell extracts for western blot analysis. EGF 
treatment of uninfected HeLa cells induced the robust stimulation of AKT phosphorylation 
(Figure 37). In contrast, cells infected with TOEA7∆core::km demonstrated no detectable 
levels of AKT phosphorylation following EGF treatment at 2, 3, 4 and 5 h post infection 
(Figure 39). Similar to the ∆core::km mutant infected cells, high levels of cell detachment 
were observed with TOEA7∆core::km mutant after 3 h of infection (data not shown), 
supported by decreasing levels of actin over the infection period (Figure 37). Again, absence 
of host kinase modified (T’’) and unmodified (T0) forms of Tir (Figure 38), in addition weak 
levels of EspF (data not shown) supports EPEC TOEA7∆core::km strain genotype. This work 
tentatively suggests that Intimin, 6 LEE effectors, 14 Nle effectors and the two effector 
chaperones (CesF & CesT) do not inhibit EGF induced AKT phosphorylation in HeLa cells. 
Again, this result differs from observations identified in the J774A.1 macrophage cell model 
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Figure 37 The EPEC TOEA7∆core::km mutant prevents EGF induced AKT phosphorylation.  
HeLa cells were left uninfected (0) or infected (MOI 100:1) with pre-activated EPEC mutant 
TOEA7Δcore::km (lacking core LEE genes [Figure 23] in addition to 14 Nle effectors [Table 7]) 
for 2, 3, 4 & 5 h before treating cells with EGF agonist (100 ng/ml) for 2 min. Total cell 
extracts were isolated (1x SDS sample buffer) and protein samples separated by SDS-PAGE 
(10%) for western blot analysis, probing for anti-p-AKTser473, anti-Tir and anti-Actin (loading 
control) antibodies. Host kinase mediated modification of Tir, dependent on its T3SS delivery 
into host cells, is indicated by an apparent increase in molecular mass from its unmodified 
(T0) to its fully modified form (T’’) (Kenny et al., 1997). Western blots represent a single 
experiment, with immunoblots (where appropriate) cropped and moved for presentation 
purposes, indicated by a dashed line. 
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4.2.9 EPEC induces the loss of EGFR in a T3SS dependent manner in HeLa cells 
The ability of the ∆core::km and TOEA7∆core::km mutant strains to prevent agonist-induced 
AKT phosphorylation in HeLa cells differed from findings made in the J774A.1 macrophage 
cell model. This suggested that 1) there is an intrinsic difference between the two cell 
models, 2) EPEC infected HeLa cells are too unhealthy to respond to the agonist EGF (note 
cell detachment), or 3) EPEC induced degradation of the EGFR prevents EGF induced AKT 
phosphorylation; the latter dependent on the effector EspF and promoted by EspZ deficient 
EPEC strains (Roxas et al., 2014). To examine EPEC induced changes to the EGFR, HeLa cells 
were left uninfected or infected with the EPEC T3SS defective mutant (cfm-14), WT EPEC 
strain or the TOEA7∆core::km mutant (does not deliver EspF and EspZ effectors) at an MOI of 
100:1 for 2, 3, 4 and 5 h prior to stimulating cells with EGF (100 ng/ml) for 2 min and 
isolating total cell extracts for western blot analysis. EGF treatment of uninfected cells 
revealed the robust detection of the EGFR signal, correlating with a strong p-AKTser473 signal 
(Figure 38A). EGF treatment of cfm-14 mutant infected cells revealed a strong signal for 
EGFR and p-AKTser473 at 2, 3, 4 and 5 h post infection (Figure 38A). In contrast, cells pre-
infected with the WT EPEC strain induced a time dependent decrease of the EGFR signal at 3, 
4 and 5 h post infection (Figure 38B). Although the detection of EGFR signal was comparable 
with the uninfected EGF treated cells (control) at 2 h of infection, p-AKTser473 signal was 
poorly detected at 2, 3, 4 and 5 h post infection with the WT EPEC strain (Figure 38B). This 
suggests the loss of p-AKTser473 signal at 2 h post infection with the WT EPEC strain is not 
linked to the degradation of the EGFR, detected at 3 h post infection. Interestingly, EGF 
treatment of TOEA7∆core::km mutant infected cells reveals the presence of two bands 
associated with EGFR (additional band of lower Mw) after 2, 3, 4 and 5 h of infection, which 
is absent from uninfected EGF treated cells (Figure 38C). As expected, TOEA7∆core::km 
infection resulted in loss of EGF induced AKT phosphorylation at 2, 3, 4 and 5 h post infection 
(Figure 38C). Again, infection of cells with the TOEA7∆core::km mutant was associated with 
high levels of cell detachment after 3 h of infection (data not shown). Taken together, these 
results reveal the EPEC induced loss of EGFR in a T3SS dependent manner in HeLa cells. In 
addition, this work suggests that the EPEC mediated inhibition of EGF induced AKT 
phosphorylation is not associated with loss in detection of EGFR at 2 h post infection. 
However, with evidence of EGFR modification at 2 h post infection with the TOEA7∆core::km 
mutant, this raises the possibility that the EGFR is inactivated and/or non-functional. 
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Figure 38 EPEC triggers the T3SS dependent loss of EGFR.  
(A-C) HeLa cells were left uninfected (0) or infected (MOI 100:1) with the pre-activated T3SS 
defective mutant (cfm-14), WT EPEC or TOEA7Δcore::km mutant (lacking ‘core’ LEE genes 
[Figure 23] in addition to 14 Nle effectors [Table 7]) strains for 2, 3, 4 & 5 h before treating 
cells with EGF agonist (100 ng/ml) for 2 min. Total cell extracts were isolated (1x SDS sample 
buffer) and protein samples separated by SDS-PAGE (10%) for western blot analysis, probing 
for anti-p-AKTser473, anti-EGFR and anti-Actin (loading control) antibodies. Western blots 
represent a single experiment, with immunoblots (where appropriate) cropped and moved 
for presentation purposes, indicated by a dashed line. 
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4.3 Discussion 
The effector proteins required and the mechanism by which they mediate EPEC induced loss 
of phosphorylated AKT remains inconclusive, with few observations reported in HeLa cells. 
This study aimed to develop a simple (non-polarised) HeLa cell model to examine the impact 
of EPEC infection on AKT phosphorylation; avoiding limitations of greater cell detachment 
(over short infection periods; Kenny et al., unpublished) and poor transfection efficiency in 
J774A.1 macrophages (Van De Parre et al., 2005) and polarised epithelial (e.g. Caco-2, TC7 & 
T84) cells (Dean et al., 2013). This study demonstrates for the first time that EPEC infection 
can prevent AKT phosphorylation stimulated by the EGF agonist in a HeLa cell model, in a 
T3SS dependent manner. Furthermore, this work suggests that the inhibition of EGF induced 
AKT phosphorylation is independent of the T3SS effector chaperone CesT, thus differing 
from observations made in the J774A.1 macrophage cell model. However, this study has 
uncovered important limitations of the HeLa cell model including infection induced cell 
detachment and EPEC triggered degradation/modification of the EGFR, thus undermining 
these observations. Since these findings were made from a single experiment, additional 
work is required to confirm these observations. Thus, further development of the HeLa cell 
model is needed to support, or not, these findings to provide an alternative and more 
transfectable cell model to investigate the impact of EPEC infection on AKT phosphorylation. 
PI3K/AKT signalling is activated downstream of a number of receptor pathways, including 
TLR’s (Brown et al., 2011). However, whether the activation of TLR’s (TLR1-TLR11) plays a 
key role in EPEC infection induced AKT phosphorylation is unknown. In this study we 
demonstrate that infection with T3SS defective mutant (cfm-14) or WT EPEC strain does not 
stimulate AKT phosphorylation in our HeLa cell model. This presumably reflects the lack of 
LPS induced TLR4 signalling (Shimazu et al., 1999) or the absence of TLR receptors, such as 
TLR5, in HeLa cells (Gewirtz et al., 2001; Yu et al., 2006; Deng et al., 2012). Indeed, EPEC 
flagella is the major antigen responsible for inducing pro-inflammatory signalling via the 
TLR5 receptor in polarised epithelial cell models (Gewirtz et al., 2001; Ruchaud-Sparagano et 
al., 2007). Furthermore, activation of the TLR5 receptor by flagella is also known to activate 
the PI3K/AKT signalling pathway (Yu et al., 2006). This premise could be supported by the 
transfection of TLR5 (and/or other receptors) into HeLa cells to determine the capacity of 
EPEC to stimulate, and then decrease, infection induced AKT phosphorylation. 
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To examine the impact of EPEC infection on AKT phosphorylation it was important to 
identify an appropriate agonist to stimulate the robust increase of p-AKTser473 in HeLa cells. 
Using the agonists EGF and TNFα, this study demonstrates the robust and transient increase 
of AKT phosphorylation following treatment over a short 20 min time course. This transient 
increase of AKT phosphorylation is consistent with similar observations reported in the 
literature using comparable conditions (Steele-Mortimer et al., 2000; Kettritz et al., 2002). 
As EGF was found to be the most potent stimulator of AKT phosphorylation in our HeLa cell 
model, EGF was selected for treatment in subsequent studies. 
In this study we provide a model whereby the pre-infection of cells with WT EPEC, but not 
the cfm-14 mutant, leads to the T3SS dependent inhibition of EGF induced AKT 
phosphorylation. Indeed, this result is consistent with similar strategies revealing the T3SS 
dependent inhibition of TNFα induced AKT phosphorylation in polarised epithelial cells pre-
infected with EPEC (Ruchaud-Sparagano et al., 2007). In contrast to J774A.1 macrophages, 
detection of the host modified form of Tir (T’’) was not correlated to the loss of p-AKTser473 
signal, with Tir modification and inhibition of AKT signalling detected at 1 h and 2 h post 
infection respectively; in contrast to 1 h for both in J774A.1 macrophages. Since Tir 
modification (T’’) was used as a marker of effector protein translocation into host cells 
(Kenny et al., 1997), this might suggest inhibitory activity of effector proteins is possibly 
slower in the HeLa cell model. Alternatively, this may suggest that insufficient levels of 
inhibitory effector protein(s) have been translocated into HeLa cells at 1 h post infection. 
It is important to note that infection with the WT EPEC strain, but not the T3SS mutant, was 
associated with low levels of cell detachment by the end of the 3 h infection period. These 
observations are consistent with studies by Shames et al., revealing the increase of cell 
lifting in a HeLa cell model with the WT EPEC (E2348/69) strain after 4 h of infection (Shames 
et al., 2010). Interestingly, previous studies within the Kenny Lab had suggested that 
infection with Intimin deficient strains displayed a reduced capacity to cause cell 
detachment (Kenny et al., unpublished). However, these observations were not supported in 
this study revealing comparable levels of cell detachment to the WT EPEC strain with the 
∆eae mutant (lacks Intimin).  
To gain insight into the factor(s) necessary for EPEC to inhibit EGF induced AKT 
phosphorylation, cells were pre-infected with EPEC strains lacking one or more virulent 
proteins. Examining the role of Intimin, using the ∆eae mutant, revealed the clear inhibition 
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of EGF stimulated AKT phosphorylation in a time dependent manner. These results support 
previous observations of an Intimin independent inhibition of AKT phosphorylation in a 
polarised epithelial cell model (Ruchaud-Sparagano et al., 2007). Comparison against the WT 
EPEC strain suggested this inhibition was delayed with the ∆eae mutant, revealing maximum 
inhibition of AKT phosphorylation at 2 h and 5 h post infection respectively. Importantly, this 
slow decline of p-AKTser473 signal was not associated with a delay or reduced detection of the 
host modified form of Tir (T’’); marker of effector translocation (Kenny et al., 1997). 
Although Intimin does not appear to be critical to inhibit AKT signalling, this result may 
suggest that Intimin is necessary to promote the rapid inhibition of AKT phosphorylation, 
possibly through mediating intimate host cell attachment (Tir-Intimin dependent) (Kenny et 
al., 1997), which is necessary for the efficient translocation of effectors (Mills et al., 2013). 
Investigations using more complex effector deficient multiple mutants, ∆mfzgorf3eh::km 
(lacks Map, EspF, EspZ, EspG, EspH & EspG2/Orf3 effectors), ∆core::km (lacks LEE EspH, Map 
& Tir effectors; CesF & CesT chaperones; and Intimin) and TOEA7∆core::km (as per 
∆core::km, and lacks LEE EspG and 14 Nle effectors: NleA, NleB1, NleB2, NleC, NleD, NleE1, 
NleE2, NleF, NleG, EspG2/Orf3, NleH1, NleH2, EspJ & EspL), revealed that pre-infection with 
each strain inhibited the capacity of cells to respond to EGF stimulated AKT phosphorylation. 
Importantly, this inhibition of AKT phosphorylation was evident at 2 h post infection, prior to 
the detection of increased cell detachment after 3 h of infection (data not shown). This 
tentatively suggested the inhibition of EGF stimulated AKT phosphorylation is not associated 
with the onset of host cell detachment. However, whether HeLa cells are indeed functional 
at 2 h post infection prior to host cell detachment remains to be determined. Increased cell 
detachment is linked to the absence of CesT chaperone dependent translocation of EspZ into 
host cells; implicated to inhibit apoptosis (Roxas et al., 2012), promote survival signalling 
(Shames et al., 2010) and prevent excessive translocation of effector proteins (cytotoxic) 
(Berger et al., 2012).  
It is interesting to note the apparent delay in inhibition of AKT phosphorylation, previously 
identified with the ∆eae mutant, was not evident in cells pre-infected with Intimin deficient 
mutants ∆mfzgorf3eh::km, ∆core::km or TOEA7∆core::km. This may suggest an effector 
missing from these latter strains is necessary to promote the phosphorylation of AKT, thus 
leading to the rapid loss of p-AKTser473 signal, counteracting the need for Intimin. Indeed, 
similar antagonistic activities of EPEC effectors have previously been reported (Schmidt, 
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2010; Shames and Finlay, 2012). For example, studies by Shames et al., have suggested that 
the EspZ effector can promote the phosphorylation of AKT in a HeLa cell model (Shames et 
al., 2010). Importantly, the translocation of EspZ effector into target cells is lacking with the 
∆mfzgorf3eh::km, ∆core::km and TOEA7∆core::km mutant strains. 
Studies by Roxas et al., have shown that the EGFR is degraded in a T3SS dependent manner 
in a polarised epithelial cell model (Roxas et al., 2014). Given this association it was 
important to determine impact of EPEC infection on the EGFR in our model. This work 
reveals the T3SS dependent loss EGFR signal at 3 h post infection in HeLa cells. Importantly, 
this observation tentatively uncouples the inhibition of EGF induced AKT phosphorylation, at 
2 h post infection, from the loss of EGFR. However, whether the EGFR is indeed still 
functional or present at the cell surface, due to receptor internalisation (Kirisits et al., 2007), 
is unknown and remains to be investigated. 
EPEC induced caspase dependent degradation of the EGFR has been reported to be 
stimulated by the effector protein EspF and curtailed by the activity of EspZ in polarised cells 
(Roxas et al., 2014). Although the TOEA7∆core::km mutant is unable to translocate these 
effector proteins, due to absence of chaperones CesF (EspF dependent) and CesT (EspZ 
dependent), changes to the EGFR were detected throughout the 5 h infection period. Whilst 
infection with the TOEA7∆core::km mutant had no obvious impact on total EGFR levels at 2 h 
post infection, extracts revealed an unexpected second band of lower apparent molecular 
mass. This band is also evident in studies by Roxas et al., supporting the EPEC induced 
degradation of the EGFR (Roxas et al., 2014). This suggested that additional T3SS dependent 
effector protein(s) other than EspF and EspZ may play a key role in disrupting EGFR function. 
Further work should look to identify the EGFR specific changes in cells infected with the EspF 
and EspZ single/double mutants to better define the capacity of the TOEA7∆core::km mutant 
to alter the EGFR in this model. Alternatively, the re-introduction of missing genes from the 
TOEA7∆core::km mutant by complementation could support the requirement of EspF, 
and/or other effectors, to degrade the EGFR similar to WT EPEC levels. Importantly, this 
work may suggest the loss of EGF induced AKT phosphorylation in the HeLa cell model is 
caused by the disruption/degradation of EGFR signalling following the infection with EPEC 
strains lacking the central ‘core’ LEE region (∆core::km & TOEA7∆core::km).  
Collectively, this work suggested that the capacity of EPEC to inhibit EGF induced AKT 
phosphorylation is independent of the outer membrane protein Intimin, 6 LEE effectors (Tir, 
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Map, EspH, EspZ, EspF & EspG), 14 Nle effectors (NleA, BleB1, NleB2, NleC, NleD, NleE1, 
NleE2, NleF, NleG, EspG2/Orf3, NleH1, NleH2, EspJ & EspL) and two effector chaperones 
(CesF & CesT). However, this interpretation is undermined by significant levels of cell 
detachment and the ability of EPEC to induce the degradation/modification of the EGFR. This 
latter finding likely explains the differing observations of CesT dependent and CesT 
independent inhibition of AKT phosphorylation in the J774A.1 macrophage and HeLa cell 
model respectively, following infection with the ∆core::km and TOEA7∆core::km mutants.  
It is important to note the observations in this study were made from one experiment and 
therefore requires further work to support, or not these findings. Taking into consideration 
the complexity of EPEC mediated T3SS dependent loss of the EGFR; it would be 
inappropriate to continue to select EGF as an agonist to examine EPEC induced inhibition of 
AKT phosphorylation. One possibility could be to develop a receptor independent AKT 
phosphorylation model, such as the transfection of constitutively activated AKT (Andjelkovic 
et al., 1997) to examine the effectors necessary to inhibit AKT phosphorylation. As discussed 
earlier, the HeLa cell model offers important advantages over J774A.1 macrophages to 
examine EPEC inhibition of AKT phosphorylation, such as greater transfection efficiency. 
Developing this HeLa cell model further, to overcome the identified limitations, could 
provide an alternative and more amenable model to interrogate the effector(s) and 
mechanism responsible for terminating AKT signalling. 
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Chapter 5 Investigating the mechanism of EPEC 
induced T3SS dependent decrease of 
phosphorylated AKT 
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5.1 Introduction 
Class I PI3K are activated downstream of receptor tyrosine kinase (RTK) and G-protein 
coupled receptors (GPCR) (Vanhaesebroeck et al., 2012). Once activated, class I PI3K’s 
phosphorylate the membrane phosphoinositide PI[4,5]P2, at the 3’ hydroxyl group, 
generating the second messenger PI[3,4,5]P3 (Vanhaesebroeck and Alessi, 2000). Increased 
availability of PI[3,4,5]P3 stimulates the recruitment of AKT to the inner membrane, 
dependent on its N-terminal PH domain (Frech et al., 1997). On binding of PI[3,4,5]P3, AKT 
undergoes a conformational change (Calleja et al., 2007), exposing its activation loop for 
phosphorylation by PDK1; the latter co-localised with AKT at the membrane in a PH 
dependent manner (Alessi et al., 1997b). In addition, AKT undergoes a second 
phosphorylation at residue Ser473 within its hydrophobic motif resulting in the full 
activation of AKT (Alessi et al., 1996; Alessi et al., 1997b). This second modification step is 
thought to be regulated by the kinase mTORC2 (Sarbassov et al., 2005), though additional 
kinases have also been reported to play a role, including DNA-dependent protein kinase 
(DNA-PK) and TANK binding kinase 1 (TBK1) (Feng et al., 2004; Ou et al., 2011). 
Regulation of the PI3K/AKT pathway is a tightly controlled multistep process; however, the 
precise mechanism by which AKT signalling is regulated is not well understood (Gao et al., 
2011). Phosphatase and tensin homolog (PTEN) is a negative regulator of AKT activity that 
opposes the action of PI3K (Hers et al., 2011). PTEN acts by dephosphorylating the second 
messenger PI[3,4,5]P3 to PI[4,5]P2, thereby preventing membrane recruitment and co-
localisation of AKT and PDK1 (Leslie et al., 2008; Hers et al., 2011). The importance of PTEN 
in regulating AKT activity is highlighted by its frequent mutation in cancer (Chalhoub and 
Baker, 2009). In addition, dephosphorylation of PI[3,4,5]P3 by the inositol-phosphatase SHIP, 
to PI[3,5]P2 is also known to terminate cell signalling downstream of PI3K (Liu et al., 1999b; 
Carver et al., 2000).  
AKT activity and phosphorylation at residues Thr308 and Ser473 are also negatively 
regulated through dephosphorylation by protein phosphatases (Bayascas and Alessi, 2005). 
Protein phosphatases PP2A and PHLPP are reported to demonstrate selectivity for residues 
Thr308 and Ser473 of AKT respectively (Bayascas and Alessi, 2005; Brognard et al., 2007; 
Liao and Hung, 2010). Subsequent dephosphorylation of both residues restores AKT to an 
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inactive conformation (Liao and Hung, 2010). Though, how these protein phosphatases are 
themselves regulated and targeted to specific AKT residues is not entirely clear. 
The ability of bacteria to manipulate the PI3K/AKT signalling pathway to promote bacterium 
colonisation and survival is not uncommon, being subverted by Salmonella enterica (Steele-
Mortimer et al., 2000; Roppenser et al., 2013), Shigella flexneri (Pendaries et al., 2006), 
Yersinia pseudotuberculosis (Uliczka et al., 2009) and UPEC (Wiles et al., 2008). These 
bacteria employ a diverse set of strategies to target the PI3K/AKT pathway; however, in 
many cases the precise mechanism of action remains to be fully defined.  
AKT phosphorylation, and thus its activation, can be regulated at three principal stages 
including: 1) PI[3,4,5]P3 mediated recruitment and colocalisation to the membrane of AKT 
and PDK1, 2) phosphorylation of AKT at residues Thr308 and Ser473, or 3) 
dephosphorylation of AKT and/or PI[3,4,5]P3 by protein and lipid phosphatases. It was 
therefore hypothesised that EPEC infection may target and subvert one or several of these 
events to induce the rapid T3SS dependent decrease of phosphorylated AKT. The aim of this 
chapter was thus to interrogate the mechanism by which EPEC disrupts AKT signalling in the 
J774A.1 macrophage cell model. 
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5.2 Results 
5.2.1 EPEC infection is associated with subtle T3SS dependent differences in key 
events associated with the AKT signalling pathway 
As discussed earlier (Chapter 3), EPEC infection induces a rapid T3SS dependent decrease of 
phosphorylated AKT in the J774A.1 macrophage cell model (Celli et al., 2001; Quitard et al., 
2006). To investigate the possible mechanism(s) of inhibition, cell extracts were fractionated 
into cytoplasmic and membrane proteins using a well-established protocol (Kenny et al., 
1997; Kenny, 1999; Warawa and Kenny, 2001), to identify potential T3SS dependent changes 
in key AKT signalling associated events. Thus, J774A.1 macrophages were left uninfected or 
infected with the pre-activated T3SS mutant (cfm-14) or WT EPEC strain at an MOI of 200:1, 
before isolating cell extracts over a 120 min infection period. J774A.1 macrophages were 
then fractionated into cytosolic and membrane fractions for western blot analysis. This 
protocol was known as the standard ‘one-wave’ infection strategy. 
Prior to interrogating the impact of EPEC infection on the PI3K-AKT signalling pathway, it was 
first necessary to confirm the T3SS dependent decrease of phosphorylated AKT (Ser473) in 
this fractionated model. As predicted, infection with the WT EPEC strain triggered a rapid 
infection induced increase of p-AKTSer473 signal followed by a swift decline to or below 
background levels in both the cytosolic (Figure 39A & Figure 39B) and membrane (Figure 39C 
& Figure 39D) fraction at 60 min post infection. In contrast, infection with the T3SS mutant 
(cfm-14) revealed a more sustained increase of p-AKTSer473 signal over the 120 min infection 
period, decreasing to background levels after 90 min of infection in both the cytosolic 
(Figure 39A & Figure 39B) and membrane fractions (Figure 39C & Figure 39D). As discussed 
in Chapter 3, this T3SS dependent decrease of phosphorylated AKT was correlated with the 
detection of the host kinase modified form of Tir (T’’). As expected (Warawa and Kenny, 
2001), host modified Tir (T’’) was detected in the membrane but not cytosolic fraction of WT 
EPEC infected cells only; supporting the insertion of EPEC effector Tir into the host cell 
membrane. Thus, this work supports the development of a fractionated cell model and 
corroborates findings of a rapid T3SS dependent decrease of phosphorylated AKT in EPEC 
infected cell extracts (cytosolic & membrane fraction). 
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Figure 39 EPEC induces a rapid T3SS dependent decrease of phosphorylated AKT in 
cytoplasmic and membrane extracts.  
J774A.1 macrophages were left uninfected (0) or infected (MOI 200:1) with the pre-activated 
WT EPEC or T3SS mutant (cfm-14) strains. Cells were washed after 15, 30, 60, 90 and 120 
min of infection and J774A.1 macrophages fractionated into host cytosolic and membrane 
proteins. (A & C) Protein samples were separated by SDS-PAGE (10%) for western blot 
analysis, probing for anti-p-AKTSer473, anti-Tir and anti-Actin (loading control) antibodies. 
Host kinase mediated modification of Tir, dependent on its T3SS delivery into host cells, is 
indicated by an apparent increase in molecular mass from its unmodified (T0) to its fully 
modified form (T’’) (Kenny et al., 1997). Western blots represent a single experiment, with 
immunoblots (where appropriate) cropped and moved for presentation purposes, indicated 
by a dashed line. (B & D) Densitometry analysis of western blots was performed using 
ImageLab software, with values representing a fold change in p-AKTSer473 signal, normalised 
to Actin (loading control) and calculated as a relative change to uninfected (0) cells.  
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To investigate the impact of EPEC infection on the localisation of AKT, cell extracts were 
probed for AKT isoforms 1, 2 and 3 (Hers et al., 2011). Analysis of the cytoplasmic fractions 
of both the WT EPEC and T3SS mutant (cfm-14) infected cells revealed very little, if any, 
change in the levels of all AKT isoforms (1, 2 & 3) from that of uninfected control (Figure 
40A-D). Though, probing for AKT1 did reveal a subtle decrease below background levels for 
both strains (Figure 40B). By contrast, infection with the WT EPEC or T3SS mutant (cfm-14) 
led to the transient increase in AKT isoforms (1, 2 & 3) above background levels in the 
membrane fraction (Figure 40E-H). This transient increase of AKT (isoforms 1, 2 & 3) at the 
membrane peaked after 30 and 60 min of infection with the WT EPEC and cfm-14 mutant 
respectively. Interestingly, peak membrane localisation of AKT (isoforms 1, 2 & 3) was 
correlated with the maximal phosphorylation of AKT (Ser473) in the membrane fraction of 
WT EPEC, but not T3SS mutant (cfm-14) infected cells (Figure 39C & Figure 40E). 
The phosphorylation of PDK1 at Ser241 is reported to increase its activity, which is necessary 
to phosphorylate AKT at Thr308 (Casamayor et al., 1999). Conversely, the phosphorylation of 
PTEN at Ser380 is thought to promote its stability and decrease its activity, thereby 
preventing the dephosphorylation of PI[3,4,5]P3 to PI[4,5]P2 (Hopkins et al., 2014; Chia et 
al., 2015). Thus, active PDK1 and PTEN have an important role in regulating AKT 
phosphorylation. Probing of the cytoplasmic fractions revealed similar profiles of p-
PDK1Ser241 and p-PTENSer380 for both the WT EPEC and cfm-14 mutant infected cells (Figure 
41A-C). This was characterised by the apparent decrease of p-PDK1Ser241 and transient 
increase of p-PTENSer380 in the cytosolic extract for both strains (Figure 41A-C). In contrast, 
analysis of the membrane fractions revealed subtle T3SS dependent differences in the 
localisation of both proteins. Infection with the WT EPEC strain led to a sustained increase of 
p-PDK1Ser241 in the membrane fraction, which was less apparent for the T3SS mutant (cfm-
14) (Figure 41D & Figure 41E). Furthermore, probing for p-PTENSer380 revealed the short 
transient increase of signal in membrane extract of WT EPEC infected cells, decreasing to or 
below background levels after 60 min of infection (Figure 41D & Figure 41F). Whilst this 
increase of p-PTENSer380 was also transient for the cfm-14 mutant, this decline of signal was 
notably more gradual; returning to background levels at 120 min post infection (Figure 41D 
& Figure 41F). 
Collectively, this work suggests that EPEC infection is linked with subtle T3SS dependent 
differences in the subcellular localisation (cytoplasmic & membrane) of key proteins 
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associated with regulating the phosphorylation of AKT. However, this one-wave infection 
model provides little insight into the cause and/or mechanism behind these T3SS dependent 
alterations. Whilst these subtle T3SS dependent differences may reflect an inhibitory 
mechanism, it was predicted these findings were likely caused by an unsynchronised (one-
wave) infection strategy, resulting in variable populations of cells at early time points with 
sufficient cell-adherent bacteria to interfere with AKT phosphorylation. 
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Figure 40 EPEC induces the transient localisation of AKT (isoforms 1, 2 & 3) to the 
membrane.  
J774A.1 macrophages were left uninfected (0) or infected (MOI 200:1) with the pre-activated 
WT EPEC or T3SS mutant (cfm-14) strains. Cells were washed after 15, 30, 60, 90 and 120 
min of infection and J774A.1 macrophages fractionated into host cytosolic and membrane 
proteins. (A & E) Protein samples were separated by SDS-PAGE (10%) for western blot 
analysis, probing for anti-AKT1, anti-AKT2, anti-AKT3 and anti-Actin (loading control) 
antibodies. Western blots represent a single experiment, with immunoblots (where 
appropriate) cropped and moved for presentation purposes, indicated by a dashed line. (B, 
C, D, F, G & H) Densitometry analysis of western blots was performed using ImageLab 
software, with values representing a fold change in AKT1, AKT2 or AKT3 signals, normalised 
to Actin (loading control) and calculated as a relative change to uninfected (0) cells. 
 
  Chapter 5 Results III 
 153 
 
 
Chapter 5 Results III 
 154 
Figure 41 EPEC induces subtle T3SS dependent changes in the localisation of 
phosphorylated PDK1 (Ser241) and PTEN (Ser380).  
J774A.1 macrophages were left uninfected (0) or infected (MOI 200:1) with the pre-activated 
WT EPEC strain or T3SS mutant (cfm-14). Cells were washed after 15, 30, 60, 90 and 120 min 
of infection and J774A.1 macrophages fractionated into host cytosolic and membrane 
proteins. (A & D) Protein samples were separated by SDS-PAGE (10%) for western blot 
analysis, probing for anti-p-PDK1ser241, anti-p-PTENser380 and anti-Actin (loading control) 
antibodies. Western blots represent a single experiment, with immunoblots (where 
appropriate) cropped and moved for presentation purposes, indicated by a dashed line. (B, 
C, E & F) Densitometry analysis of western blots was performed using ImageLab software, 
with values representing a fold change in p-PDK1ser241 or p-PTENser380 signals, normalised to 
Actin (loading control) and calculated as a relative change to uninfected (0) cells.  
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5.2.2 EPEC induced loss of phosphorylated AKT is not readily reversible in a 
fractionated two-wave infection model 
To overcome the limitations of a one-wave infection model, this study switched to a two-
wave infection strategy. This strategy examines the ability of cells pre-infected with EPEC to 
phosphorylate AKT in response to a second-wave infection with the T3SS mutant (cfm-14). 
Thus, J774A.1 macrophages were left uninfected or infected with pre-activated EPEC strains 
(WT EPEC, cfm-14 or quad [lacking LEE encoded Map, EspF, Tir & Intimin] mutant) at an 
MOI of 200:1 for 1 h. After infection, cells were washed and then treated with gentamicin 
(kill extracellular bacteria) for 1 h, before leaving cells to recover in fresh cell culture media 
for 1 h. Post recovery, cells were then left uninfected or infected with the T3SS mutant (cfm-
14) for 15, 30 and 60 min at an MOI of 100:1 to trigger AKT phosphorylation. Cell extracts 
were isolated after treatment with gentamicin/recovery (1st wave) and after a second 
infection with the cfm-14 strain (2nd wave). As described earlier, cell extracts were then 
fractionated into cytosolic and membrane fractions for western blot analysis (Kenny et al., 
1997; Kenny, 1999; Warawa and Kenny, 2001). 
As expected, analysis of the first-wave infection (post gentamicin/recovery) with the T3SS 
mutant (cfm-14), but not the WT EPEC or quad strain, revealed the robust increase of 
phosphorylated AKT (Ser473 & Thr308) above the level of uninfected control in the cytosolic 
fraction (Figure 42A-C). Furthermore, subsequent challenge with the cfm-14 mutant (2nd 
wave) induced the significant time dependent increase of phosphorylated AKT (Ser473 & 
Thr308) in cells pre-infected with the T3SS mutant (cfm-14), but not the WT EPEC or quad 
strain (Figure 42A-C). Similar results were evident in the membrane fraction for cells pre-
infected T3SS mutant (cfm-14) or WT EPEC strain as part of a first-wave and second-wave 
infection strategy (Figure 42D-F). However, in contrast to the cytosolic fraction, cells pre-
infected with the quad mutant revealed an increase in the levels of membrane p-AKTThr308, 
but not p-AKTSer473, after the first-wave (post gentamicin/recovery) and second-wave (cfm-
14) infections (Figure 42D-F). Though not statistically significant, this increase of membrane 
p-AKTThr308 signal after infection with the quad mutant was similar to that induced in cells 
pre-infected with the T3SS mutant (cfm-14). Whilst not verified statistically, it is also 
interesting to note the detection of phosphorylated AKT (Ser473 & Thr308) was notably 
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greater in the cytosol than membrane fraction following infection with all strains, with the 
levels of p-AKTSer473 typically higher than that of p-AKTThr308 (Figure 42). 
Fractionation of host cells into cytoplasmic and membrane proteins were examined by 
probing for the host cytosolic protein lactate dehydrogenase (LDH) and the insertion 
modification of the EPEC effector Tir (T’’) into the host cell membrane (Warawa and Kenny, 
2001). As expected, greater levels of LDH were detected in the cytosolic fraction of all 
samples (Figure 42A & Figure 42D), whilst detection of the host kinase modified form of Tir 
(T’’) was primarily detected in the membrane fraction of WT EPEC infected cells only (Figure 
42D & Figure 42A). EPEC strain genotype was supported by the absence of Tir (quad), 
detection of the unmodified form of Tir (T0; cfm-14) or the host modified form of Tir (T’’; WT 
EPEC) in samples from infected cells (Figure 42A & Figure 42D). 
This work reveals that EPEC infection can prevent AKT phosphorylation in a T3SS dependent 
manner, which is stable for up to 3 h (time between 1st & 2nd wave infections) and thus not 
readily reversible. Furthermore, these findings show that EPEC effectors Map, EspF, Tir and 
the outer membrane protein Intimin do not play a role in the loss of p-AKTSer473 signal 
(cytosolic & membrane), though may be necessary to prevent/decrease the levels of p-
AKTThr308 at the membrane. Taken together, this work supports the development of a robust 
two-wave (fractionated) infection model to examine the T3SS dependent loss of 
phosphorylated AKT. 
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Figure 42 EPEC pre-infection inhibits cfm-14 induced AKT phosphorylation in a T3SS 
dependent manner in a two-wave infection model.  
J774A.1 macrophages were left uninfected (Ctrl) or infected (MOI 200:1) for 1 h with the 
pre-activated WT EPEC, Δquad (lacking LEE genes map, espF, tir & eae [Intimin]) or the T3SS 
mutant (cfm-14) strains. Cells were washed to remove non-adherent bacteria before 
treating with gentamicin [100µg/ml] for 1 h (kill extracellular bacteria), followed by a second 
wash step and final incubation in fresh DMEM for 1 h to allow for cell recovery. Post 
recovery, cells were left uninfected or infected with the cfm-14 strain (2nd infection; MOI 
100:1) for 15, 30 and 60 min. Cell extracts were isolated after the first-wave infection (‘-‘; 
post gentamicin treatment & recovery) or following a second-wave infection with the cfm-14 
strain. (A & D) J774A.1 macrophages were fractionated into cytosolic and membrane 
proteins, before separating by SDS-PAGE (10%) for western blot analysis; probing for anti-p-
AKTThr308, anti-p-AKTser241, anti-Tir (membrane marker), anti-LDH (cytosolic marker) and anti-
Actin (loading control) antibodies. Host kinase mediated modification of Tir, dependent on 
its T3SS delivery into host cells, is indicated by an apparent increase in molecular mass from 
its unmodified (T0) to its fully modified form (T’’) (Kenny et al., 1997). Where appropriate, 
immunoblots were cropped and moved for presentation purposes, indicated by a dashed 
line. (B, C, E & F) Densitometry analysis of western blot was performed using ImageLab 
software, with values representing a fold change in p-AKTser241 or p-AKTThr308 signals, 
normalised to Actin (loading control) and calculated as a relative change to uninfected (Ctrl) 
cells. Quantification data are from a minimum of three independent experiments, with 
values shown being the mean ± SD. Statistical analysis was performed by two-way ANOVA 
followed by Dunnett’s post-test for comparison against uninfected control cells (Ctrl; 
****p<0.0001, ***p<0.001, **P<0.01 and *p<0.05).  
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5.2.3 EPEC infection does not decrease AKT membrane localisation 
To examine if the capacity of EPEC to prevent AKT phosphorylation (Ser473 & Thr308) in a 
T3SS dependent manner was due to a decrease in the localisation of AKT to the membrane, 
cell extracts were probed for the AKT isoforms 1, 2 and 3. Analysis of the cytosolic fractions 
revealed the robust detection AKT isoforms 1, 2 and 3 in uninfected cells, with no notable 
change after the first-wave infection (post gentamicin/recovery) with the cfm-14, WT EPEC 
or quad mutant; or following a second-wave infection with the cfm-14 strain (Figure 43A-
D). Though not immediately obvious by western blot analysis, quantification of cytosolic 
AKT2 revealed a small but significant decrease in levels for cells pre-infected with the WT 
EPEC, quad and T3SS mutant (cfm-14), stimulated after a second infection with the cfm-14 
strain (2nd wave; Figure 43C). 
Similar to the cytosolic fraction, detection of AKT1 and AKT2 was largely unaltered from 
background levels in membrane extract after the first-wave infection (post 
gentamicin/recovery) with the cfm-14, WT EPEC or quad mutant; or following a second 
infection with the cfm-14 strain (2nd wave; Figure 43E-H). However, infection with the cfm-
14, WT EPEC or quad mutant (1st wave infection; post gentamicin/recovery) was associated 
with the increase of AKT3 at the membrane, though not always statistically significant 
(Figure 43H). Interestingly, this increase of AKT3 was sustained after a second infection with 
the cfm-14 strain (2nd wave) in cells pre-infected with the WT EPEC and quad strain. Whilst 
this increase in AKT3 signal was also evident for cells pre-infected with the T3SS mutant 
(cfm-14) this was not supported to be statistically significant by quantification (Figure 43H). 
These findings suggest that EPEC infection does not prevent AKT (isoforms 1, 2 & 3) 
localisation to the membrane fraction in a T3SS dependent manner. This implies that the 
capacity of EPEC to prevent AKT phosphorylation (Ser473 & Thr308) is likely mediated by an 
alternate mechanism. In addition, this work suggests that increased AKT phosphorylation in 
T3SS mutant (cfm-14) pre-infected cells, stimulated by second-wave infection (cfm-14), may 
be linked to the increase of AKT3 at the membrane. 
 
Chapter 5 Results III 
 160 
 
 
  Chapter 5 Results III 
 161 
 
 
Chapter 5 Results III 
 162 
Figure 43 The localisation of AKT (isoforms 1, 2 & 3) is not significantly disrupted by EPEC 
infection in a T3SS dependent manner.  
J774A.1 macrophages were left uninfected (Ctrl) or infected (MOI 200:1) for 1 h with the 
pre-activated WT EPEC, Δquad (lacking LEE genes map, espF, tir & eae [Intimin]) or the T3SS 
mutant (cfm-14) strains. Cells were washed to remove non-adherent bacteria before 
treating with gentamicin [100µg/ml] for 1 h (kill extracellular bacteria), followed by a second 
wash step and final incubation in fresh DMEM for 1 h to allow for cell recovery. Post 
recovery, cells were left uninfected or infected with the cfm-14 strain (2nd infection; MOI 
100:1) for 15, 30 and 60 min. Cell extracts were isolated after the first-wave infection (‘-‘; 
post gentamicin treatment & recovery) or following a second-wave infection with the cfm-14 
strain. (A & E) J774A.1 macrophages were fractionated into cytosolic and membrane 
proteins, before separating by SDS-PAGE (10%) for western blot analysis; probing for anti-
AKT1, anti-AKT2, anti-AKT3 and anti-Actin (loading control) antibodies. Where appropriate, 
immunoblots were cropped and moved for presentation purposes, indicated by a dashed 
line. (B, C, D, F, G & H) Densitometry analysis of western blot was performed using ImageLab 
software, with values representing a fold change in AKT1, AKT2 or AKT3 signals, normalised 
to Actin (loading control) and calculated as a relative change to uninfected (Ctrl) cells. 
Quantification data are from a minimum of three independent experiments, with values 
shown being the mean ± SD. Statistical analysis was performed by two-way ANOVA followed 
by Dunnett’s post-test for comparison against uninfected control cells (Ctrl; **P<0.01 and 
*p<0.05). 
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5.2.4 The T3SS dependent inhibition of phosphorylated AKT is not linked to 
notable differences in the localisation of phosphorylated PDK1 (Ser241) or 
PTEN (Ser380) 
As discussed earlier, AKT phosphorylation at Thr308 is regulated by the kinase PDK1 (Alessi 
et al., 1997b). This phosphorylation is antagonised by the phosphoinositide phosphatase 
PTEN, converting PI[3,4,5]P3 to PI[4,5]P2 and thus preventing co-localisation of AKT and 
PDK1 at the membrane (Leslie et al., 2001; Hers et al., 2011). To investigate whether the 
T3SS dependent inhibition of AKT phosphorylation is linked to T3SS dependent changes in 
the phosphorylation associated activation of PDK1 (Ser214) or the inhibition of PTEN 
(Ser380), cell extracts were probed for p-PDK1Ser214 and p-PTENSer380 (Casamayor et al., 1999; 
Hopkins et al., 2014). 
Examining the cytosolic extract revealed very little notable change in the levels of p-
PDK1Ser214 or p-PTENSer380 from that of uninfected control after infection (1st wave post 
gentamicin/recovery) with the WT EPEC, quad or T3SS mutant (cfm-14; Figure 44A-C). 
Furthermore, this level of p-PDK1Ser214 or p-PTENSer380 was largely maintained after a second-
wave infection with the cfm-14 strain (2nd wave; Figure 44A-C). However, quantification 
analysis did reveal a small but significant decrease in levels of cytosolic p-PDK1Ser214 after this 
second wave infection for cells pre-infected with the WT EPEC (15 & 30 min post 2nd 
infection) and quad (15 min post 2nd infection) strain (Figure 44B). In contrast, analysis of 
the membrane fraction revealed a small, though rarely significant, increase of p-PDK1Ser214 
and p-PTENSer380 in cells pre-infected with the WT EPEC, quad or T3SS mutant (cfm-14; 1st 
wave infections); and following a second infection with the cfm-14 strain (2nd wave; Figure 
44D-F). 
This work suggests there are no notable T3SS dependent changes in the level or subcellular 
localisation of p-PDK1Ser214 (active form) or p-PTENSer380 (inactive form) that may explain the 
T3SS dependent inhibition of AKT phosphorylation induced by second wave infection (cfm-
14). 
 
Chapter 5 Results III 
 164 
 
 
  Chapter 5 Results III 
 165 
Figure 44 EPEC infection does not impact on the localisation or level of phosphorylated 
PDK1 (Ser241) or PTEN (Ser380) in a T3SS dependent manner.  
J774A.1 macrophages were left uninfected (Ctrl) or infected (MOI 200:1) for 1 h with the 
pre-activated WT EPEC, Δquad (lacking LEE genes map, espF, tir & eae [Intimin]) or the T3SS 
mutant (cfm-14) strains. Cells were washed to remove non-adherent bacteria before 
treating with gentamicin [100µg/ml] for 1 h (kill extracellular bacteria), followed by a second 
wash step and final incubation in fresh DMEM for 1 h to allow for cell recovery. Post 
recovery, cells were left uninfected or infected with the cfm-14 strain (2nd infection; MOI 
100:1) for 15, 30 and 60 min. Cell extracts were isolated after the first-wave infection (‘-‘; 
post gentamicin treatment & recovery) or following a second-wave infection with the cfm-14 
strain. (A & D) J774A.1 macrophages were fractionated into cytosolic and membrane 
proteins, before separating by SDS-PAGE (10%) for western blot analysis; probing for anti- p-
PDK1ser241, anti-p-PTENser380 and anti-Actin (loading control) antibodies. Where appropriate, 
immunoblots were cropped and moved for presentation purposes, indicated by a dashed 
line. (B, C, E & F) Densitometry analysis of western blot was performed using ImageLab 
software, with values representing a fold change in p-PDK1ser241 or p-PTENser380 signals, 
normalised to Actin (loading control) and calculated as a relative change to uninfected (Ctrl) 
cells. Quantification data are from a minimum of three independent experiments, with 
values shown being the mean ± SD. Statistical analysis was performed by two-way ANOVA 
followed by Dunnett’s post-test for comparison against uninfected control cells (Ctrl; 
**P<0.01 and *p<0.05). 
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5.2.5 EPEC infection decreases the level of phosphorylated cytosolic c-Raf (Ser259) 
in a T3SS dependent manner 
Once fully active, AKT can phosphorylate a number of downstream targets including c-Raf 
(Ser259) and GSK3 (Ser9) (Manning and Cantley, 2007). To support the capacity of EPEC to 
prevent AKT phosphorylation and thus its activation in a T3SS dependent manner, cell 
extracts were probed for p-c-RafSer259 and p-GSK3Ser9. 
Probing of the cytosolic fractions revealed a notable, though not statistically significant, 
decrease of p-c-RafSer259 and p-GSK3Ser9 after the first-wave infection (post 
gentamicin/recovery) of cells pre-infected with the WT EPEC and quad strain, but not the 
T3SS mutant (cfm-14; Figure 45A-C). Whilst the second-wave infection with the cfm-14 strain 
(2nd wave) was found to induce a modest increase of cytosolic p-c-RafSer259 and p-GSK3Ser9 
in cells pre-infected with the T3SS mutant (cfm-14), this was not the case for WT EPEC or 
quad mutant (Figure 45A-C). Intriguingly, the second-wave infection of cells pre-infected 
with the WT EPEC or quad strain was associated with little change in levels of p-GSK3Ser9, 
yet induced a significant time dependent decrease of p-c-RafSer259 below the level of 
uninfected control (Figure 45B). By contrast, analysis of the membrane fraction of cells 
infected with the WT EPEC, quad or T3SS mutant; as part of a one-wave (post 
gentamicin/recovery) or two-wave infection strategy, revealed little if any T3SS dependent 
differences in the p-c-RafSer259 or p-GSK3Ser9 signals (Figure 45D-F). Quantification analysis 
demonstrates the increase of membrane p-c-RafSer259, but not p-GSK3Ser9, after first-wave 
and second-wave infection of cells pre-infected with the WT EPEC, quad and T3SS mutant 
(Figure 45E-F). 
This work suggests that EPEC infection can prevent, in the cytosol, the increase in 
phosphorylation of downstream AKT substrates p-c-RafSer259 and p-GSK3Ser9 in a T3SS 
dependent manner. Furthermore, the continuing decrease of the p-c-RafSer259 signal in the 
cytoplasmic fractions, during second-wave infections of cells pre-infected with the WT EPEC 
and quad mutant (not cfm-14), may suggest a role for increased protein phosphatase 
activity. However, with some cell detachment evident during two-wave infections (data not 
shown), decreased phosphorylation of c-Raf (Ser259) could indicate the loss of host cell 
viability.  
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Figure 45 EPEC pre-infection inhibits the cfm-14 induced phosphorylation of cytosolic c-Raf 
(Ser259) and GSK3β (ser9) in a T3SS dependent manner.  
J774A.1 macrophages were left uninfected (Ctrl) or infected (MOI 200:1) for 1 h with the 
pre-activated WT EPEC, Δquad (lacking LEE genes map, espF, tir & eae [Intimin]) or the T3SS 
mutant (cfm-14) strains. Cells were washed to remove non-adherent bacteria before 
treating with gentamicin [100µg/ml] for 1 h (kill extracellular bacteria), followed by a second 
wash step and final incubation in fresh DMEM for 1 h to allow for cell recovery. Post 
recovery, cells were left uninfected or infected with the cfm-14 strain (2nd infection; MOI 
100:1) for 15, 30 and 60 min. Cell extracts were isolated after the first-wave infection (‘-‘; 
post gentamicin treatment & recovery) or following a second-wave infection with the cfm-14 
strain. (A & D) J774A.1 macrophages were fractionated into cytosolic and membrane 
proteins, before separating by SDS-PAGE (10%) for western blot analysis; probing for anti-p-
c-Rafser259, anti-p-GSK3βser9 and anti-Actin (loading control) antibodies. Where appropriate, 
immunoblots were cropped and moved for presentation purposes, indicated by a dashed 
line. (B, C, E & F) Densitometry analysis of western blot was performed using ImageLab 
software, with values representing a fold change in p-c-Rafser259 or p-GSK3βser9 signals, 
normalised to Actin (loading control) and calculated as a relative change to uninfected (Ctrl) 
cells. Quantification data are from a minimum of three independent experiments, with 
values shown being the mean ± SD. Statistical analysis was performed by two-way ANOVA 
followed by Dunnett’s post-test for comparison against uninfected control cells (Ctrl; 
**P<0.01 and *p<0.05). 
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5.2.6 Phagocytosis of T3SS mutant (cfm-14) bacteria supports the viability of 
J774A.1 macrophages in the two-wave infection model 
To assess the viability of cells in the two-wave infection model, J774A.1 macrophages were 
examined for their ability to internalise bacteria following a second-wave infection (T3SS 
mutant), compared to a standard one-wave infection protocol. Quitard et al., have shown 
that the capacity of EPEC to inhibit its uptake, through PI3K dependent mechanisms, 
requires the activity of the LEE effector EspF (Quitard et al., 2006). This T3SS dependent 
inhibition of phagocytosis was correlated with the decrease of membrane PI[3,4,5]P3, linked 
to the inhibition of PI3K activity (Celli et al., 2001) and thus upstream of AKT activation 
(Fayard et al., 2005; Vanhaesebroeck et al., 2012). 
Briefly, J774A.1 macrophages were infected with the pre-activated WT EPEC, quad (lacks 
LEE encoded Map, EspF, Tir & Intimin) or T3SS mutant (cfm-14) at an MOI of 100:1 for 1 h. 
Cells were then washed and treated for 1 h with either: 1) chloramphenicol for one-wave 
infections (prevent further effector delivery & enable cell associated bacteria to be fully 
internalised) then fixed; or 2) gentamicin for two-wave infections (kill extracellular bacteria) 
before leaving to recover in fresh cell culture media for 1 h. Two-wave infections were then 
challenged with the GFP expressing T3SS mutant (cfm-14/pGFP) at an MOI of 100:1 for 1 h, 
prior to treating with chloramphenicol (1 h) and fixing cells. The percentage of bacteria 
internalised by the standard one-wave infection protocol was determined by a differential 
fluorescence based antibody assay to label extracellular bacteria (Red) and total bacteria 
(Green). In two-wave infection protocols, second-wave infected bacteria (cfm-14/pGFP) 
were detected by their expression of GFP (Green), with extracellular bacteria identified as 
those labelled Red (antibody labelling) and Green (GFP). 
As reported (Goosney et al., 1999; Celli et al., 2001; Quitard et al., 2006), infection with the 
T3SS mutant (cfm-14) led to significantly greater number of cell-associated bacteria being 
internalised than that of the WT EPEC strain (74.9 ± 1.7% & 35 ± 6.2% respectively; p<0.001; 
Figure 46). Furthermore, infection with the quad mutant, lacking the EspF effector, 
revealed a similar high percentage of internalised bacteria (62.9 ± 1.9%; p<0.001; Figure 46). 
This latter finding was consistent with previous reports indicating a major defect in the 
inhibition of PI3K mediated phagocytosis with the quad mutant (Quitard et al., 2006). 
Importantly, examining the uptake of GFP expressing T3SS mutant (cfm-14/pGFP) in cells 
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pre-infected with the WT EPEC (30.2 ± 1.6), cfm-14 (74.9 ± 1.7%) or quad (62.9 ± 1.9%) 
strain demonstrated that the near identical levels of internalised bacteria as identified by 
one-wave infections (Figure 46). These findings revealed that cells pre-infected the T3SS 
(cfm-14) or quad mutants show no defect in internalising second-wave infected (cfm-
14/pGFP) bacteria, thus supporting host cell viability. The uptake of T3SS mutant (cfm-
14/pGFP) bacteria by macrophages pre-infected with WT EPEC further supports host cell 
viability as this relates to internalisation by PI3K independent pathways; not inhibited by 
EPEC (Celli et al., 2001). 
This work supports previous findings demonstrating the inhibition of PI3K mediated 
phagocytosis in a T3SS dependent manner that requires the effector EspF (Goosney et al., 
1999; Celli et al., 2001; Quitard et al., 2006; Martinez-Argudo et al., 2007; Tahoun et al., 
2011). Furthermore, this work suggests that pre-infection with the WT EPEC strain can stably 
inhibit the uptake of the T3SS mutant (cfm-14) for up to 3 h (time between 1st & 2nd wave 
infections). The ability of cells pre-infected with the quad and T3SS mutant (cfm-14) to 
internalise cfm-14/pGFP bacteria would imply that that these cells are viable and that PI3K is 
active. Taken together, these findings would suggest the rapid loss of phosphorylated AKT 
(Set473 & Thr308) in WT EPEC or quad mutant pre-infected cells is not due to the loss of 
host cell viability in the two-wave infection model. 
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Figure 46 Internalisation of the EPEC T3SS mutant (cfm-14) supports the viability of EPEC 
pre-infected cells.  
J774A.1 macrophages were infected for 1 h (MOI 100:1) with the pre-activated WT EPEC, 
T3SS mutant (cfm-14) or Δquad (lacking LEE genes map, espF, tir & eae [Intimin]) strain. 
After infection, cells were processed for a single or two-wave infection strategy. Single 
infection; cells were washed and treated with chloramphenicol [25 µg/ml] for 1 h, prior to 
fixing cells in PFA [2.5%]. Co-infection; cells were washed and infection stopped by 1 h 
treatment with gentamicin [100 µg/ml], followed by a 1 h recovery period in fresh DMEM 
and a second infection with the pre-activated cfm-14/pGFP strain for 1 h (MOI 100:1). After 
infection, cells were washed and treated with chloramphenicol [25 µg/ml] for 1h, prior to 
fixing cells in PFA [2.5%]. Fixed cells were processed for differential immunofluorescence 
antibody labelling, probing for extracellular bacteria (Red) and total cell associated bacteria 
(Green) using anti EPEC antibodies. Two-wave infected (cfm-14/pGFP) bacteria were 
distinguished by their expression of GFP (Green), with extracellular bacteria labelled Red 
(antibody labelling) and distinguished from first-wave infected bacteria by GFP fluorescence 
(Red/Green co-localisation). Total intracellular bacteria was calculated by subtraction of 
extracellular bacteria from total bacteria and calculated as a percentage. Values represent 
the mean ± SD from three independent experiments. Statistical analysis was performed by 
two-way ANOVA followed by Sidak’s post-test *p<0.05, ***p<0.001. 
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5.2.7 Possible role for protein phosphatases in the rapid T3SS dependent decrease 
of phosphorylated AKT 
Serine/Threonine protein phosphatases play an important role in the dephosphorylation of 
AKT. As discussed earlier, protein phosphatases PP2A and PHLPP are recognised to 
selectively dephosphorylate AKT at residues Thr308 and Ser473 respectively (Bayascas and 
Alessi, 2005), with PP1 also reported to antagonise the phosphorylation of both these 
residues (Chen et al., 2005; Thayyullathil et al., 2011). Furthermore, PP1 and PP2A are also 
implicated to dephosphorylate downstream AKT targets p-GSK3βSer9 and p-c-RafSer259 
(Abraham et al., 2000; Jaumot and Hancock, 2001; Hernandez et al., 2010). To investigate 
the requirement for these protein phosphatases to induce the T3SS dependent decrease of 
phosphorylated AKT cells were treated with the potent inhibitor of PP1 and PP2A, Calyculin 
A (Swingle et al., 2007). Thus, J774A.1 macrophages were left untreated or treated with 
Calyculin A (5 & 100 nM) for 1 h, prior to leaving cells uninfected or infected for 15, 60 and 
120 min with the pre-activated T3SS mutant (cfm-14) or WT EPEC strain at an MOI of 200:1, 
with or without inhibitor.  
The infection of untreated cells with the T3SS defective mutant (cfm-14) demonstrated the 
strong increase of phosphorylated AKT (Ser473 & Thr308) above the level of uninfected 
control after 15, 60 and 120 min of infection, with similar results identified in cells pre-
treated with 5 nM Calyculin A (Figure 47A & B). Consistent with the literature (Pozuelo-Rubio 
et al., 2010), treatment of cells with 100 nM Calyculin A led to the dramatic increase of 
phosphorylated AKT (Ser473 & Thr308) in uninfected cells (Figure 47A & B). Furthermore, 
subsequent infection with the T3SS mutant (cfm-14) for 15, 60 and 120 min sustained this 
dramatic increase of phosphorylated AKT (Ser473 & Thr308) above background levels (Figure 
47A & B). By contrast, infection of untreated cells with the WT EPEC strain led to the 
expected short transient increase in AKT phosphorylation (Ser473 & Thr308; Figure 47C & D). 
This increase of phosphorylated AKT was maximal at 15 min, before decreasing rapidly to 
background levels at 60 and 120 min post infection (Figure 47C & D). Furthermore, this WT 
EPEC induced transient increase in phosphorylated AKT (Ser473 & Thr308) was also evident 
in cells pre-treated with 5 nM Calyculin A (Figure 47C & D). Importantly, pre-treatment of 
cells with 100 nM Calyculin A prevented this rapid T3SS dependent decrease of 
phosphorylated AKT, demonstrating the sustained increase of p-AKTSer473 and p-AKTThr308 
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signal after 15, 60 and 120 min with the WT EPEC strain. These results were supported by 
quantification analysis of p-AKTser473 signal, normalised to Actin (loading control) and 
calculated as a relative change to untreated-uninfected cells (Figure 47B & D). As this work is 
from a single experiment, these results were not statistically verified. EPEC strain genotype 
was supported by detection of the host kinase modified form of Tir (T’’) in cells infected with 
the WT EPEC strain (Figure 47C), but not the cfm-14 mutant (Figure 47A), after 60 min of 
infection.  
This work suggests that the capacity of EPEC to induce a rapid T3SS dependent decrease of 
phosphorylated AKT can be inhibited by treatment with Calyculin A (100 nM). This would 
imply that the rapid loss of phosphorylated AKT is caused by the dephosphorylation of AKT 
at Thr308 and Ser473 by a Calyculin A sensitive protein phosphatase, likely PP1 and/or PP2A. 
 
 
Chapter 5 Results III 
 174 
 
Figure 47 EPEC induced T3SS dependent decrease of phosphorylated AKT is inhibited by 
phosphatase inhibitor Calyculin A.  
J774A.1 macrophages were left untreated or treated with Calyculin A (5 or 100 nM) for 1 h, 
prior to leaving cells uninfected (0) or infected with pre-activated T3SS mutant (cfm-14) or 
WT EPEC strain (MOI 200:1). Total cell extracts were isolated (1x SDS sample buffer) after 15, 
60 and 120 min of infection. (A & C) Protein samples were separated by SDS-PAGE (10%) for 
western blot analysis, probing for anti-p-AKTSer473, anti-p-AKTThr308, anti-Tir and anti-Actin 
(loading control) antibodies. Host kinase mediated modification of Tir, dependent on its T3SS 
delivery into host cells, is indicated by an apparent increase in molecular mass from its 
unmodified (T0) to its fully modified form (T’’) (Kenny et al., 1997). Western blots represent a 
single experiment, with immunoblots (where appropriate) cropped and moved for 
presentation purposes. (B & D) Densitometry analysis of western blots was performed using 
ImageLab software, with values representing a fold change in p-AKTSer473 signal, normalised 
to Actin (loading control) and calculated as a relative change to untreated-uninfected cells.  
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5.2.8 The T3SS dependent decrease of phosphorylated AKT is insensitive to the 
treatment of phosphatase inhibitor Okadaic Acid 
To examine the relative roles for PP1 and/or PP2A to induce the rapid T3SS dependent 
decrease of phosphorylated AKT, cells were treated with the phosphatase inhibitor Okadaic 
Acid, which is selective for PP2A over PP1 at low concentrations (≤100 nM) (Chen et al., 
2005; Wiles et al., 2008). Thus, J774A.1 macrophages were left untreated or treated with 
Okadaic Acid (100 & 400 nM) for 1 h, prior to leaving cells uninfected or infected for 15, 60 
and 120 min with the pre-activated T3SS mutant (cfm-14) or WT EPEC strain at an MOI of 
200:1, with or without inhibitor. 
As before, infection of untreated cells with the T3SS mutant (cfm-14) led to a strong increase 
of phosphorylated AKT (Ser473 & Thr308) after 15, 60 and 120 min of infection (Figure 48A 
& B). Although treatment of cells with Okadaic Acid (100 & 400 nM) did not increase 
background levels of p-AKTThr308 or p-AKTSer473, subsequent infection with the T3SS mutant 
(cfm-14) revealed a strong increase of phosphorylated AKT (Ser473 & Thr308), which was 
most dramatic for cells pre-treated with 400 nM Okadaic Acid (Figure 48A & B). In contrast, 
infection of untreated cells with the WT EPEC strain led to the expected short transient 
increase of phosphorylated AKT (Ser473 & Thr308), decreasing to background levels after 60 
min post infection (Figure 48C & D). This T3SS dependent transient increase of 
phosphorylated AKT was also evident in cells pre-treated with Okadaic Acid at 100 and 400 
nM (Figure 48C & D). Intriguingly, whilst pre-treatment of cells with 400 nM Okadaic Acid did 
not prevent the rapid decrease of phosphorylated AKT induced by the WT EPEC strain, p-
AKTser473 levels were notably greater than that of untreated WT EPEC infected controls at 60 
and 120 min post infection (Figure 48C & D). Again, these results were supported by 
quantification analysis of p-AKTser473 signal, normalised to Actin (loading control) and 
calculated as a relative change to untreated-uninfected cells. However, as this work is from a 
single experiment, these results were not statistically verified. EPEC strain genotype was 
supported by the by the detection of modified form of Tir (T’’) in cells infected with the WT 
EPEC strain (Figure 48A), but not cfm-14 mutant (Figure 48C); detected after 60 min of 
infection. 
These findings suggest that although 400 nM Okadaic Acid (lesser extent at 100 nM) can 
reduce the total dephosphorylation of AKT at Thr308 and Ser473, it cannot prevent the rapid 
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T3SS dependent decrease at 60 and 120 min post infection. This would imply that the T3SS 
dependent decrease of phosphorylated AKT is dependent on Calyculin A sensitive but 
Okadaic acid insensitive protein phosphatase, thus arguing against a role for PP1 and/or 
PP2A. 
 
 
Figure 48 Phosphatase inhibitor Okadaic Acid does not prevent the rapid T3SS dependent 
decrease of phosphorylated AKT.  
J774A.1 macrophages were left untreated or treated with Okadaic Acid (100 & 400 nM) for 1 
h, prior to leaving cells uninfected (0) or infected with the pre-activated T3SS mutant (cfm-
14) or WT EPEC strain (MOI 200:1). Total cell extracts were isolated (1x SDS sample buffer) 
after 15, 60 and 120 min of infection. (A & C) Protein samples were separated by SDS-PAGE 
(10%) for western blot analysis, probing for anti-p-AKTSer473, anti-p-AKTThr308, anti-Tir and 
anti-Actin (loading control) antibodies. Host kinase mediated modification of Tir, dependent 
on its T3SS delivery into host cells, is indicated by an apparent increase in molecular mass 
from its unmodified (T0) to its fully modified form (T’’) (Kenny et al., 1997). Western blots 
represent a single experiment, with immunoblots (where appropriate) cropped and moved 
for presentation purposes. (B & D) Densitometry analysis of western blots was performed 
using ImageLab software, with values representing a fold change in p-AKTSer473 signal, 
normalised to Actin (loading control) and calculated as a relative change to untreated-
uninfected cells.  
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5.2.9 Calyculin A can restore AKT phosphorylation in cells pre-infected with EPEC 
Having demonstrated the ability of EPEC to inhibit AKT phosphorylation in a T3SS dependent 
manner, studies were undertaken to examine whether cells pre-infected with EPEC could 
phosphorylate AKT in response to treatment with Calyculin A or following a second-wave 
infection with the T3SS mutant (cfm-14). Thus, J774A.1 macrophages were left uninfected or 
infected with the pre-activated WT EPEC, Δquad or T3SS mutant (cfm-14) at an MOI of 200:1 
for 1 h. Infections were then stopped and cells treated with gentamicin (kill extracellular 
bacteria) and Calycilun A (100 nM) for 1 h, before cells were washed and left to recover in 
fresh cell culture media supplemented with Calyculin A (100 nM) for 1 h. After recovery, all 
cells were infected with the cfm-14 strain at an MOI of 100:1 for 1 h. Total cell extracts were 
isolated and processed for western blot analysis after each stage of the two-wave infection 
assay: post EPEC infection (1st wave), post gentamicin treatment/recovery, and post 
infection with the cfm-14 mutant (2nd wave). In untreated cells, infection with the T3SS 
mutant (cfm-14), but not the WT EPEC or Δquad mutant, led to the strong increase of 
phosphorylated AKT above background levels as expected (Figure 49A). Subsequent 
treatment of cells with gentamicin and Calyculin A induced the dramatic increase in p-
AKTser473 and p-AKTThr308 signals in uninfected cells (Figure 49B). This strong increase of 
phosphorylated AKT (Ser473 & Thr308) was also evident in cells per-infected with the WT 
EPEC, Δquad and T3SS mutant (cfm-14) (Figure 49B). Moreover, the second-wave infection 
with the cfm-14 strain, in the presence of Calcyculin A, led to a further increase of 
phosphorylated AKT in uninfected control, T3SS mutant (cfm-14), WT EPEC and Δquad 
mutant pre-infected cells (Figure 49C). This increase of phosphorylated AKT was notably 
weaker for cells pre-infected with EPEC (WT EPEC, Δquad or cfm-14 strain) than uninfected 
control cells (Figure 49C). These results are supported by quantification analysis of p-
AKTser473 signal normalised to Actin (loading control) and calculated as a relative change to 
uninfected-untreated cells (Figure 49D).  Again, as this work is from a single experiement 
these findings were not statistically verified. EPEC strain genotype was supported by the 
absence (Δquad) or presence (cfm-14 & WT EPEC) of Tir, with the detection of the host 
kinase modified form (T’’) supporting the T3SS dependent delivery of Tir with the WT EPEC 
strain (Figure 49A). Two-wave infection of cells is supported by the strong detection of the 
unmodified form of Tir (T0) in all infected cell extracts (Figure 49C). This work suggests the 
T3SS dependent inhibition of AKT phosphorylation, stimulated by second-wave infection 
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with the T3SS mutant (cfm-14), can be blocked/reversed by treatment of cells with 
phosphatase inhibitor Calyculin A. This finding supports the suggestion that the rapid T3SS 
dependent decrease of phosphorylated AKT is mediated by a Calyculin A sensitive protein 
phosphatase, triggering the dephosphorylation of AKT. 
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Figure 49 Calyculin A induces AKT phosphorylation in EPEC pre-infected macrophages.  
J774A.1 macrophages were left uninfected (Ctrl) or infected (MOI 200:1) with the pre-
activated WT EPEC, Δquad (lacking LEE genes map, espF, tir & eae [Intimin]) or T3SS mutant 
(cfm-14) strains for 1 h. Cells were washed and treated with gentamicin (100 µg/ml; 
bactericidal levels) and Calyculin A (100 nM) for 1 h, prior to a second infection with the cfm-
14 strain (MOI 100:1) in the presence of Calyculin A for 1 h. Total cell extracts isolated (1x 
SDS sample buffer) after the first infection (A), post gentamicin/Calyculin A treatment (B) or 
following a second infection with cfm-14 strain (C). Protein samples were separated by SDS-
PAGE (10%) for western blot analysis, probing for anti-p-AKTSer473, anti-p-AKTThr308, anti-Tir 
and anti-Actin (loading control) antibodies. Host kinase mediated modification of Tir, 
dependent on its T3SS delivery into host cells, is indicated by an apparent increase in 
molecular mass from its unmodified (T0) to its fully modified form (T’’) (Kenny et al., 1997). 
Western blots represent a single experiment, with immunoblots (where appropriate) 
cropped and moved for presentation purposes, indicated by a dashed line. (D) Densitometry 
analysis of western blots was performed using ImageLab software, with values representing 
a fold change in p-AKTser473 signal, normalised to Actin (loading control) and calculated as a 
relative change to untreated-uninfected cells. 
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5.3 Discussion 
EPEC infection induces a rapid T3SS dependent decrease of phosphorylated AKT, though 
little is known about how this occurs. To gain insight into this inhibitory mechanism, this 
study looked to examine the impact of EPEC infection on the phosphorylation of AKT (Ser473 
& Thr308), in addition to the localisation of AKT (isoforms 1, 2 & 3) and key signalling 
associated proteins (p-PDK1Ser241, p-PTENSer380, p-GSK3Ser9 & p-c-RafSer259). This study 
suggests the inhibition of AKT phosphorylation by EPEC is not due to notable T3SS 
dependent changes in localisation of AKT (isoforms 1, 2 & 3), p-PDK1Ser241 (active form) 
and/or p-PTENSer380 (inactive form). However, this study provides evidence to suggest the 
rapid T3SS dependent decrease of phosphorylated AKT (Ser473 & Thr308) is linked to the 
activity of a host activated or bacterial delivered serine/threonine protein phosphatase.  
PI3K conversion of PI[4,5]P2 to PI[3,4,5]P3 at the membrane stimulates the recruitment/co-
localisation of AKT and PDK1 via their respective PH domains, which is crucial to 
phosphorylate AKT at Thr308. AKT is then fully activated by a second phosphorylation step at 
Ser473 before phosphorylating downstream substrates such as GSK3 (Ser9) and c-Raf 
(Ser259), thereby inhibiting their activity. AKT activation can therefore be broken down into 
three critical steps: 1) PI[3,4,5]P3 mediated recruitment to the membrane of AKT and PDK1; 
2) phosphorylation of AKT at Thr308 and Ser473; and 3) dephosphorylation of AKT, thus 
terminating AKT signalling.  
To investigate these possibilities, studies examined the localisation of proteins associated 
with key events in the PI3K-AKT signalling pathway. This was initially investigated using a 
one-wave infection strategy, fractionated into cytosolic and membrane proteins. As 
expected (Yu et al., 2015), this study confirms the expression of all three AKT isoforms in the 
macrophage model, with the majority localised to the cytosolic fraction. Furthermore, this 
work demonstrates for the first time that EPEC infection is associated with the transient 
localisation of all three AKT isoforms to the membrane, consistent with the literature for the 
activation of AKT (Astoul et al., 1999). Importantly, this work supports the infection induced 
increase of AKT phosphorylation, followed by a rapid T3SS dependent decrease to 
background levels. These findings are consistent with those obtained from total cell extracts, 
as reported in literature (Goosney et al., 1999; Celli et al., 2001) and this study (see Chapter 
3 Figure 13). Although this one-wave infection strategy has identified subtle T3SS dependent 
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differences in the localisation of AKT (isoforms 1, 2 & 3), p-PDK1Ser241, p-PTENSer380 and the 
phosphorylation of AKT (Ser473), the mechanism behind these differences could not be 
identified. Due to the unsynchronised infection of the one-wave infection strategy, it was 
speculated that these T3SS dependent differences could stem from variable populations of 
cells, at early time points, having sufficient levels of cell associated bacteria to decrease AKT 
phosphorylation. 
This unsynchronised infection associated issue was circumvented by use of a two-wave 
infection model (Ruchaud-Sparagano et al., 2007). Using this model it was predicted that the 
pre-infection of cells with EPEC would inhibit, in a T3SS dependent manner, inducers of AKT 
phosphorylation, which in this study was stimulated by a second-wave infection with the 
T3SS mutant (cfm-14). Indeed, this was shown to be the case with this study revealing the 
stable inhibition of AKT phosphorylation (Ser473 & Thr308) over a 3 h period (time between 
1st & 2nd wave infection) in cells pre-infected with the WT EPEC, but not the T3SS mutant 
(cfm-14). Importantly, this result corroborates findings identified earlier in total cell extracts 
(see Chapter 3 Figure 19). As expected (Ananthanarayanan et al., 2007), the majority of 
phosphorylated AKT (Ser473 & Thr308) was detected in the cytosolic fraction, supporting the 
cycling of AKT away from the plasma membrane once fully activated. Although the level of 
infection induced phosphorylation of AKT on Ser473 (10-20 fold increase) was notably 
greater than that of Thr308 (5-10-fold increase) in both fractions (cytosolic & membrane), 
though not statistically verified, it is important to note that the p-AKTThr308 signal was found 
to mirror that of p-AKTser473 in cells pre-infected with the WT EPEC or T3SS mutant (cfm-14). 
In contrast to the one-wave infection strategy, the unorthodox two-wave infection model 
did not trigger the transient localisation of AKT (isoforms 1, 2 & 3) to the membrane. 
Although EPEC infection was associated with the increase of AKT3 at the membrane, but not 
AKT1 or AKT2, this was surprisingly linked to the first-wave infection and sustained in 
response to a second-wave (T3SS mutant) infection. It is therefore tempting to speculate 
that the increase of phosphorylated AKT (Ser473 & Thr308) in response to the T3SS mutant 
(cfm-14) in the two-wave infection model is driven by the AKT3 isoform. To confirm this, 
further investigations could examine the two-wave infection induced phosphorylation of 
AKT in macrophages deficient of AKT3 and/or by siRNA knockdown of the AKT3 isoform. If 
confirmed, this model could prove useful to understand how specific AKT isoforms (AKT3) 
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are retained at the membrane following recruitment and why AKT1/2 are not recruited 
following a second-wave infection. 
An interesting observation from the two-wave infection model, for cells pre-infected with 
the quad mutant, was the apparent increase in AKT phosphorylation on Thr308 (membrane 
only), similar to that induced by the T3SS mutant (cfm-14). Surprisingly, this increase of 
membrane p-AKTThr308 signal did not correlate with increased levels of p-AKTser473 at the 
membrane. This suggests that EPEC may interfere with AKT phosphorylation by two distinct 
T3SS dependent mechanisms: 1) inducing the loss of AKT phosphorylation, Ser473/Thr308 in 
the cytosol and Ser473 at the membrane; and 2) inducing the loss of Thr308 phosphorylation 
of AKT at the membrane. This latter finding implicates a role for one or more proteins 
lacking from the quad mutant (Map, Tir, EspF & Intimin) to promote the loss of p-AKTThr308 
signal at the membrane. One possibility could be the recruitment of the inositol 
phosphatase SHIP to the membrane by the EPEC effector Tir (Smith et al., 2010). SHIP is 
known to dephosphorylate membrane PI[3,4,5]P3 to PI[3,4]P2 and thus antagonise the 
localisation and activation of AKT (Liu et al., 1999b; Carver et al., 2000). It is therefore 
tempting to speculate that in the absence of Tir mediated recruitment of SHIP; p-AKTThr308 is 
retained at the membrane, which may prevent its dephosphorylation. 
AKT phosphorylation at Thr308 and Ser473 is reported to increase AKT activity by 100 and 10 
fold respectively (Alessi et al., 1996; Alessi et al., 1997b). Phosphorylated AKT regulates the 
activity of a number of downstream targets, including GSK3 (Ser9) and c-Raf (Ser259), by 
phosphorylation; thus providing an output for AKT activity. This study illustrates, for the first 
time, that increased AKT phosphorylation (Ser473 & Thr308), stimulated by 2nd-wave 
infection in cells pre-infected with the T3SS mutant (cfm-14), is linked to the increase of p-
GSK3Ser9 and p-c-RafSer259 signals. In contrast, cells pre-infected with the WT EPEC or quad 
mutant displayed unaltered levels of cytosolic p-GSK3Ser9 in response to the second wave 
infection, though unexpectedly had significantly reduced levels of p-c-RafSer259 compared to 
first-wave infection controls. Therefore, despite the increase of p-AKTThr308 signal in the 
membrane fraction of quad mutant pre-infected cells, this did not translate to an increase 
in AKT activity as would be expected (Vincent et al., 2011). These findings suggested that the 
decrease in phosphorylated AKT (Ser473 & Thr308) and p-c-RafSer259 signal may be triggered 
by dephosphorylation, possibly through the increased activity of serine/threonine protein 
phosphatases. However, due to notable levels of cell detachment with the WT EPEC and 
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quad mutant in the two-wave infection model (data not shown), it could not be discounted 
that this decrease in phosphorylation was due to the loss of host cell viability. 
It is important to note the well-established detergent based fractionation protocol employed 
in this study separated host proteins into cytosolic and membrane fractions (Kenny et al., 
1997; Kenny, 1999; Warawa and Kenny, 2001). In addition to the plasma membrane, these 
membrane fractions may contain mitochondria, endoplasmic reticulum (ER) and Golgi 
membrane components. Therefore, whether localisation of AKT (isoforms 1, 2 & 3), PDK1 
and PTEN are indeed localised at the host plasma membrane, and not at organelles, remains 
to be determined. However, as AKT signalling associated proteins (AKT, PDK1, PTEN and 
mTORC2) have been identified at the mitochondria and ER, it is possible that AKT activation 
might also occur at these organelles (Antico Arciuch et al., 2009; Boulbes et al., 2011; Betz 
and Hall, 2013). It would therefore be of interest to examine the localisation of AKT 
signalling related proteins by immunofluorescence experiments during EPEC infection. In 
addition, it should be noted that quantification of host membrane proteins by western blot 
analysis were normalised against the loading control Actin; consistent with methods 
reported in the literature (Li et al., 2006; Dasgupta et al., 2015). The suitability of Actin as a 
membrane marker was supported by the reproducibility of the data following the 
normalisation of signals. Nevertheless, as Actin is not exclusively a host membrane protein, 
future work could look to use alternative membrane house keeping protein expressed by 
macrophages, such as the Na+/K+ ATPase (Gaskill et al., 2012). 
EPEC inhibition of PI3K mediated phagocytosis, thus upstream of AKT phosphorylation, is 
linked to the subversive activities of LEE encoded effectors EspB (Iizumi et al., 2007), EspH 
(Dong et al., 2010) and EspF (Quitard et al., 2006; Martinez-Argudo et al., 2007). Studies by 
Quitard et al., were the first to demonstrate that EPEC strains lacking the EspF effector (e.g. 
quad mutant) do not inhibit PI3K mediated phagocytosis (>60% of cell associated bacteria 
internalised), though they can trigger the rapid loss of phosphorylated AKT similar to WT 
EPEC (Quitard et al., 2006). Importantly, these results were corroborated in this study 
revealing the majority cell associated quad (63%) and T3SS mutant (75%) bacteria 
internalised, in contrast to 35% for the WT EPEC strain. Thus, this work supports the 
assertion that EPEC inhibition of PI3K activity is not coupled to the T3SS dependent decrease 
of phosphorylated AKT (Quitard et al., 2006). 
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Using phagocytosis of EPEC as a marker of PI3K activity and cell viability, cells pre-infected 
with EPEC strains were examined for the ability to internalise bacteria in a second-wave 
infection (GFP expressing T3SS mutant, cfm-14). This study demonstrates for the first time 
that cells pre-infected with the WT EPEC, but not quad or T3SS mutant (cfm-14), inhibited 
the uptake of bacteria by the second wave infection, with <35% of cell-associated bacteria 
(cfm-14/pGFP) shown to be internalised. These findings demonstrated four things: 1) EPEC 
inhibition of PI3K mediated phagocytosis is stable for up to 3 h (time between 1st & 2nd wave 
infection); 2) PI3K is active in cells pre-infected with the quad or T3SS mutant (cfm-14); 3) 
cells pre-infected with the quad mutant are healthy as capable of internalising second-
wave infected (cfm-14) bacteria by PI3K dependent and independent mechanisms; and 4) 
cells pre-infected with EPEC are healthy as internalised second-wave infected (cfm-14) 
bacteria by the PI3K independent pathway (≤40% of bacteria internalised). This work 
suggests that EPEC can inhibit the PI3K-AKT signalling pathway at multiple points in a T3SS 
dependent manner and that phosphorylation on Thr308 can be used as a marker of PI3K 
activity in this infection model (Vincent et al., 2011). Furthermore, this work argues that the 
decrease in phosphorylated AKT (Ser473 & Thr308) and the downstream substrate p-c-
RafSer259, in cells pre-infected with the WT EPEC and quad mutant (membrane &/or 
cytosolic), is not due to the loss of cell viability. Taken together, these findings suggest the 
decrease in phosphorylated AKT (Ser473 & Thr308) and p-c-RafSer259 is likely driven by an 
increase in serine/threonine protein phosphatase activity.  
Protein phosphatases, PP1 and PP2A, are estimated to account for more than 90% of the 
total cellular serine/threonine dephosphorylation events (Faux and Scott, 1996; Sim and 
Ludowyke, 2002). PP1 is implicated to play a key role in the dephosphorylation of p-
GSK3Ser9 (Hernandez et al., 2010), which in addition to PP2A also regulates the 
phosphorylation p-c-RafSer259 (Abraham et al., 2000; Jaumot and Hancock, 2001). 
Furthermore, both PP1 and PP2A, along with the phosphatase PHLPP, are also recognised to 
dephosphorylate AKT at residues Ser473 and/or Thr308 (Andjelkovic et al., 1996; Chen et al., 
2005). The requirement for phosphatases PP1 and/or PP2A to trigger the rapid T3SS 
dependent decrease of phosphorylated AKT was investigated in this study using the selective 
phosphatase inhibitors Okadaic acid (PP2A selective at low concentrations; 100 nM) and 
Calyculin A (PP1 and PP2A selective) (Chen et al., 2005; Wiles et al., 2008). This study 
demonstrates for the first time that pre-treatment of cells with Calyculin A (100 nM), but not 
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Okadaic acid (100 or 400 nM), can prevent the rapid T3SS dependent decrease of 
phosphorylated AKT (Ser473 & Thr308) in WT EPEC infected cells. Moreover, this study 
demonstrates for the first time that the T3SS dependent inhibitory mechanism that rapidly 
decreases infection induced AKT phosphorylation can be blocked/reversed by treatment 
with Calyculin A (100 nM) in cells pre-infected with the WT EPEC or quad mutant. Thus, 
these findings suggest a key role for a Calyculin A sensitive, but Okadaic Acid insensitive, 
protein phosphatase to trigger the rapid T3SS dependent decrease of phosphorylated AKT 
(Ser473 & Thr308).  
Inhibition of the T3SS dependent dephosphorylation of AKT in WT EPEC infected cell extracts 
treated with Calyculin A, but not Okadaic Acid (PP2A selective at 100 nM), would suggest a 
role for the protein phosphatase PP1, but not PP2A (Favre et al., 1997). However, the 
apparent inability of Okadaic acid at the highest concentration examined (400 nM; PP1 & 
PP2A selective) to inhibit the T3SS dependent decrease of phosphorylated AKT would argue 
against this assumption. Whilst it might be tempting to suggest Okadaic Acid did not work in 
this study, treatment at 400 nM was found to increase the levels of phosphorylated AKT in 
T3SS mutant (cfm-14) infected cells. Though, as these findings using inhibitors Calyculin A 
and Okadaic Acid were from a single experiment, caution should be taken with these 
interpretations requiring additional experiments to confirm these results.   
Importantly, Calyculin A is also reported to inhibit protein phosphatases PP4, PP5 and PP6 at 
differing concentrations (Cohen, 1997; Swingle et al., 2007). Whether these phosphatases 
play a critical role in the T3SS dependent dephosphorylation of AKT cannot be excluded from 
this study. To better address the requirement for PP1, PP2A and/or other phosphatases, 
additional studies could examine the impact of other commercially available phosphatase 
inhibitors, including Tautomycin (PP1 selective), Cantharidin (PP2A selective) and Fostriecin 
(PP2A & PP4 selective). Alternatively this could be investigated through siRNA knockdown of 
the catalytic subunits of PP1 (isoforms 1, 2, , 1 & 2), PP2A (isoforms  & ) and/or 
other protein phosphatases (Wang et al., 2008). How EPEC might trigger the increase in 
activity of Calyculin A sensitive protein phosphatase(s) is not entirely clear. Moreover, it 
cannot be discounted that the increase in phosphatase activity is due to a translocated EPEC 
effector with protein phosphatase function. 
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It should be noted that in our J774A.1 macrophage cell model, Calyculin A at 100 nM was 
found to induce the dramatic increase in AKT phosphorylation in uninfected cells. It is 
therefore concieveable that in our assay this overwhelming inhibitor-induced stimulation of 
AKT phosphortylation may simply be masking the EPEC induced rapid decline of 
phosphorylated AKT. This could be due to oversaturation of the p-AKTSer473 signal or, though 
unlikely, that Calyculin A induced AKT phosphorylation is inaccessible to EPEC-induced 
dephosphorylation. Although our findings are consistent with the hypothesis for the 
requirement of a protein phosphatase, additional work is required to corroborate our 
findings and provide more conclusive evidence towards the role for a Calyculin A sensitive 
protein phosphatase. 
In summary, this study has provided valuable insight into the inhibitory mechanism 
employed by EPEC to induce the rapid T3SS dependent decrease of phosphorylated AKT. 
Whilst EPEC is recognised to subvert PI3K activity and PI[3,4,5]P3 availability (Celli et al., 
2001; Quitard et al., 2006; Sason et al., 2009), this study suggests that the loss of 
phosphorylated AKT is not caused by T3SS dependent changes in membrane localisation for 
AKT (isoform 1, 2 & 3), PDK1ser241 and/or p-PTENser380. Importantly, this study proposes a 
mechanism whereby EPEC rapidly decreases infection induced AKT phosphorylation by 
introducing or activating a Calyculin A sensitive protein phosphatase.  
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Studying pathogenic bacteria, such as EPEC, has provided a valuable insight into the 
mammalian signalling pathways disrupted during infection, including those of inflammation 
and pro-survival signalling (Krachler et al., 2011; Alto and Orth, 2012; Clements et al., 2012). 
The capacity of EPEC to subvert these signalling cascades is dependent on the T3SS, critical 
for the translocation of up to 24 proven effector proteins (Dean and Kenny, 2009; Iguchi et 
al., 2009; Deng et al., 2012). The ability of EPEC to disrupt the PI3K-AKT signalling pathway 
has previously been described, though how precisely EPEC subverts AKT activity is unknown. 
The aim of this project was to investigate the virulent mechanism(s) and bacterial factor(s) 
necessary for EPEC to trigger the rapid decrease of phosphorylated AKT. This study provides 
novel information to suggest the capacity of EPEC to inhibit AKT phosphorylation is stable, 
involving multiple mechanisms and linked to the increased activity of protein 
phosphatase(s); pathogen delivered or host activated. Although the effectors responsible for 
the inhibition of AKT phosphorylation were not identified, this study discounts a key role for 
up to 21 of 24 published EPEC effector proteins. Thus, this work implicates a role for 
unexamined effectors (LifA, NleJ & EspC), 6 experimentally supported effectors (identified by 
bioinformatics; Dean et al., unpublished), and/or EPEC effectors not yet identified. 
Importantly, this study suggests the decline of phosphorylated AKT by unknown effector(s) 
is/are likely dependent on the LEE encoded chaperone, CesT.  
Previous studies examining the ability of EPEC to trigger the rapid decline of phosphorylated 
AKT have been limited, with the majority of work undertaken in a macrophage cell model 
(Celli et al., 2001; Quitard et al., 2006). In these studies, the capacity of EPEC to both 
stimulate and decrease AKT phosphorylation in a PI3K dependent manner was reported, 
illustrating a characteristic T3SS-dependent transient increase in AKT phosphorylation over a 
90 min infection period (Celli et al., 2001; Quitard et al., 2006). These observations were 
made by non-quantitative western blot analysis for the phosphorylation of AKT at Ser473, 
but not Thr308; the latter representing the first step in AKT activation by PDK1 (Alessi et al., 
1996; Alessi et al., 1997b). Moreover, these interpretations were made from infected total 
cell extracts and provided little insight into the mechanism(s) behind this inhibitory process. 
This study has employed a number of different strategies to investigate the mechanism(s) 
responsible for the T3SS-dependent decrease in phosphorylated AKT. Using a quantitative 
approach, this study examined for the first time the impact of EPEC infection on AKT 
phosphorylation at Ser473 and Thr308; and reported on the activity of AKT by assessing its 
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ability to phosphorylate downstream targets c-Raf and GSK3. Through the development of 
a two-wave infected fractionated macrophage cell model this work has uncovered 
previously unrecognised T3SS-dependent changes in the membrane localisation and 
phosphorylation of AKT. Furthermore, by examining the impact of EPEC infection using a 
single and two-wave infection strategy this study has revealed that the T3SS-dependent 
inhibition of AKT phosphorylation is stable and not readily reversible for up to 3 h post-
infection, implicating an inhibitory mechanism involving a host activated or bacterial 
delivered serine/threonine protein phosphatase. Thus, this work has significantly extended 
previous observations, providing greater insight into the disruptive capacity of EPEC on AKT 
activity. 
The work presented in this study suggests the capacity of EPEC to inhibit phosphorylation-
associated activation of AKT is not linked to T3SS-dependent changes in the membrane 
localisation of AKT (isoforms 1, 2 & 3) or key associated signalling proteins (PDK1 & PTEN). 
Instead, this study suggests the rapid dephosphorylation of AKT is linked to the activity of 
serine/threonine protein phosphatase(s); either bacterial delivered or host activated. This 
was supported using two-wave infection models, revealing a rapid T3SS-dependent decrease 
of phosphorylated AKT (Ser473 & Thr308) and cytosolic c-Raf (Ser259) in EPEC infected cells. 
These findings were corroborated by phosphatase inhibitor data, revealing the inhibition of 
EPEC-induced T3SS-dependent decrease of phosphorylated AKT after treatment with 
Calyculin A. However, since this latter result is from a single experiment, additional work is 
required to confirm these observations. Moreover, since protein phosphatase activity was 
not measured directly during EPEC infection, future experiments could look to examine this 
using commercially available phosphatase assay kits. In addition, it would be interesting to 
examine the impact of EPEC infection on cells transfected with constitutively active forms of 
AKT such as m/p-AKT and ΔPH-AKT. m/p-AKT possesses a myristoylation signal that enables 
PI[3,4,5]P3 independent membrane translocation, resulting in AKT hyper activation 
(Andjelkovic et al., 1997), whilst ΔPH-AKT lacks the PH domain resulting in an altered 
conformation that exposes the Thr308 residue thus enabling cytosolic ΔPH-AKT to be 
phosphorylated by PDK1 (Alessi et al., 1997a). The prediction would be that EPEC infection 
should lead to the decreased phosphorylation of these constitutively active and 
phosphorylated forms of AKT. Such studies could lend support to the findings of a protein 
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phosphatase-mediated T3SS-dependent decrease of phosphorylated AKT, which is not due 
to a defect in membrane recruitment of AKT. 
Protein phosphatases PP1 and PP2A regulate the activity of almost two thirds of the >500 
kinases encoded in the human genome, accounting for 90% of total eukaryotic 
dephosphorylation events. The regulation of these protein phosphatases is highly complex. 
PP1 and PP2A are composed of a catalytic subunit bound to one or more regulatory subunits 
which regulate their subcellular localisation, catalytic activity and substrate specificity 
(Cohen, 2002; Sim and Ludowyke, 2002; Shi, 2009). Furthermore, these catalytic and 
regulatory subunits are also regulated by post-translational modifications such as 
phosphorylation and methylation (Sim and Ludowyke, 2002). Thus, how EPEC might 
precisely regulate/increase the activity of host phosphatases to dephosphorylate AKT is not 
entirely clear.  
It is becoming increasingly recognised that pathogenic bacteria target the PI3K/AKT 
signalling pathway as an important step to establishing an infection, with most bacteria 
associated with AKT activation and only a few linked to AKT dephosphorylation. For 
example, secretion of the pore-forming toxin HlyA by uropathogenic E. coli (UPEC) is 
reported to inhibit AKT phosphorylation at residues Ser473 and Thr308 (Wiles et al., 2008). 
Moreover, other pore forming toxins including aerolysin and -toxin have also been shown 
to inhibit AKT phosphorylation (Wiles et al., 2008). Although the mechanism behind this 
inhibition remains to be defined, Wiles et al., have identified a critical role for phosphatases 
PP1 and PP2A (Wiles et al., 2008). This seemingly aberrant activation of protein 
phosphatases was linked to a toxin-induced increase of osmotic stress in target cells. Indeed, 
osmotic stress has been shown to decrease AKT phosphorylation through the activation of 
protein phosphatases (Parrott and Templeton, 1999; Plescher et al., 2015). Although EPEC 
does not encode a homologous pore-forming toxin, EPEC can induce pore formation by the 
secretion of effectors EspB and EspD. It was therefore speculated that EPEC might trigger 
AKT dephosphorylation by a similar mechanism. However, infection of J774A.1 macrophages 
with the EPEC strain TOEA7∆core::km, which has a functional T3SS and translocon for 
effector delivery, did not trigger the decline of phosphorylated AKT. Furthermore, treatment 
of cells with dextran (Mr ~100,000 & ~20,000), which is known to block EspB/EspD 
membrane pores thus limiting osmotic stress (Ide et al., 2001; Wiles et al., 2008), did not 
prevent the rapid T3SS-dependent decrease of p-AKTser473 signal (data not shown). Taken 
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together, this would argue against a role for EspB/EspD pore formation and osmotic stress in 
the rapid decline of phosphorylated AKT. 
PP1 and PP2A are implicated in the regulation of phosphorylated AKT (Ser473 & Thr308), 
GSK3β (Ser9) and c-Raf (Ser259). It is therefore significant that inhibition of these 
phosphatases by Calyculin A prevented the rapid decline of phosphorylated AKT induced by 
EPEC infection. However, the inability to reproduce these results using the inhibitor Okadaic 
Acid (PP1 & PP2A selective at concentrations ≥ 100 nM) argued against a role for both these 
phosphatases in the T3SS-dependent dephosphorylation of AKT (Chen et al., 2005; Wiles et 
al., 2008). Importantly, Okadaic Acid treatment did lead to a small increase in EPEC induced 
AKT phosphorylation in J774A.1 macrophages, supporting inhibitor function. Taken together, 
this implied a role for a Calyculin A-sensitive, but Okadaic Acid-insensitive, protein 
phosphatase. However, as both inhibitors are reported to target the same phosphatases 
(PP4, PP5, PP6 & PP7) with similar IC50’s (Swingle et al., 2007), but for PP1 and PP2A, this 
result seems difficult to comprehend. Since Okadaic Acid is significantly (100 fold) less 
permeable than that of the potent phosphatase inhibitor Calyculin A (Favre et al., 1997; 
Herzig and Neumann, 2000), it is tempting to suggest that PP1 and/or PP2A were not fully 
inhibited by Okadaic Acid (at 100 or 400 nM) in this model. This would suggest the need to 
measure PP1 and PP2A activity after treatment with Okadaic acid and Calyculin A. Although 
the data presented are consistent with the role for a protein phosphatase, that is likely 
sensitive to Calyculin A inhibition, it cannot be discounted that this inhibitor at high 
concentrations is simply masking the EPEC-induced decline of phosphorylated AKT. Since 
Calyculin A is able to stimulate AKT phosphorylation at high concentrations (100 nM), 
additional work is required to confirm whether this inhibition of a T3SS dependent decrease 
of phosphorylated AKT is indeed due to the inhibition of protein phosphatases and not 
caused by oversaturation of the p-AKTSer473 signal. Specific targeting of the catalytic 
subunits of protein phosphatases by siRNA could thus provide an alternative and more direct 
method of examining the role of Calyculin A sensitive phosphatase such as PP1, PP2A and/or 
other protein phosphatases in EPEC-induced dephosphorylation of AKT. 
The ability of EPEC to induce the extensive dephosphorylation of host phosphotyrosine 
proteins has previously been identified (Kenny and Finlay, 1997; Goosney et al., 1999; Celli 
et al., 2001; Quitard et al., 2006). Whether this is linked with the rapid dephosphorylation of 
AKT has never been examined, thus it would be interesting to investigate the impact of 
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serine/threonine and tyrosine phosphatase inhibitors on the T3SS-dependent 
dephosphorylation of host proteins such as AKT. One possibility could be that EPEC secretes 
and/or activates a dual specificity phosphatase that targets both tyrosine and 
serine/threonine phosphorylated proteins. Examining the phosphorylation status of 
alternative targets downstream of AKT (e.g. Bad, Bax & FOXO transcription factors) and/or 
all serine/threonine phosphorylated proteins during EPEC infection could provide insight 
into the specificity of the increased phosphatase activity. 
As previously discussed, bacterial manipulation of the host phophoproteome is not 
uncommon, linked to the direct or indirect activity of effector proteins (Rogers et al., 2011; 
Grishin et al., 2015; Scholz et al., 2015). The results of this study suggest that EPEC induced 
rapid dephosphorylation of AKT is either due to an effector with protein phosphatase 
function or caused by the indirect increase of host phosphatase activity. The Yersinia 
effector YopH is one example of an effector with phosphatase function, inducing the 
tyrosine dephosphorylation of several host proteins (Andersson et al., 1996). Indeed, YopH 
has been shown to induce the dephosphorylation of AKT, which is dependent of its tyrosine 
phosphatase activity (Sauvonnet et al., 2002). Whilst previous studies have suggested that 
EPEC does not secrete an effector with Tyrosine phosphatase function, it is important to 
note that these studies only examined secreted EPEC effectors (Goosney et al., 1999). 
Furthermore, these studies did not examine for effectors with serine/threonine phosphatase 
activity (Goosney et al., 1999). To resolve the question of a direct or indirect effector-
mediated increase in phosphatase activity, this study sought to identify the virulent factors 
necessary to trigger the rapid T3SS-dependent decrease of phosphorylated AKT. 
To investigate the requirement for the EPEC effector repertoire, this study examined 
available EPEC strains lacking subsets of LEE and/or Nle effector proteins. The work 
presented in this study demonstrates for the first time that 21 EPEC effectors do not play a 
critical role in the rapid T3SS dependent dephosphorylation of AKT. This collective 
elimination of 21 effectors was achieved by examining the role for 7 LEE and 14 of the most 
studied Nle effectors in isolation, in addition to the recently generated complex EPEC 
effector mutant TOEA7∆core::km (unable to deliver 20 of 24 known EPEC effectors). 
However, whether there exists cooperation between LEE and Nle-encoded effectors to 
induce the rapid decline of phosphorylated AKT cannot be discounted. Whilst this is unlikely, 
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this would suggest the need to examine an EPEC strain lacking the 14 Nle effectors and all 
known LEE effectors, but for the translocation critical effector EspB. 
T3SS effector chaperones CesF and CesT play a critical role in translocation of most EPEC 
effector proteins; implicated to promote effector stabilisation, maintain effector 
conformation suitable for translocation and targeting of the effector to the T3SS apparatus 
(Ghosh, 2004). An intriguing result of this study was the identification of a CesT chaperone 
dependent decrease of infection induced AKT phosphorylation in J774A.1 macrophages. This 
study revealed that infection with CesT deficient strains (∆cesT, ∆core::km, gorf3∆core::km & 
TOEA7∆core::km) displayed a T3SS mutant-like defect in ability to induce a rapid decrease of 
phosphorylated AKT. Crucially, re-introduction of the CesT chaperone - encoded on a 
plasmid - into a tested CesT deficient (∆core::km) mutant restored the capacity of this strain 
to induce the rapid dephosphorylation of AKT. Thus, this work implicated the role for a CesT 
dependent effector to induce AKT dephosphorylation. 
The CesT chaperone is recognised to play a critical role in the efficient translocation of 5 LEE 
(EspH, Map, EspZ, EspF & Tir) and 8 Nle (EspJ, NleG, NleH1, NleH2, NleB1, NleB2, NleC & 
NleA) effector proteins (Thomas et al., 2005; Mills et al., 2008; Mills et al., 2013; Ramu et al., 
2013). Having already discounted the role for 7 LEE and 14 Nle effectors, this suggested the 
requirement for an unknown CesT dependent effector; thus implicating a role for 
unexamined effectors (EspC, LifA & NleJ), 6 experimentally supported effectors (Dean et al., 
unpublished) and/or effectors not yet identified. Whether effectors EspC, LifA and NleJ 
require the CesT chaperone for effector translocation is unknown (Thomas et al., 2007; 
Ramu et al., 2013).  
To date, no function has been reported for the recently identified effector NleJ (Deng et al., 
2012). In contrast, the serine protease auto-transporter of EPEC (SPATE), EspC is reported to 
induce host cell death through degradation of the focal adhesion kinase (FAK) and by 
activation of the mitochondrial apoptotic pathway (Vidal and Navarro-Garcia, 2008; Navarro-
Garcia et al., 2014; Serapio-Palacios and Navarro-Garcia, 2016). Interestingly, LifA 
(lymphocyte inhibitory factor A) is reported to promote EPEC cell attachment, host 
immunosuppression and disruption of epithelial barrier function (Klapproth et al., 2000; 
Babbin et al., 2009; Klapproth, 2010). Indeed, this large multifunctional toxin, of 
approximately 360 kDa, is reported to encode three enzymatic activities: glycosyltransferase, 
protease and aminotransferase. Whether, LifA also possess protein phosphatase activity is 
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an intriguing possibility. To confirm the requirement for one or more of these effectors in 
the dephosphorylation of AKT would require the deletion of these effector genes; ideally 
generating an EPEC strain lacking all LEE and all known Nle effectors. 
EPEC induced host cell toxicity in J774A.1 macrophages was a prominent problem during this 
study; evident in WT EPEC infected cells, which was more prominent for EPEC strains lacking 
the EspZ effector and/or CesT chaperone (critical for EspZ translocation into target cells) 
(Shames et al., 2010; Shames et al., 2011; Roxas et al., 2012). Indeed, EPEC strains lacking 
the CesT chaperone were associated with significant cell detachment, increased cytotoxicity 
and the dramatic loss of phosphorylated AKT by the end of infection (90/120 min post 
infection). Whilst it might be tempting to suggest the T3SS-dependent loss of 
phosphorylated AKT during EPEC infection was due to increased host cell toxicity and loss of 
cell viability in this study, several results would argue against this possibility. These include: 
1) the capacity to restore AKT phosphorylation, stimulated by second-wave infection, in 
EPEC pre-infected cells following treatment with the phosphatase inhibitor Calyculin A; 2) 
the ability of macrophages to internalise the ∆quad mutant by PI3K mediated phagocytosis; 
and 3) the ability of macrophages to internalise WT EPEC by PI3K independent mechanisms 
(<40% internalised) (Celli et al., 2001; Quitard et al., 2006). These latter findings were 
supported by one-wave and two-wave infection strategies. 
Crucially, this toxicity associated loss of phosphorylated AKT was absent in macrophages 
infected with the TOEA7∆core::km mutant (lacks CesT chaperone), inducing a T3SS mutant-
like p-AKTser473 profile. This strain, lacking all published Nle effectors (except EspC, LifA & 
NleJ) and 6 genes of the central ‘core’ LEE region (map, espH, tir, cesT, cesF & eae [Intimin]) 
is thus theoretically unable to express or deliver up to 20 of 24 published EPEC effectors. 
This strain not only supports a critical role for CesT, but also discounts a key role for the EspB 
effector in the T3SS-dependent decrease of phosphorylated AKT. Furthermore, this strain 
suggests that the toxicity-associated decline in phosphorylated AKT is linked to the activity of 
one or more of the 14 Nle effectors lacking from the TOEA7∆core::km mutant. Surprisingly, 
significant infection induced cell detachment was evident after infection with the 
TOEA7∆core::km mutant on HeLa cells, thus highlighting important differences with the 
macrophage cell model. 
The HeLa cell model was developed to circumvent the identified issues of EPEC induced cell 
detachment/toxicity and avoid limitations of poor transfection efficiency in J774A.1 
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macrophages that could limit future investigations. This model could then be used to aid 
identification and characterisation of the EPEC effector(s) required to inhibit AKT 
phosphorylation. Although the HeLa cell model is reportedly more resistant to EPEC induced 
cell detachment (Kenny et al., unpublished), this was found not to be the case using our 
infection protocol; revealing notable levels of EPEC induced cell detachment, which 
increased significantly for strains lacking the EspZ effector and/or CesT chaperone. Due to 
the absence of infection induced AKT phosphorylation in this HeLa cell model, this study 
examined the ability of EPEC to decrease/inhibit EGF stimulated AKT phosphorylation. 
Importantly, infections with EPEC strains failed to reproduce key findings identified in 
J774A.1 macrophages of a CesT dependent decrease of phosphorylated AKT. This 
discrepancy between models was linked to the ability of EPEC to induce the degradation of 
the EGFR, reported to be mediated by EspF (induce EGFR degradation) and EspZ effectors 
(prevents EGFR degradation) (Roxas et al., 2014). Importantly, modification of the EGFR was 
also evident following infection with the TOEA7∆core::km mutant (unable to deliver EspF or 
EspZ effectors), implicating a role for other effectors that alter the EGFR. Whether this 
altered EGFR is indeed functional was not examined in this study. These findings tentatively 
suggest that degradation/modification of the EGFR is responsible for the inhibition of EGF 
induced AKT phosphorylation with TOEA7∆core::km mutant infected cells. However, as this 
is from a single experiment, further work is required to confirm these observations before 
drawing firm conclusions. 
The results of the HeLa cell model therefore suggest three possibilities: 1) EPEC inhibition of 
EGF induced AKT phosphorylation is due to cell death/toxicity; 2) inhibition of EGF triggered 
AKT phosphorylation is due to EPEC induced cleavage of the EGFR; or 3) involves a CesT 
independent mechanism. This latter possibility seems unlikely as this would suggest there 
are two different mechanisms (CesT dependent & CesT independent) which EPEC inhibits 
AKT phosphorylation in HeLa cells and J774A.1 macrophages. To resolve these questions 
would require further development and optimisation of the HeLa cell model. For example, 
studies could transfect the EspZ effector into HeLa cells to prevent EPEC induced toxicity and 
host cell detachment. In addition, studies could look to use a receptor independent 
mechanism for AKT phosphorylation such as transfection of constitutively active forms of 
AKT (m/p-AKT &/or ΔPH-AKT), as discussed earlier. Alternatively, agonists of AKT 
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phosphorylation other than EGF could be used to examine the ability of EPEC to inhibit AKT 
phosphorylation, such as TNFα.  
Although the HeLa cell model in its current form does not seem to be the best model to 
identify the EPEC effectors responsible for inhibiting AKT phosphorylation, this model could 
prove useful for future transfection studies to examine and characterise candidate EPEC 
effectors in isolation. Future work should therefore continue to develop the macrophage 
model, to overcome the identified limitations of increased cell detachment and reported 
poor transfection efficiency, to interrogate the EPEC effectors and mechanism required to 
inhibit infection induced AKT phosphorylation. 
To conclude, this study has provided novel insights into the role of the EPEC effector 
repertoire in the T3SS-dependent decrease of phosphorylated AKT. Furthermore, by 
interrogating the mechanisms regulating AKT activation in the macrophage cell model, this 
study proposes a critical role for a host activated or bacterial delivered protein phosphatase 
to induce the rapid dephosphorylation of AKT. These experiments have set the groundwork 
to enable future studies to identify the virulence factors responsible and uncover its 
mechanism for inhibiting AKT phosphorylation, thus providing insight into the role of AKT 
and protein phosphatases in EPEC induced disease.  
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Appendix Figure 1 EPEC induced decrease of phosphorylated AKT requires a functional 
T3SS.  
(A & B) J774A.1 macrophages were left uninfected (0) or infected (MOI 200:1) with the pre-
activated T3SS mutant CVD452 (ΔsepB) or Class-5 strains. Total cell extracts were was 
isolated (1x SDS sample buffer) at 15, 30, 60, 90 and 120 min post infection. Protein samples 
were separated by SDS-PAGE (10%) for western blot analysis, probing for anti-p-AKTser473, 
anti-Tir and anti-Actin (loading control) antibodies. Host kinase mediated modification of Tir, 
dependent on its T3SS delivery into host cells, is indicated by an apparent increase in 
molecular mass from its unmodified (T0) to its fully modified form (T’’) (Kenny et al., 1997). 
Western blots presented are of a single experiment, with immunoblots (where appropriate) 
cropped and moved for presentation purposes, indicated by a dashed line. 
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Appendix Figure 2 The T3SS dependent decrease of phosphorylated requires translocon 
proteins EspA and EspD.  
(A & B) J774A.1 macrophages were left uninfected (0) or infected (MOI 200:1) with pre-
activated ∆espA (lacks EspA) or ∆espD (lacks EspD) strains. Total cell extracts were was 
isolated (1x SDS sample buffer) at 15, 30, 60, 90 and 120 min post infection. Protein samples 
were separated by SDS-PAGE (10%) for western blot analysis, probing for anti-p-AKTser473, 
anti-Tir and anti-Actin (loading control) antibodies. Host kinase mediated modification of Tir, 
dependent on its T3SS delivery into host cells, is indicated by an apparent increase in 
molecular mass from its unmodified (T0) to its fully modified form (T’’) (Kenny et al., 1997). 
Western blots presented are of a single experiment, with immunoblots (where appropriate) 
cropped and moved for presentation purposes, indicated by a dashed line. 
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Appendix Figure 3 The T3SS dependent decrease of phosphorylated AKT is dependent on 
one or more genes encoded on the central 'core' LEE region.  
(A) J774A.1 macrophages were left uninfected (0) or infected (MOI 200:1) with the pre-
activated gorf3∆core::km (lacking the Nle effector EspG2/Orf3, LEE effector EspG & proteins 
of the central core LEE region [EspH, Map Tir, CesF, CesT & Intimin] strain. Total protein cell 
extracts were isolated (1x SDS sample buffer) at 15, 30, 60, 90 and 120 min post infection. 
Protein samples were separated by SDS-PAGE (10%) for western blot analysis, probing for 
anti-p-AKTser473, anti-Tir and anti-Actin (loading control) antibodies. Host kinase mediated 
modification of Tir, dependent on its T3SS delivery into host cells, is indicated by an 
apparent increase in molecular mass from its unmodified (T0) to its fully modified form (T’’) 
(Kenny et al., 1997). Where appropriate, immunoblots were cropped and moved for 
presentation purposes. (B) Densitometry analysis of western blots was performed using 
ImageLab software, with values representing a fold change in p-AKTser473 signal, normalised 
to Actin (loading control) and calculated as relative change to uninfected control (0) cells. 
Quantification data are from a minimum of three independent experiments, with values 
shown being the mean ± SD. Values for p-AKTser473 levels from WT EPEC infected cell extracts 
are taken from Figure 13. Statistical analysis was performed by two-way ANOVA followed by 
Dunnett’s post-test for comparison against uninfected control cells (****p<0.0001, 
***p<0.001. **p<0.01 and *p<0.05) or by Sidak’s post-test for comparison of values at each 
corresponding time point (####p<0.0001, ###p<0.001, ##p<0.01 and #p<0.05). 
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